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General Introduction1  
 
Amyloid Biology 
Amyloids are distinct proteinaceous fibers 
Amyloids are distinct proteinaceous fibers traditionally associated with many 
human ailments such as neurodegenerative diseases and prion-based encephalopathies. 
Amyloid was first termed by Rudolph Vichow in 1854 to describe the abnormal 
substance in brain tissue stained positively by iodine (reviewed by Sipe and Cohen, 2000). 
Amyloid was derived from the Latin amylum and the Greek amylon since the chemical 
nature of amyloid was thought to be starch-like because it stained with iodine (Sipe and 
Cohen, 2000). Later, amyloid was demonstrated to be protein aggregates with ordered 
structures (Bonar et al., 1969; Glenner et al., 1969; Glenner et al., 1971; Glenner et al., 
1971; Kim et al., 1969; Shirahama and Cohen, 1967). Amyloids could be stained with 
Congo red, displaying an apple-green birefringence when viewed with polarized light 
(Figure 1.1A) (Divry P, 1927). Besides their distinct tinctorial properties, amyloid 
deposits are ordered structures with distinctive filaments as detected by electron 
microscopy (EM) (Figure 1.1B). These fibers are 4-10 nm wide and long unbranched and 
found in various amyloid deposits from different amyloidotic tissues. X-ray diffraction of 
amyloid powders showed that these ordered proteinaceous structures have cross-beta  
 
1 Some part of this chapter is derived from Hammer et al., 2008, J Alzheimers Dis 13, 407-419. 
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sheet structure, in which beta strands are oriented perpendicular to fibril axis (Sunde et al., 
1997). Due to the aggregative properties of amyloidogenic proteins, the amyloid structure 
at atomic level has been difficult to solve. Solid-state NMR and X-ray 
microcrystallography have been successfully used to elucidate the amyloid structure of 
Aβ40 (Figure 1.1C), the fragments of yeast prions Sup35p (Figure 1.1D) and HET-s 
(Figure 1.1E) (Nelson et al., 2005; Petkova et al., 2002; Wasmer et al., 2008). In these 
amyloid structures at atomic resolution, β strands form either β helices by paring two β 
sheets or β solenoid composed of three β sheets perpendicular to their fibril axis (Figure 
1.1C, 1.1D and 1.1E).  
Amyloid diseases 
Amyloid-like fibril aggregates are associated with at least 10 neurodegenerative 
diseases including Alzheimer’s disease, Parkinson’s disease and Huntington’s disease 
(Chiti and Dobson, 2006). Amyloid fibers are also found in certain tissues proposed to be 
associated with more than 20 nonneuropathic amyloidoses in humans (Chiti and Dobson, 
2006). The accumulation of similar amyloid aggregates in these various diseases suggests 
they may share some common etiologies 
To better illustrate amyloid pathology and biogenesis, I will detail the 
biochemical and pathological characteristics of Aβ, arguably the most studied of all 
amyloids. The clinical and neuropathological characteristics of Alzheimer’s disease (AD) 
were first reported by Alois Alzheimer (Alzheimer, 1907). Later, EM analysis identified 
long, unbranched 4-10 nanometer wide fibers to be the core component of these abnormal 
brain lesions (Kidd, 1963; Terry et al., 1964). The Aβ polypeptide was purified from AD 
associated plaques and was determined to be the major protein component of amyloid 
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plaques (Glenner and Wong, 1984; Wischik et al., 1988). Aβ is formed when the amyloid 
precursor protein (APP) is sequentially cleaved by β- and γ-secretases (Haass, 2004). It is 
proposed that APP plays important physiological roles in cell adhesion, neurite outgrowth, 
synaptogenesis and synapse remodeling (Zheng and Koo, 2006), however, the function of 
the Aβ polypeptide is currently unknown. There are two major cleavage products, Aβ40 
and Aβ42 (Hartmann et al., 1997). The primary sequences of Aβ40 and Aβ42 only differ 
in that Aβ42 has 2 additional C-terminal residues, Ile41 and Ala42. Mutations in 
presenilins, a central component of γ-secretase, account for most cases of familial AD. 
These mutations increase the production of Aβ42 in both transfected cells and transgenic 
mice (Citron et al., 1997).  
Several lines of evidence link APP and misfolded Aβ to AD. Firstly, genetic 
evidence links chromosome 21 and familial AD, including missense mutations in the 
APP gene (Cheng et al., 1988; Patterson et al., 1988; St George-Hyslop et al., 1987). 
(Goate et al., 1991). Furthermore, AD like neuropathologies were observed in Down’s 
syndrome (trisomy of chromosome 21) (Masters et al., 1985; Robakis et al., 1987). It is 
plausible that increased APP expression and high Aβ level induces cerebrovascular 
amyloidosis in Down’s syndrome. In 2006, Rovelet-Lecrux et al showed that duplication 
of the APP locus on chromosome 21 in five families with autosomal dominant early-onset 
Alzheimer disease resulting in Aβ accumulation and early-onset Alzheimer disease 
(Rovelet-Lecrux et al., 2006). Secondly, various experimental in vivo models suggest a 
critical role of Aβ in disease development. Overexpression of a carboxyl-terminal 
fragment of APP in pheochromocytoma (PC12) and fibroblast (NIH 3T3) cell lines 
induced degenerative changes. Also overexpression of full-length human APP cDNA 
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caused degenerative changes to post-mitotic neurons (Yankner et al., 1989; Yoshikawa et 
al., 1992). Two different transgenic mouse models that express high level of human 
mutant APP developed many pathological hallmarks of AD (Games et al., 1995; Hsiao et 
al., 1996). Thirdly, there is an overwhelming amount of evidence showing in vitro 
chemically synthesized Aβ peptides are potent neurotoxins (Hartley et al., 1999; Lambert 
et al., 1998; Pike et al., 1991). Collectively, these findings point toward Aβ as the 
mitigating factor in AD development. 
However, the molecular mechanism behind Aβ misfolding and AD development 
remain unclear. Hardy and Selkoe proposed the “amyloid cascade hypothesis” in which 
the central event in AD development is an imbalance between Aβ production and 
clearance leading to the accumulation and aggregation of Aβ (Hardy and Selkoe, 2002). 
The biochemical species of Aβ that induces pathogenesis is still a hotly debated topic. 
Experimental evidence suggests two major models: (1) the final amyloid fiber product 
causes neuronal damage or (2) neuronal cells are exposed to a toxic intermediate formed 
as Aβ polymerizes into the amyloid fiber. 
Amyloid laden plaques are often found in post-mortem AD brains, which led to 
the suggestion that mature insoluble fiber aggregates of the causative agent for AD. 
However, statistical analyses have found only a weak correlation between the number of 
amyloid aggregates and the severity of AD (Lue et al., 1999; Terry et al., 1991). In 
addition, high molecular weight Aβ42 aggregates do not correlate with toxicity in the 
Caenorhabiditis elegans AD model (Cohen et al., 2006). The formation of high molecular 
weight protein aggregates may be a mechanism to protect cells from cytoxicity by 
sequestering the toxic intermediates present formed during Aβ misregulation (Arrasate et 
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al., 2004; Slow et al., 2005).  
A wide range of nonfibrillar Aβ forms including dimer, trimer, oligomer, spherical 
aggregates and protofibrils have been reported to be cytotoxic and support this idea 
(Cleary et al., 2005; Hartley et al., 1999; Hoshi et al., 2003; Lambert et al., 1998; Lesne 
et al., 2006; Nilsberth et al., 2001; Roher et al., 1996; Townsend et al., 2006; Walsh et al., 
2002). Different Aβ forms, including the small diffusible Aβ oligomer, high molecular 
weight oligomer, and fibers effect cortical neurons differently (Deshpande et al., 2006). 
Collectively, these data suggest nonfibrillar intermediates trigger neuropathologies. 
Therefore, the development of neurodegeneration could be induced by a complicated 
combinatory effect of several toxic Aβ conformers.  
Despite evidence that prefibrillar aggregates may be the causative agents AD 
toxicity, many researchers have reported that mature Aβ fibers to be toxic to cultured 
neuronal cells (Busciglio et al., 1992; Deshpande et al., 2006; Hartley et al., 1999; 
Petkova et al., 2005; Tsai et al., 2004). How can this apparently conflicting data be 
reconciled? Recent study has demonstrated that the amyloid fiber is not a static structure. 
For instance, amyloid fibers formed from an SH3 domain showed very dynamic 
properties, in which molecules can be recycled by a dissociation and re-association 
mechanism within the fibril population (Carulla et al., 2005). Therefore, amyloid fibrils 
could provide a reservoir for toxic soluble oligomers, which could trigger the pathology 
(Haass and Selkoe, 2007). Under different experimental conditions amyloid fibrils may 
have different potentials to liberate soluble oligomers, which may be cytotoxic to the 
cultured neurons.  
Nevertheless, the ability to effectively develop therapeutics that will deter 
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amyloid disease development is hindered due to the lack of experimental evidence 
defining a toxic species. Moreover, the molecular mechanism behind the initial 
misfolding events that convert soluble amyloid proteins into an amyloid fiber in vivo has 
not been forthcoming. Perhaps exploring systems where amyloid formation occurs as a 
natural functional process will provide answers to these questions.     
 
Functional Amyloids 
Although amyloid formation is traditionally associated with protein misfolding 
human disease, recent studies have identified functional amyloid fibers in bacteria, fungi, 
and mammals (Fowler et al., 2007; Hammer et al., 2008). Functional amyloid fibers are 
not the products of protein misfolding but those of protein folding and assembly, and they 
contribute toward the physiological well-being of the cell.  
Bacterial functional amyloids 
Amyloid fibers have distinct physical strength that is comparable by weight to 
steel (Smith et al., 2006). Amyloid fibers are also chemically stable and insoluble at some 
extent even in common denaturants such as sodium dodecyl sulfate (SDS), urea and 
guanidine hydrochloride (GdnHCl) (Masters et al., 1985). Bacteria can reside in 
relatively harsh environments that lack nutrients, or that are chemically challenging. 
Recent studies have shown that amyloid-like structures are abundant in natural biofilms 
(Larsen et al., 2007). It is plausible that bacteria use these strong fibers as extracellular 
organelles to interact with their environments to survive from the difficult environments 
(Barnhart et al., 2006; Epstein and Chapman, 2008). 
The best understood bacterially produced amyloid fiber is curli. Curli fibers share 
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all the hallmarks of amyloids including staining thioflavin T and Congo red (Chapman et 
al., 2002). Curli fibers bound to Congo red also display apple-green birefringence under 
cross-polarized light (Lundmark et al., 2005). In addition, curli fibers are protease-
resistant and SDS insoluble (Collinson et al., 1991). Curli fibers are 4-10 nm wide fibrous 
proteinaceous structure composed of curlin subunits, CsgA and CsgB (csg stands for curli 
specific gene) (Barnhart and Chapman, 2006). Curli fibers can mediate interactions 
between individual bacteria, between bacteria and host tissues, and even to inert surfaces 
that often resist bacterial colonization, like Teflon and stainless steel (Bokranz et al., 2005; 
Gophna et al., 2001; Gophna et al., 2002; Ryu and Beuchat, 2005; Uhlich et al., 2002; 
Zogaj et al., 2003). Curli induce a potent host inflammatory response, initiate binding to 
host cells, and increase the ability of the bacteria to persist within the environment and 
the host (Barnhart and Chapman, 2006).  
The chaplins are another well-known example of bacterial extracellular amyloid 
structure produced by the Gram-positive bacterium Streptomyces coelicolor. S. coelicolor 
are soil bacteria and produce aerial hyphae growing into the air that are critical for their 
spore formation. In the absence of the chaplins, development of aerial hyphea is impaired 
(Elliot et al., 2003). It was proposed that the amyloid properties of chaplins may reduce 
the surface tension at the water/air interface by its hydrophobic nature to free hyphae to 
grow up into the air (Claessen et al., 2003; Claessen et al., 2004). Chaplins isolated from 
the S. coelicolor cell wall can form thioflavin T-positive, β-sheet-rich fibers (Claessen et 
al., 2003). The assembly of chaplins is a coordinated process. Chaplins in S. coelicolor 
are encoded by chpA-H and ChpE and ChpH are secreted and assembled into a network 
of amyloid fibers at the air-water interface (Claessen et al., 2003). ChpC, ChpE and 
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ChpH were shown to be most important for assembling chaplins (Di Berardo et al., 2008) 
Since bacterial amyloid structures are abundant in the native environment (Larsen 
et al., 2007), the number of bacterially produced amyloids described is increasing. Two 
recent discoveries showed that extracellular structures of Mycobacterium tuberculosis 
and bacterial endospore from Bacillus and Clostridium have amyloid characteristics 
(Alteri et al., 2007; Plomp et al., 2007). M. tuberculosis pili (MTP) shows that they are 
non-branching fibers similar to curli and other amyloid fibers as detected by electron 
microscopy (Alteri et al., 2007). Isolated MTP also showed biochemical properties 
similar to amyloid fibers such as SDS-insolublity and Congo red binding (Alteri et al., 
2007). Bacteria like Bacillus and Clostridium can produce an endospore when the 
nutrients are limited. Atomic force microscopic analysis showed that the spore coat of 
Bacillus atrophaeus is composed of fibers similar to amyloid (Plomp et al., 2007). It is 
plausible that the amyloid properties make the endospore an extremely stable structure 
highly resistant to pH extremes, heat and radiation as a protective coat.  
Besides using amyloid fibers to perform physiological tasks, bacteria also use 
toxic amyloid intermediates to defend themselves. Klebsiella pneumoniae produces 
Microcin E492 (MccE492), assembled into oligomeric pores to induce the death of 
neighboring enteric bacteria (Destoumieux-Garzon et al., 2003). Like other oligomeric 
amyloid intermediates (Quist et al., 2005), MccE492 has been shown to form voltage 
independent ion channels in planar lipid bilayers (Lagos et al., 1993). MccE492 loses its 
cytotoxic properties when it polymerizes into amyloid fibers (Bieler et al., 2005). The 
cytotoxicity of MccE492 was proposed to be correlated to its pre-amyloid oligomric state 
(Bieler et al., 2005). It is possible that the toxic MccE492 species share some common 
 9
structural features and toxic mechanism with disease-associated amyloid intermediates. 
Another interesting example that bacteria used the toxic properties of amyloid is hairpin 
produced by some plant pathogens like Xanthomonas and Psedomonas species (Oh et al., 
2007). Hairpins are secreted virulence factors that induce the hypersensitive response in 
plants (Kim et al., 2003). The hypersensitive response is a plant defense mechanism that 
inhibits intracellular pathogen growth by eliciting plant cell death akin to apoptosis in 
animal cells (Pennell and Lamb, 1997). It was recently shown that HpaG, a harpin 
produced by Xanthomonas, can polymerize into amyloid-like fibers (Oh et al., 2007). In 
contrast to MccE492, injection of HpaG protofibrils and mature fiber into plant cells 
induced cell death (Oh et al., 2007). The competence to induce hypersensitive response 
appears to be correlated to amyloidogenic tendency of Hairpin proteins (Oh et al., 2007). 
However, the exact cytotoxicity mechanism induced by hairpins remains elusive.  
Fungal functional amyloids 
Amyloid-like structures were discovered in various fungal species. Actually much 
of our knowledge concerning prion infectivity comes from a lot of excellent work using 
fungal prion as a model system (Shorter and Lindquist, 2005). Prion proteins were 
initially identified in the context of the transmissible spongiform encephalopathies 
(TSEs), the fatal neurodegenerative disorders including Creutzfeldt-Jakob disease and 
kuru in humans and scrapie and mad cow disease in animals (Prusiner et al., 1998). A 
prion is defined as an infectious protein (Prusiner et al., 1998). Disease-associated prions 
with amyloid properties could convert the soluble prion with a native conformation into 
disease-associated conformation (Prusiner et al., 1998). Prion proteins have a high 
propensity to assemble into self-propagating amyloid fibers under physiological 
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conditions both in vivo and in vitro (Glover et al., 1997; Prusiner et al., 1983; Prusiner et 
al., 1998; Taylor et al., 1999). Just like amyloid formation, preformed fibers composed of 
prion proteins could function as “seeds” to promote the conformation conversion of prion 
proteins in the native fold (Glover et al., 1997). This seeded catalysis of polymerization is 
proposed to be critical for prion infectivity (Prusiner et al., 1998). The definitive evidence 
to show prion infectivity is to induce prion-based phenotype by purely recombinant 
proteins with amyloid properties. The failure to accomplish this with recombinant animal 
prions and wild-type animal raised the doubts about the prion hypothesis. However, the 
first definitive evidence for “protein only” hypothesis was achieved by Maddelein et al 
(Maddelein et al., 2002). They successfully infected wild-type filamentous fungus 
Podospora anserine with in vitro preformed amyloid fibers from P. anseria prion protein 
HET-s, suggesting amyloid fibers alone can harbor prion infectivity (Maddelein et al., 
2002).  
The cellular function of HET-s in filamentous fungus P. anserine is associated 
with heterokaryon incompatibility (Coustou-Linares et al., 2001). Cells fusions could 
occur between adjacent individual cells of the filamentous fungus P. anserine and result 
in multinucleated cells called heterokaryon (Dales et al., 1983). The het-s locus of P. 
anserine has two alleles, het-s and het-S which encode HET-s and HET-S, respectively. 
HET-S is soluble whereas HET-s could be soluble or insoluble aggregates in the cytosol 
(Coustou et al., 1997). When hyphae that contain HET-s aggregates fuse with cells 
containing HET-S, the heterokaryon occurs and results in cell death to prevent further 
fusion (Coustou et al., 1997). Even though the biological significance of heterokaryon 
incompatibility is not completely understood, it is suggested that prion state of HET-s 
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play a beneficial role potentially in reducing the transmission of viruses or other 
infectious agents (Shorter and Lindquist, 2005). The nonamyloidogenic mutants of HET-s 
also lost its infectivity, suggesting the infectivity of HET-s aggregates is due to its 
amyloid properties (Ritter et al., 2005). 
Yeast prion proteins such as Sup35p, Ure2p and Rnq1p have been extensively 
studied. They all have Gln/Asn rich domain essential for their amyloidogenic properties.  
Sup35p, Ure2p and Rnq1p can form amyloid-like aggregates in the cytosol, leading to a 
certain phenotype heritable by daughter cells in a non-Mendelian manner (Ross et al., 
2005; Shorter and Lindquist, 2005). Sup35p is a termination factor in its native 
conformation (Liebman and Cavenagh, 1980). The aggregation of Sup35p leads to the 
increased read through of the stop codon and alters translation-termination fidelity (King 
et al., 1997). This prion phenotype [PSI+] was thought to be beneficial for yeast because 
yeast populations with [PSI+] have selective growth advantage under some conditions 
and it can confer both phenotypic and evolutionary plasticity (True et al., 2004; True and 
Lindquist, 2000).  
In a good nitrogen source, native Ure2p regulates nitrogen catabolism by binding 
to the positive transcriptional regulator Gln3 and repressing the genetic network to use 
poor nitrogen sources (Blinder et al., 1996). When it forms amyloid-like aggregates, it 
loses its repressing activity (Masison and Wickner, 1995; Wickner, 1994). The potential 
benefits of Ure2P amyloid state remains unclear. It was reported that yeasts proliferate 
more rapidly without Ure2p activity compared to wild-type strain under the salt stress 
(Crespo et al., 2001). In addition, a recent study showed that Ure2p missing the 
amyloidogenic Gln/Asn rich domain had substantially reduced stability and activity 
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(Shewmaker et al., 2007).  
Rnq1p was identified as an epigenetic modifier to induce the prion phenotype 
[PSI+] in yeasts (Sondheimer and Lindquist, 2000). The cellular function of Rnq1 
remains poorly understood. However, Rnq1p in amyloid state is commonly found in 
natural yeast isolates, suggesting its potential beneficial roles (Shorter and Lindquist, 
2005). It is proposed that Rnq1p in amyloid state facilitate protein-folding transition 
including regulating [PSI+] phenotype (Shorter and Lindquist, 2005). 
Amyloid-like structures are also invoked by Candida albicans, the most common 
fungal opportunistic pathogen, as cell surface-expressed adhesins (Otoo et al., 2008; 
Rauceo et al., 2004). Candida albicans has broad specificity in adhering to host tissues, 
and adherence is followed by biofilm formation and colonization (Blankenship and 
Mitchell, 2006). Among many adhesins produced by C. albicans, the agglutinin-like (Als) 
proteins have been implicated in pathogenesis and biofilm formation (Chandra et al., 
2001). Als adhesins were shown to have amyloid-like properties and these amyloid-like 
properties of Als proteins mediate multicellular aggregation reminiscence of bacterial 
extracellular amyloid-like matrix (Otoo et al., 2008; Rauceo et al., 2004). 
Animal functional amyloids 
Functional amyloid-like structures are also present in various animals (Fowler et 
al., 2007). A functional amyloid composed of the protein Pmel17 was reported to function 
as a template and to accelerate the biosynthesis of melanin polymers, which protects 
against UV and oxidative damage in various mammalian species such as mouse (Fowler 
et al., 2006). Pmel17 is synthesized as a transmembrane protein transiently localized in 
endoplasmic reticulum membrane. It is transported to Golgi and then to melanosome 
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organelles, specialized membrane enclosed vesicles where the melanin is synthesized 
(Raposo et al., 2001). In a post-Golgi compartment, the luminal fragment (Mα) was 
cleaved from its transmembrane domain (Mβ) and the degradation of Mβ free Mα to 
initiate amyloid polymerization process (Fowler et al., 2006). Mα has remarkably high 
amyloidogenic tendency as shown in vitro (Fowler et al., 2006). The Mα fibers bind the 
melanin precursors and facilitate the synthesis of melanin (Fowler et al., 2006). This 
suggests that amyloid is a conserved protein quaternary structure produced from bacteria 
to mammals contributing to normal cell physiology. Moreover, cells have evolved the 
mechanism to control amyloid propagation. The proteolysis of Pmel17 is critical to 
initiate amyloid formation, which is tightly coordinated and controlled. 
Amyloid was also proposed to be the molecular basis of certain long-term 
memory formation (Si et al., 2003). Cytoplasmic polyadenylation element binding 
proteins (CPEBs) are highly conserved RNA-binding proteins localized at neuronal 
synapses that promote the elongation of the polyadenine tail of messenger RNA (Hake 
and Richter, 1994). In Aplysia (sea slug), a neuron-specific isoform of CPEB was 
reported to be important for long-term synaptic facilitation, but not for early expression 
(Si et al., 2003). This isoform of CPEB is conserved in Drosophila, mouse and human (Si 
et al., 2003). Interestingly, this CPEB has an N-terminal Gln/Asn rich domain very 
similar to the prion domains of yeast prions (Si et al., 2003). CPEB protein at full length 
has amyloidogenic properties and can induce prion-based phenotype in a yeast model (Si 
et al., 2003). It is intriguing to investigate whether the amyloid state of CPEB linked to its 
activity. The CPEB at the prion state is more active than it at the non-prion state, 
suggesting the prion property promotes CPEB biological function (Si et al., 2003). 
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However, the existence of CPEB at the prion state in Aplysia remains undescribed. It is 
plausible that the high tolerant amyloid properties could constitute the molecular basis of 
long-term memory due to its physical and chemical endurance.  
The discovery of functional amyloids suggests that amyloid may be an ancient 
and conserved quaternary structure. Functional amyloids provide a unique niche to 
understand how nature modulates amyloid propagation and prevents cytotoxicity 
associated with amyloidogenesis.  
 
Amyloid Polymerization Mechanism 
Amyloid formation is proposed to be a common property of most proteins by 
Dobson and his colleagues (Chiti and Dobson, 2006). The denatured globular proteins 
such as muscle myoglobin can be converted into amyloid fibrils in vitro (Fandrich et al., 
2001). Polypeptide SH3 domain which is not associated with diseases can be converted 
into amyloid fibrils and early nonfibrillar intermediates are inherently highly cytotoxic, 
suggesting a common mechanism for amyloid proteotoxicity (Bucciantini et al., 2002). 
Even though their primary sequences are very different, all amyloid proteins including 
disease-associated or not disease-associated assemble into structurally similar fibrils. 
During early in vitro aggregation, they share a structurally similar transient species which 
can be recognized by a conformational-specific antibody A11 (Figure 1.2) (Kayed et al., 
2003). A11 reactive species of different disease-associated amyloid proteins are cytotoxic 
and this toxicity can be inhibited by A11, suggesting a common pathogenesis mechanism 
for different amyloid diseases (Kayed et al., 2003).  
In vitro many amyloid proteins polymerize into ordered fibers follows a triphasic 
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process (Figure 1.2A black line). The polymerization is proposed to follow nucleation-
dependent kinetics like protein crystallization, microtubule assembly, flagellum assembly, 
and virus coat assembly (Jarrett and Lansbury, 1993; Lomakin et al., 1996). Before 
mature fiber aggregates are detectable, there is a time period where the polymerization of 
amyloidogenic polypeptides appears to be stagnant. However, during this lag phase trace 
amounts of dimer, trimer, and eventually, nucleus (oligomer) are formed (Figure 1.2B) 
(Podlisny et al., 1995; Podlisny et al., 1998; Walsh et al., 1999). Nucleus formation is the 
rate-limiting step of fibril assembly. Once a nucleus has formed, monomer addition to the 
growing fiber becomes thermodynamically favorable and occurs quickly (Figure 1.2B) 
(Jarrett and Lansbury, 1993). As with any dynamic polymerization process where 
different folding intermediates are present at any one time, the monomer, oligomer, 
protofibrils (short fibrillar aggregates) and fibrils have been observed using different 
techniques including atomic force microscopy (Roher et al., 1996; Walsh et al., 1999).  
Nucleation is the rate-limiting step of in vitro amyloid polymerization and is 
potentially critical to control amyloidogenesis in vivo. The nucleation might represent the 
latent phase of the development of various amyloid diseases (Selkoe, 2003). Most of 
amyloidoses and neurodegenerative diseases occur in middle or late life (Selkoe, 2003).  
Presumably, the factors promoting nucleation or shortening the latent lag time of 
amyloidogenesis will enhance the disease development. Since amyloid polymerization is 
similar to the process of crystallization, Jarrett and Lansbury proposed “seeding” may 
play an important role occur in amyloid assembly like crystallization (Jarrett and 
Lansbury, 1993). In facts, amyloid can promote its own polymerization, where soluble 
subunits can be efficiently incorporated into the preformed fiber (Figure 1.2A red line). 
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This template-directed polymerization or seeding potentially drives prion infectivity and 
the development of noninfectious amyloid diseases (Harper and Lansbury, 1997; Prusiner 
et al., 1998; Shorter and Lindquist, 2005). For instance, serum amyloid A amyloidosis 
(AA amyloidosis) in different animal models were enhanced by providing different 
preformed amyloid fibrils (Lundmark et al., 2002; Lundmark et al., 2005; Sigurdsson et 
al., 2002; Zhang et al., 2008). Even though nucleation and seeding is very important, the 
nature of this template-driven polymerization remains elusive. In this thesis, I used a 
functional amyloid propagation system to extensively elucidate this process. 
 
Sequence Determinants of Amyloid Formation 
Anfinsen proposed that the structure of a protein is determined by its specific 
amino acid sequence (Anfinsen and Scheraga, 1975; Haber and Anfinsen, 1961). 
Interestingly, amyloid formation seems an inherent property of a polypeptide chain 
independent of the amino acid sequence (Chiti and Dobson, 2006). Amyloid structure 
was reported to be dictated by main chain interactions (Fandrich and Dobson, 2002). 
Amyloidogenic proteins do not necessarily share any similarity at amino acid level even 
though the assembled fibers share the common cross-beta structure (Chiti and Dobson, 
2006). However, there were many reports that the mutation or modification of the certain 
side chains changed protein aggregation and therefore changed the pathological effects 
(Chamberlain et al., 2001; Games et al., 1995; Hsiao et al., 1996; Van Nostrand et al., 
2001). It is plausible that amyloidogenic proteins use diverse side-chain interactions to 
facilitate polymerization. For instance, hydrophobic stretch of Aβ42 instead of the 
specific sequence is sufficient for its aggregation (Kim and Hecht, 2005). It was proposed 
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that the interaction between aromatic residues in IAPP fragment is essential for its 
aggregation in vitro (Azriel and Gazit, 2001). Yeast prion proteins Sup35p, Ure2p and 
Rnq1p all have Gln/Asn rich domains that are essential for prion propagation (Ross et al., 
2005; Shorter and Lindquist, 2005). Gln/Asn rich domains were proposed to have a high 
propensity to form self-propagating amyloid fibrils (Michelitsch and Weissman, 2000). 
Moreover, the specific sequences in the Gln/Asn rich domain of Sup35p govern its self-
association and species-specific seeding activity (Tessier and Lindquist, 2007). Gln 
repeats are involved in the development of Huntington’s and Kennedy’s diseases 
(Scherzinger et al., 1997). The CAG repeat expansion of Huntingtin gene results in the 
increase of the length of poly-Gln stretch and the self-aggregation tendency in vitro 
(Chen et al., 2002). When CAG expansion is above the threshold, typically 37 Gln 
residues, huntingtin forms aggregates and induces the neuron death (Chen et al., 2002). 
This poly-Gln codon expansion causes amyloidogenic pathology has been validated in 
Caenorhabditis elegans (Faber et al., 1999), zebrafish (Schiffer et al., 2007) and mouse 
model (Reddy et al., 1998). It is plausible that poly-Gln can facilitate the polypeptide to 
form amyloid, therefore inducing degenerative pathology.  
Dobson and Chiti et al. proposed that simple intrinsic physicochemical properties, 
such as hydrophobicity, secondary structure propensity and charge of unfolded 
polypeptides were correlated to aggregation rate (Chiti and Dobson, 2006; Chiti et al., 
2003). However, this prediction of amyloidogenecity only based on global amino acid 
composition is limited because it did not consider the positional effect. In fact, the strong 
positional effects for proline substitution in Aβ and the point mutation for amyloidogenic 
peptide STVIIE were observed (Lopez de la Paz and Serrano, 2004; Williams et al., 2004; 
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Williams et al., 2006). My data presented in Chapter 4 demonstrates that CsgA protein 
has critical residues that drive self-aggregation and assembly into curli fibers. Secondly, 
this prediction algorithm did not consider the cellular factors influencing 
amyloidogenesis. For instance, Hsp104 plays an important role in yeast prion Sup35p 
polymerization (Shorter and Lindquist, 2004) and CsgB in E. coli initiates CsgA 
polymerization in vivo (Hammar et al., 1996). A protein that has high intrinsic 
aggregation properties does not necessarily efficiently assemble into fibers in vivo if its 
sequence disfavors the interactions with other important factors in amyloidogenesis. One 
interesting example like this was shown in Chapter 3.  
Many amyloidogenic proteins including synuclein, yeast prions, HET-s, human 
prion, bacterial amyloid protein CsgA, CsgB etc. have imperfect repeated sequences. 
These repeats constitute the protease-resistant core and were shown to play important role 
in fiber assembly (Ross et al., 2005). For instance, the N-terminal prion-determining 
domain of Sup35p has five imperfect oligopeptide repeats, and certain deletions of the 
repeats resulted in the defectiveness in propagation of Sup35p fibrils (Liu and Lindquist, 
1999). Moreover, in vitro, repeat expansion peptides (with two extra repeats) were shown 
to be more amyloidogenic than wild-type peptides (Liu and Lindquist, 1999). It is 
plausible that intramolecular interactions within repeated sequence facilitate amyloid 
formation.  
There have been several prediction algorithms reported to successfully identify 
amyloidogenic regions (Fernandez-Escamilla et al., 2004; Tartaglia and Vendruscolo, 
2008). These aggregation-prone sequences are very abundant in globular proteins 
(Linding et al., 2004). Cellular molecular chaperons and quality control mechanisms are 
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employed to prevent uncontrolled protein aggregation. Besides these mechanisms, it has 
been proposed that proteins have evolved intrinsic strategies to prevent aggregation using 
the arrangement of structural and sequence elements (Richardson and Richardson, 2002). 
For instance, some proteins have conserved residues that are important for preventing 
misfolding or aggregation. It has been postulated that charged residues and other β 
breaker residues such as Pro could function as ‘gatekeeper’ residues to prevent amyloid 
formation because their low tendency to be incorporated into cross-beta amyloid 
conformation (Monsellier and Chiti, 2007; Richardson and Richardson, 2002). 
Gatekeeper residues are commonly found at the edge β strand (the peripheral β strand) in 
the native β sheet conformations to prevent protein aggregation (Richardson and 
Richardson, 2002). The existence of gatekeeper residues could change folding kinetic 
partitioning to prevent nonproductive pathways including aggregation or other misfolding 
pathway (Figure 1.3A). It is also possible that the existence of gatekeeper residues alter 
the free energy state of the folded products. Mutation of gatekeeper residues resulted in 
more efficient amyloidogenesis and therefore early onset of amyloid pathology (Figure 
1.3B) (Chiti et al., 2003; Orpiszewski and Benson, 1999; Otzen et al., 2000). For example, 
the mutation of Asp at position 23 in Aβ is linked to some familial Alzheimer’s disease 
and this mutation D23N enhances fibrillogenesis in vitro (Grabowski et al., 2001; Van 
Nostrand et al., 2001).  
Collectively, amyloid structure appears to be a main-chain dominated structure, 
but side chains influence both positively and negatively on amyloidogenesis in vivo and 
in vitro. What side chains exactly contribute to amyloid polymerization, especially in vivo 
amyloidogenesis, remains poorly understood. In this thesis I aim to elucidate the roles of 
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important side-chains in curli assembly. 
 
Curli Assembly Mechanism 
Our lab studies the biogenesis of bacterially produced amyloid fibers, curli. Curli 
are extracellular amyloids that contribute in many ways to cell survival and maintenance. 
Curli are important components of extracellular matrix of biofilms produced by enteric 
bacteria such as E. coli and Salmonella spp (Barnhart and Chapman, 2006). Due to the 
amyloid properties of curli fibers, the colonies of curli-producing E. coli stain red when 
grown on Congo red indicator plates, which provides a convenient assay to monitor curli 
assembly in vivo. Curli assembly in E. coli requires genes encoded by the csgBA and 
csgDEFG operons (Figure 1.4). CsgD is a transcriptional regulator in the FixJ/UhpA 
family and activates the transcription of csgBA operon under specific conditions 
(Barnhart et al., 2006). The expression of csgBA absolutely requires CsgD and there is no 
other known positive regulator for the csgBA operon (Barnhart et al., 2006). The 
regulation of curli gene expression is complex and is influenced by many environmental 
cues. Most laboratory strains of E. coli and most Salmonella strains, curli expression is 
best at temperatures below 30 °C (Arnqvist et al., 1992). Interestingly, many clinic strains 
of E. coli including sepsis isolates, can express curli at 37 °C and some mutations in the 
csgD promoter result in strains that produce curli regardless of temperature (Romling et 
al., 1998; Uhlich et al., 2001). In addition, the low salt condition and nutrient limitation 
(nitrogen, phosphate and iron) stimulate curli gene expression (Gerstel and Romling, 
2001; Romling et al., 1998). Oxygen tension also plays a role in curli expression, with 
microaerophilic conditions resulting in maximal csgD transcription (Gerstel and Romling, 
2001). There are many transcriptional regulators modulating the csgDEFG transcription. 
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OmpR/EnvZ, RpoS, Crl, MlrA and IHF positively activate the transcription of csgDEFG. 
CpxA/R and Rcs negatively influence the transcription of csgDEFG (Barnhart et al., 
2006). 
CsgE, CsgF, CsgG, CsgA and CsgB expressed from csgBA and csgDEFG operons 
have N-terminal Sec-signal sequence which directs these proteins across the inner 
membrane into periplasmic space through SecYEG machinery (Figure 1.4). CsgG is an 
outer membrane lipoprotein and is proposed to be the major component of curli-specific 
secretion machinery. In the absence of CsgG, curli fiber subunits CsgA and CsgB are not 
stable (Loferer et al., 1997). Overexpression of both CsgG and CsgA resulted in secretion 
of CsgA into the extracellular milieu (Chapman et al., 2002). CsgG interacts with CsgE 
and CsgF at the outer membrane (Robinson et al., 2006). Purified CsgG forms barrel-
structured oligomers and overexpression of CsgG increases outer membrane permeability 
(Robinson et al., 2006). All these data suggest CsgG may function as a curli-specific 
secretion machine and coordinate the efficient curli assembly.  
CsgE and CsgF are indispensable for curli assembly (Chapman et al., 2002). Their 
exact functions are beginning to be elucidated. In the absence of CsgE, the protein levels 
of CsgA and CsgB significantly are decreased and curli formation is dramatically 
disrupted (Chapman et al., 2002). A csgF mutant is defective in the nucleation of CsgB 
and many fibers produced by csgF cells were found not associated with cells (Chapman 
et al., 2002; Hammer et al., 2007).  
The amino acid sequences of CsgA and CsgB share approximately 30% identity 
and 50% similarity. Their primary structure can be divided into three parts, a Sec signal 
sequence, an N-terminal 22 or 23 residues and five imperfect repeating units (R1, R2, R3, 
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R4 and R5) (Figure 1.5A and 1.5B). The Sec signal sequences are cleaved when they pass 
through inner membrane (Collinson et al., 1999; White et al., 2001). Therefore, the 
mature CsgA and CsgB only contain N-terminal stretches and five repeating units. The 
N-terminal stretches are sensitive to proteinase K treatment, whereas the five repeating 
units are resistant to proteinase K treatment indicating that they comprise the amyloid 
cores (Collinson et al., 1999; White et al., 2001). The N-terminal stretch of CsgA was 
reported to target CsgA to CsgG secretion machinery while the role of the N-terminal 
stretch of CsgB remains elusive (Robinson et al., 2006). 
The repeating units of CsgA contain a consensus sequence (S-X5-Q-X-G-X2-N-X-
A-X3-Q) and each repeating unit is predicted to form a β strand-loop-β strand motif, 
thereby five repeats comprising a cross-β structure with two β sheets (Figure 1.5C) 
(Collinson et al., 1999). Similar to CsgA, the first four repeating units of CsgB have a 
consensus sequence (X6-Q-X-G-X2-N-X-A-X3-Q) and the five repeating units are 
predicted to form a cross-β structure (White et al., 2001). The R5 of CsgB is different 
from other repeats in that it does not have conserved Gln and Gly residues (Figure 1.5B). 
Although CsgA and CsgB share similar amino acid sequences and predicted structural 
features, the theoretic isoelectric points (pI) of mature CsgA and CsgB are 4.51 and 9.30, 
respectively, because CsgB has significantly more cationic residues such as Arg and Lys 
than CsgA, especially in R5 (Figure 1.5B). Unlike CsgA, CsgB is associated to outer 
membrane and tethered on the cell surface (Hammar et al., 1996; Loferer et al., 1997). 
The deletion of the last repeat of CsgB resulted in a molecule disassociated from cells 
(Hammer et al., 2007). The majority component of outer membrane of Gram-negative 
bacteria is lipopolysaccharides (LPS) and it was reported that some LPS-binding 
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sequences are rich in cationic residues (Ferguson et al., 2000). It is possible that this 
distinct enrichment of cationic residues especially at the C-terminus of CsgB contributes 
to its affinity to LPS at the outer membrane.  
The polymerization of CsgA in vivo requires the nucleator CsgB. CsgA is secreted 
to the milieu and remains soluble in the absence of CsgB (Hammar et al., 1996). CsgA 
secreted from csgB cells can interact with CsgB presented on the csgA cell surface and 
assemble into fibers (Hammar et al., 1996). This successful interbacterial 
complementation builds the basis of our current curli assembly model (Figure 1.4). CsgB 
is proposed to prime the polymerization of CsgA, termed nucleation-precipitation process 
(Bian and Normark, 1997; Hammar et al., 1996). The molecular details of this 
mechanism are beginning to be elucidated. We proposed that there are two key events 
that facilitate CsgA polymerization on the cell surface. Firstly, CsgB functions as a 
template to initiate and accelerate secreted CsgA polymerization (Figure 1.4). Since most 
amyloid formation is a self-propagation process, we hypothesize that preformed CsgA 
fibers also can function as a template to direct CsgA polymerization (Figure 1.4). 
Elucidation of these two critical events is one goal of this thesis. There are several 
fundamental questions I am trying to address using curli as a model system to study 
highly evolved amyloidogenic machine. 
1) The polymerization of most disease-associated amyloids is a triphasic process and 
follows self-propagating mechanism. Is the polymerization of bacterial amyloid protein 
such as CsgA similar to disease-associated amyloids? If amyloid formation is an inherent 
property of polypeptide chains, is the folding or polymerization process conserved? 
2) What are the sequence determinants for CsgA nucleation and polymerization? Is the 
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five-fold internal sequence homology of CsgA critical to its ability to polymerize into an 
amyloid fiber? 
3) Amyloid structures are dictated by backbone interactions. The high conservation of 
polar residues such as Ser, Gln and Asn of CsgA suggests their potentially importance for 
CsgA polymerization. How do these side-chains influence bacterial amyloid formation?  
4) How does E .coli control the toxicity usually associated with amyloid propagation? 
How does E.coli harness the polymerization of CsgA using the evolved machinery? What 


















Figure 1.1. Amyloids are distinct proteinaceous fibers. 
(A) Amyloids formed in brains associated with serum A amyloidosis in the presence of 
Congo red under polarized light (Zhang et al., 2008). (B) Negative-stain EM micrographs 
of Aβ40 amyloid fibers. (C) The structural model of Aβ40 resolved by solid-state NMR 
(Petkova et al., 2002). (D) The structure of peptide GNNQQNY derived from Sup35p and 
resolved by X-ray microcrystallography (Nelson et al., 2005). (E) The structural model of 
amyloid fibril of the HET-s prion domain in Het-s resolved by solid-state NMR (Wasmer 























Figure 1.2. In vitro polymerization mechanism of amyloid proteins. 
(A) A graphic representation of amyloid fiber formation showing a characteristic lag 
phase in the absence of seeds (black). By contrast, preformed amyloid fibers can act as 
seeds to eliminate the lag phase (red). (B) Schematic of amyloid fiber polymerization. 
Soluble precursor proteins assemble into a common intermediate prior to polymerizing 
into a stable amyloid fiber. The formation of the intermediate is proposed to be the rate-














Figure 1.3. The gatekeeper residues influence the aggregation of amyloid proteins. 
(A) Schematic of the influence of gatekeeper residues on amyloid aggregation. The 
gatekeeper residues prevent the association of aggregative domains and thereby decrease 
the nonproductive folding intermediates. (B) In the absence of gatekeeper residues, 












Figure 1.4. Model of curli regulation and assembly. 
Except CsgD, All other Csg proteins have Sec-dependent signal sequences. CsgE and 
CsgF are required for efficient curli assembly. The major subunit protein (CsgA) and the 
nucleator (CsgB) are secreted to the cell surface in a CsgG dependent fashion. CsgB 
associates with the outer membrane where it nucleates soluble, unstructured CsgA into a 
highly ordered amyloid fiber as indicated by (1). Preformed CsgA fibers also promote 










Figure 1.5. The amino acid sequence and predicted structure of CsgA and CsgB. 
(A) Schematic of CsgA including an N-terminal Sec signal sequence and the N-terminal 
22 residues that precede the five repeating units. The imperfect repeating units in CsgA 
(R1–R5) are predicted to form β strand-loop- β strand structures. Amino acids 
comprising the β strand are located below the arrows. Boxed letters represent amino acids 
conserved throughout the repeating units. (B) Schematic of CsgB amino acid sequence. 
Boxed letters represent amino acids conserved throughout the repeating units. Positively 
charged amino acids in the fifth repeating unit of CsgB are marked with asterisks. (C) 
The predicted structural model of CsgA shows that the repeating units form β strand-
loop- β strand motifs comprising cross β structure. The structure was constructed by Dr. 
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Investigation of CsgA in vitro Polymerization2 
 
Abstract 
Amyloid formation is characterized by the conversion of soluble proteins into 
biochemically and structurally distinct fibers. Although amyloid formation is traditionally 
associated with diseases like Alzheimer’s disease, a number of biologically functional 
amyloids have recently been described. Curli are amyloid fibers produced by Escherichia 
coli that contribute to biofilm formation and other important physiological processes. We 
characterized the polymerization properties of the major curli subunit protein CsgA. 
CsgA polymerizes into an amyloid fiber in a sigmoidal kinetic fashion with a distinct lag, 
growth and stationary phase. Adding sonicated preformed CsgA fibers to the 
polymerization reaction can significantly shorten the duration of the lag phase. I also 
demonstrated that the conversion of soluble CsgA into an insoluble fiber involves the 
transient formation of an intermediate similar to that characterized for several 
disease-associated amyloids. The CsgA core amyloid domain can be divided into 5 
repeating units that share sequence and structural hallmarks. I showed that peptides 
representing three of these repeating units are amyloidogenic in vitro. Although the 
defining characteristics of CsgA polymerization appear conserved with disease-associated  
2 A version of this chapter has been published as Wang et al., 2007, J Biol Chem 282, 3713-3719. 
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amyloids, these proteins evolved in diverse systems and for different purposes. Therefore, 
amyloidogenesis appears to be an innate protein folding pathway that can be capitalized 
on to fulfill normal physiological tasks. 
 
Introduction 
Amyloid formation is the hallmark of medically related disorders such as 
Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and the transmissible 
spongiform encephalopathies (Chiti and Dobson, 2006). The root of these diseases is the 
uncontrolled conversion of seemingly unrelated soluble proteins into biochemically and 
structurally related fibers known as amyloids. Despite their diversity in size and amino 
acid content, all amyloid proteins assemble into 4-12nm wide fibers that are β-sheet rich 
and exhibit conserved tinctorial properties. Soluble pre-amyloid species also share 
common pore-like epitopes and these globular species may induce cytotoxicity (Hardy 
and Selkoe, 2002; Kayed et al., 2003; Quist et al., 2005).  
Numerous studies have revealed that amyloidogenic proteins are mostly 
unstructured or contain mixtures of β-sheets and α-helices in their native state, but when 
polymerized into fibers they invariably adopt a characteristic cross β-sheet structure 
(Barrow and Zagorski, 1991; Barrow et al., 1992; Hurshman et al., 2004). This cross 
β-sheet structure is common to all amyloids and is characterized by β-strands that orient 
perpendicular to the fiber axis. In vitro, disease-associated amyloids polymerize into 
fibers with nucleation-dependent kinetics with characteristic lag, growth and stationary 
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phase. The lag phase is proposed to contain folding intermediates that are key to the 
toxicity associated with certain amyloidogenic proteins (Lashuel et al., 2002; Lesne et al., 
2006). During the lag phase, amyloidogenic proteins adopt a transient folding species that 
disrupts membrane integrity (Bucciantini et al., 2002; Kayed et al., 2003; Lashuel et al., 
2002). Loss of membrane integrity is proposed to underlie the cell death and disease 
associated with many amyloids (Bucciantini et al., 2002; Kayed et al., 2003). A 
conformational-specific antibody has been generated that recognizes a transient 
intermediate formed during amyloidogenesis of several disease-associated proteins 
(Kayed et al., 2003). 
A new class of amyloids has recently been found that play important physiological 
roles for the cell. These so-called ‘functional’ amyloids are found in bacteria (Bieler et al., 
2005; Chapman et al., 2002; Elliot et al., 2003), fungi (Coustou-Linares et al., 2001; True 
and Lindquist, 2000) and mammals (Fowler et al., 2005). The first example of a 
functional amyloid in bacteria was curli (Chapman et al., 2002). Curli compose part of 
the complex extracellular matrix that is required for biofilm formation (Austin et al., 
1998; Zogaj et al., 2003; Zogaj et al., 2001), host cell adhesion (Johansson et al., 2001) 
and invasion (Gophna et al., 2001; Gophna et al., 2002), and they are proposed to be 
important stimulants of the host inflammatory response (Bian et al., 2000; Bian et al., 
2001; Tukel et al., 2005). An intriguing question is whether these functional amyloid 
proteins polymerize in a manner similar to disease-associated amyloids.  
Curli formation is the result of an elegant biosynthetic pathway directed by the 
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Csg proteins in E. coli. The major curli subunit, CsgA, can be secreted to the cell surface 
as a soluble, unstructured protein (Barnhart and Chapman, 2006; Chapman et al., 2002). 
CsgA is efficiently nucleated into an insoluble amyloid fiber in the presence of the outer 
membrane-associated protein, CsgB (27). After nucleation, the fibers are predicted to 
grow by subsequent CsgA addition to the amyloid fiber’s tip (Barnhart and Chapman, 
2006). 
Both CsgA and CsgB display a remarkable five fold internal symmetry 
characterized by conserved polar residues. These five repeating units consist of 19-24 
amino acids and align along serine, glutamine and asparagine residues (Barnhart and 
Chapman, 2006; Collinson et al., 1999). Each repeating unit is predicted to form a 
strand-loop-strand motif that closely resembles the cross β-spine structure described for 
many disease-associated amyloids (Collinson et al., 1999; Nelson and Eisenberg, 2006; 
Nelson et al., 2005).  
Here we characterized the folding of purified CsgA and showed that its 
polymerization is similar to that of disease-associated amyloids. CsgA polymerization 
involves a transient structurally conserved intermediate that implies a common 
polymerization pathway between functional and disease-associated amyloids. We found 
that the conserved folding intermediate for CsgA is a monomer or low molecular weight 
multimer. We demonstrated that at least three of five repeating units of CsgA are 
amyloidogenic. These results suggest that covalent linkage of multiple amyloidogenic 
units facilitates efficient fiber formation. 
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Experimental Procedures 
CsgA Purification  
CsgG and CsgA-his were overexpressed in LSR12 (C600::∆csgBA and 
∆csgDEFG ) as previously described (Chapman et al., 2002). Following centrifugation 
for 15 minutes at 10,000g, the supernatant was clarified by filtration though a 0.22 µm 
PES bottle-top filter (Corning, Acton, MA). Filtrates containing CsgA were passed over a 
HIS-Select™ HF NiNTA (Sigma Aldrich, Atlanta, GA) column, washed with 10 volumes 
of 10 mM potassium phosphate buffer (KPi) pH 7.2, and eluted with 10 mM KPi 100 
mM imidazole pH 7.2. CsgA-containing fractions were combined and passed through a 
0.02 µm Anotop 10 filter (Whatman, Maidstone, England). The N-terminal portion of 
purified CsgA-his was sequenced by mass spectrometry and found to be identical to the 
predicted CsgA amino acid sequence. A modified protocol using guanidine hydrochloride 
(GdnHCl) was employed to fully denature CsgA-his. Following the first wash, the 
column was equilibrated with 5 volumes 10 mM KPi 8 M GdnHCl pH 7.2 and eluted 
with 50 mM KPi 8 M GdnHCl pH 2. Sephadex G25 was used for desalting/buffer 
exchange. To create CsgA-his seeds, 2-week-old fibers were sonicated using a Sonic 
Dismembrator (Fisher Model 100, Fisher, Pittsburg, PA) for three 15-second bursts on ice. 
Where indicated, CsgA samples were filtered through a prewashed Amicon Ultra-4 
(Millipore, Bedford, MA) centrifugal filter devices. Samples were centrifuged at 4,000g 
for 2 minutes and the retentate and filtrate fractions were collected. A plasmid encoding 
CsgA-his can complement ΔcsgA cells in vivo and purified CsgA-his polymerizes into an 
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amyloid fiber with similar kinetics as wild-type CsgA (Chapman et al., 2002). Therefore, 
CsgA-his is referred to as ‘CsgA’ throughout this chapter. 
Thioflavin T (ThT) assay  
Following desalting to remove imidazole or GdnHCl, CsgA was incubated at 
room temperature. At different time intervals, CsgA samples were mixed with 20 µM 
ThT and fluorescence was measured using a Spectramax M2 plate reader (Molecular 
Devices, Sunnyvale, CA) set to 438nm excitation and 495nm emission with a 475nm 
cutoff. Alternatively, samples amended with 25 µM ThT were assayed directly in the 
Spectramax M2 plate reader every 10 minutes after shaking for 5 seconds.  
Circular Dichroism (CD) Spectroscopy  
CsgA samples (10 μM CsgA in 50 mM KPi, pH 7.2) were assayed in a Jasco 
J-810 spectropolarimeter from 190 to 250nm in a quartz cell with 1-mm path length at 25 
°C.  
Blot assay with A11 and anti-CsgA antibody  
CsgA samples were dripped onto 0.2µm Transblot Nitrocellulose membranes 
(Bio-Rad, Hercules, CA) as described (Kayed et al., 2003) and allowed to dry for 5 
minutes. The membrane was blocked in 5% milk in TBS-T (0.01% Tween-20) for at least 
1 hour. The dot blots were washed 3 times in TBS-T before and after incubating with 
1:10000 dilutions of A11 primary antibody (BioSource, Camarillo, California) and goat 
anti-rabbit-HRP (Sigma-Aldrich) in 3%BSA/TBS-T. The blots were developed using the 
SuperSignal® West Dura system (Pierce, Rockford, IL). Blots were stripped and 
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reprobed with a 1:10000 dilution of rabbit anti-CsgA antibody (Barnhart et al., 2006).  
Electron microscopy  
Philips CM12 Scanning transmission electron microscope was used to visualize 
the fiber aggregates. Samples (10 μl) were placed on formvar coated copper grids (Ernest 
F. Fullam, Inc, Latham, NY) for 2 min, washed with deionized water, and negatively 
stained with 2% uranyl acetate for 90 seconds.    
Peptide preparation  
Peptides were chemically synthesized by Proteintech Group Inc., Chicago. Purity 
was greater than 90% by HPLC and size was confirmed by mass spectroscopy. To 
equilibrate the pH of each sample and to remove any potential seed in the peptide 
preparations, the peptides were denatured using a modified protocol described previously 
(Chen and Wetzel, 2001). Briefly, peptides were dissolved to 0.5 mg/ml in TFA/HFIP 
(1:1 v/v) and sonicated for 10 min. The suspensions were incubated at room temperature 
until they visibly cleared. The solvent was then removed by vacuum. Peptides were then 
dissolved in cold 2 mM HCl and centrifuged at 100,000 X g in a TLA-55 (Beckman, 
Fullerton, CA) for 1 hour at 4°C. The supernatants were equilibrated to 50mM K-Pi 
pH7.2 by 200mM K-Pi pH7.2 on ice. When the samples were shifted to room 
temperature, the polymerization was measured by ThT assay.  
 
Results 
CsgA polymerization kinetics  
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To determine the polymerization kinetics of CsgA, an in vitro polymerization 
assay was developed. The transition of freshly purified, soluble CsgA to amyloid fibers 
was monitored using thioflavin T (ThT), an amyloid-specific dye commonly used to 
assay amyloid formation (LeVine, 1993; LeVine, 1999). The ThT fluorescence of CsgA 
samples followed a sigmoidal curve with distinguishable lag, growth and stationary 
phases (Figure 2.1A). The length of the lag phase was concentration independent when 
CsgA was incubated at concentrations above 4 μM (Figure 2.1A). 
Concentration-independent lag phases have been reported for other amyloidogenic 
proteins (Lomakin et al., 1997; Rhoades and Gafni, 2003). ThT fluorescence signal did 
not appreciably change after 8 hours, remaining at approximately the same level for over 
30 days (data not shown).  
Circular dichroism spectroscopy and transmission electron microscopy (TEM) 
were used to measure the structural changes that occurred during CsgA amyloidogenesis. 
Circular dichroism spectrum indicated that immediately after purification CsgA was 
largely unstructured (Figure 2.1B). However, CsgA adopted a β-sheet-rich structure after 
2 days of incubation at room temperature (Figure 2.1B). Immediately after purification 
there was no apparent fiber formation or aggregation by TEM (Figure 2.1C). Two hours 
after purification regular, unbranched fibers were readily observed (Figure 2.1D). Dense 
fiber aggregates were also observed 7 days post purification (Figure 2.1E).  
The A11 antibody recognizes a transient CsgA folding species  
The polymerization of eukaryotic amyloids involves the formation of an 
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intermediate folding species proposed to cause amyloid-associated toxicity to host cells 
(Hardy and Selkoe, 2002; Kayed et al., 2003). The A11 antibody recognizes an Aβ 
transient intermediate (Kayed et al., 2003). Remarkably, this antibody also recognizes a 
transient intermediate formed by IAPP, poly Q, PrP, and Sup35p, among others (Kayed et 
al., 2003; Shorter and Lindquist, 2004). The A11 antibody recognizes only a transient 
intermediate species, not soluble monomers or mature amyloid fibers derived from these 
proteins.  
The A11 antibody was used to determine if CsgA shared a common 
polymerization intermediate with eukaryotic amyloids. We found that immediately after 
purification CsgA was recognized by the A11 antibody (Figure 2.2A). As fiber formation 
proceeded, evidenced by increased ThT fluorescence and the appearance of fiber 
aggregates by TEM, the A11 antibody lost its affinity for CsgA (Figure 2.2A). A 
polyclonal antibody generated against CsgA recognized purified CsgA independent of its 
polymerization status (Figure 2.2A). 
The observation that the A11 antibody recognized CsgA suggested that CsgA 
polymerization intermediates might be structurally similar to those formed by 
disease-associated amyloid proteins. It also suggested that, immediately after purification, 
CsgA had already begun its transition to an amyloid fiber. To prevent CsgA from folding 
during purification, the CsgA-containing fractions were amended with 8 M GdnHCl. 
Under these strongly denaturing conditions, the A11 antibody did not recognize CsgA; 
however, denatured CsgA was strongly recognized by the CsgA antibody (Figure 2.2B). 
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Immediately after GdnHCl removal with a desalting column, CsgA was recognized by 
the A11 antibody (Figure 2. 2B).  
       To determine the minimum size of the CsgA transient intermediate, freshly 
purified protein was passed through Amicon Ultra centrifugal membranes with different 
molecular weight cutoffs. The retentate and filtrate were probed with the A11 antibody 
(Figure 2.2C). The A11 antibody recognized a species in the filtrate of the 30kD 
membrane, suggesting that the smallest reactive species of CsgA is 30 kD or less. 
Because CsgA-his has a predicted molecular mass of 13.9 kD, the species recognized by 
the A11 antibody is likely either a monomer or dimer. 
CsgA fibers can catalyze self-polymerization  
The approximately sigmoidal ThT fluorescence curve suggests that CsgA 
polymerizes in a nucleation-dependent mechanism. Therefore, the growing fiber would 
be expected to direct the polymerization of new CsgA molecules. We tested the 
hypothesis that preformed CsgA fibers could catalyze CsgA polymerization. Addition of 
2.5% (w/w) sonicated CsgA fibers to freshly purified, soluble CsgA resulted in a 
significant reduction of the lag phase (Figure 2.3A). Coincident with the dramatically 
shorter lag phase in seeded reactions, CsgA was recognized by the A11 antibody for a 
significantly shorter time compared to unseeded reactions (Figure 2.3B).  
CsgA is composed of several amyloid-forming units  
The observation that CsgA was recognized by the A11 antibody immediately after 
passing through a 30 kDa cutoff filter (Figure 2.2C) was unexpected since the A11 
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antibody is thought to recognize an oligomeric form of amyloidogenic proteins ( Kayed 
et al., 2003; Shorter and Lindquist, 2004; Lesne et al., 2006). The number of molecules 
present in the oligomeric state recognized by A11 varies among amyloidogenic proteins, 
and Aβ oligomers have been estimated to be larger than tetramers ( Kayed et al., 2003; 
Lesne et al., 2006). However, CsgA is recognized by A11 as a monomer or at most a 
dimer as estimated by cutoff filtration. It is possible that a single CsgA molecule includes 
multiple amyloidogenic domains that collectively contribute to its interaction with the 
A11 antibody. The primary sequence of CsgA can be divided into three parts: the 
Sec-dependent signal sequence, the N-terminal 22 amino acids of the mature protein, and 
a repeat domain that contains five 19-22 amino acid repeating units (Figure 2.4A). The 
five repeating units form a protease resistant structure that is proposed to be the amyloid 
core of CsgA (Barnhart and Chapman, 2006; Collinson et al., 1999). Each repeat has four 
conserved polar amino acids: serine, glutamine, asparagine and glutamine (Figure 2.4A). 
The regular arrangement of glutamine and asparagine residues also occurs in CsgA 
homologs from different Enterobacteriaceae (Wang and Chapman unpublished 
observation). 
We hypothesized that these repeating units might represent single amyloid 
forming units. Peptides corresponding to each repeating unit were chemically synthesized 
and tested for their ability to form amyloid fibers. Two independently derived 
preparations of each peptide were assayed. Peptides corresponding to repeating unit 1, 3 
or 5 (R1, R3 or R5) produced a ThT-positive signal and self-assembled into fibers as 
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evidenced by TEM when incubated at 0.2 mg/ml (Figure 2.4B-E). Neither R2 nor R4 
showed evidence of amyloidogenesis when resuspended at a concentration of 0.2 mg/ml, 
although fibers were observed by TEM when R2 or R4 were incubated at 2 mg/ml 
(Figure 2.4B and data not shown). The morphology of R1 fibers was similar to those 
formed by purified CsgA, being generally longer than 1000nm (compare Figure 2.4C to 
Figure 2.1D and 2.1E). R3 fibers were consistently shorter (ranging from 200nm-1000nm) 
than those formed by CsgA (compare Figure 2.4D to Figure 2.1D and 2.1E). R5 fibers 
appeared more rigid and aggregated than CsgA fibers (Figure 2.4E). The morphologies of 
the fibers did not appreciably change over the course of a ten-day incubation. This 
analysis suggests that CsgA contains at least 3 highly amyloidogenic domains, R1, R3 
and R5, that likely drive fiber formation in vivo.  
 
Discussion 
Amyloid formation is traditionally associated with uncontrolled protein 
misfolding and aggregation that results in many systemic and neurodegenerative 
disorders (Chiti and Dobson, 2006; Shorter and Lindquist, 2005). However, there are a 
growing number of functional amyloids that suggest amyloidogenesis is also a general 
tenet of normal cellular physiology. In fact, amyloid formation may be a common 
property of most proteins (Fandrich et al., 2001; Guijarro et al., 1998).  
    The work presented in this chapter, as well as that published previously, 
demonstrates that both disease-associated and functional amyloids share a common 
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amyloid formation pathway (Glover et al., 1997). CsgA polymerizes with 
nucleation-dependent kinetics and fiber formation is ameliorated by the addition of 
pre-formed CsgA fibers. We also found that CsgA polymerization involves the formation 
of a transient species similar to that produced by other amyloidogenic proteins such as Aβ, 
synuclein, IAPP, insulin, lysozyme and polyglutamine ( Kayed et al., 2003).  
The transient species that the A11 antibody recognizes during CsgA 
polymerization is a monomer or low-molecular weight multimer (Figure 2.2C). It was 
reported that the A11-recognized species of Aβ and Sup35p were probably large 
molecular weight oligomers (Kayed et al., 2003; Shorter and Lindquist, 2004). Unlike Aβ 
and Sup35p (Kayed et al., 2003; Shorter and Lindquist, 2004), CsgA was immediately 
recognized by the A11 antibody upon removal of strong denaturants like GdnHCl or after 
its passage through a 30 kD Amicon filter. At least two hypotheses can be proposed to 
explain CsgA’s ability to be recognized by A11 immediately after denaturation or passage 
through a 30 kD cutoff filter. First, CsgA may adopt an oligomeric conformation so 
quickly that our ability to measure this transition is lost in the time that it takes to 
immobilize CsgA on the blotting paper. Another possibility is that the CsgA species 
recognized by A11 is not an oligomer, but a monomer that contains multiple 
amyloidogenic units. It is possible that CsgA monomer or dimer rapidly folds into a 
conformation recognized by A11. Nevertheless, these two hypotheses are not mutually 
exclusive, and there may be other plausible interpretations.  
Nonetheless, CsgA contains multiple amyloidogenic domains that may contribute 
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to its ability to efficiently transition from a soluble protein to an amyloid fiber. Many 
studies have led to the proposal that amyloid fibers themselves are not toxic to cells, 
instead toxicity is proposed to be caused by transient folding intermediates ( Demuro et 
al., 2005; Glabe and Kayed, 2006; Hardy and Selkoe, 2002). Therefore, one mechanism 
that might be used by functional amyloids to prevent toxicity is to minimize the duration 
of toxic folding intermediates. This is apparently how Pmel17, an extremely rapidly 
forming functional amyloid found in mammalian cells, is able to assemble within the cell 
without eliciting a toxicity cascade (Fowler et al., 2005).  
CsgA has a striking primary sequence arrangement (Figure 2.4A). The five 
repeats of CsgA are very similar and share greater than 30% sequence identity. We 
showed that each repeating unit is potentially a single amyloid domain and that R1, R3 
and R5 are the highly amyloidogenic in vitro (Figure 2.4B-E). The covalent linkage of 
multiple amyloid domains may facilitate amyloid fiber formation by increasing the 
number of amyloidogenic building blocks. This also results in rapid formation of the 
intermediate recognized by the A11 antibody. Other amyloidogenic proteins contain 
repeat sequences that have been postulated to facilitate fiber formation (Ross et al., 2005; 
Wright et al., 2005). For instance, the N-terminal prion-determining domain of Sup35p 
has five imperfect oligopeptide repeats and certain deletions of the repeats are defective 
in propagation of Sup35p fibrils. Moreover, in vitro, repeat-expansion peptides (with 2 
extra repeats) were shown to be more amyloidogenic than wild-type peptides (Liu and 
Lindquist, 1999). Previous work suggested the most amyloidogenic domains of CsgA 
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were contained in the hexapeptide GHGGGN and QFGGGN, which are present in R2 
and R4 respectively (Cherny et al., 2005). However, our analysis suggests that R1, R3 
and R5 contain the more highly amyloidogenic sequences. A thorough mutagenesis study 
in later chapters defined the residues that contribute to the highly amyloidogenic nature 
and interaction specificity of CsgA. 
The amyloidogenic peptides R1 and R5 contain sequences that contribute 
significantly to the ability of CsgA to bind human proteins such as fibronectin, 
plasminogen, tissue plasminogen activator, and β2-microglobulin (Olsen et al., 2002). 
This correlation suggests amyloidogenecity of CsgA may be directly linked to these 
biological activities. In fact, work by Gebbink et al suggested that curli contribute to 
colonization in animal hosts by activating host proteases that are involved in haemostasis 
(Gebbink et al., 2005).  
Curli can also enhance amyloid protein A amyloidosis in mice (Lundmark et al., 
2005). It is proposed that cross-seeding may play a role in the development of amyloid 
diseases (Kisilevsky, 2000; Lundmark et al., 2005). The in vitro system that we have 
established here provides an ideal vehicle to test the specificity of curli seeding with other 
amyloids. Understanding how functional amyloid proteins interact with other host 
proteins may lead to new ideas about cellular physiology and the processes that promote 
the toxicity associated with many amyloids. 
Most amyloids are known to self-propagate in a process called seeding. In prion 
diseases such as Bovine Spongiform Encephalopathy, seeding underlies protein 
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infectivity (Prusiner, 1998). Amyloid self-propagation is also critical to disease 
development in the non-transmissible amyloid diseases(Kisilevsky, 2000; Lansbury, 
1999). Our demonstration of CsgA seeding suggests that functional amyloids also utilize 
a controlled self-propagation process to fulfill their biological function. In vivo CsgA 
polymerization is nucleated by the outer membrane associated protein CsgB, which 
shares nearly 49% sequence similarity with CsgA (Hammar et al., 1996). One proposed 
model of nucleation is that CsgB provides an amyloid-like template that initiates CsgA 
polymerization (Barnhart and Chapman, 2006; Hammar et al., 1996). The growing fiber 
tip could then act as a template to direct subsequent CsgA polymerization. 
Proteins that are not predicted to form stable globular folds may be prone to aggregation 
and amyloid formation, and indeed most functional amyloid proteins have natively 
disordered segments (Nelson and Eisenberg, 2006; Uversky et al., 2000). Consistent with 
this, some proteins have been shown to form amyloid fibers only after the native, 
globular fold has been compromised by chemical denaturants or by mutations ( Fandrich 
et al., 2001; Guijarro et al., 1998; Booth et al., 1997). Circular dichroism studies 
presented here suggest that CsgA is unstructured after secretion (Figure 2.1B). Mature 
CsgA is also predicted to be natively unfolded (data not shown) by the Uversky and 
Galzitskaya algorithms (Galzitskaya and Garbuzynskiy, 2006; Uversky et al., 2000). The 
natively unfolded segments of CsgA may facilitate amyloidogenesis indirectly by 
preventing formation of stable globular structures that would be less likely to aggregate 
and precipitate into a fiber. Alternatively, the unfolded regions of CsgA may actively 
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direct amyloidogenesis by presenting specific aggregative surfaces to neighboring 
molecules. In this context ‘natively unfolded’ would be a transition state during the 
formation of a stably folded amyloid fiber. Importantly, in the case of functional amyloids 
the amyloid fiber would not be the product of protein misfolding, but that of protein 
folding. Certainly, the growing number of functional amyloids suggests that amyloid is an 
evolutionarily conserved structure. The selective processes that have been employed by 
functional amyloids to limit cellular toxicity provide a unique context from which to 




























Figure 2.1. In vitro polymerization of CsgA measured by ThT fluorescence, CD and 
TEM. 
(A) The fluorescence of freshly purified CsgA mixed with 25 μM ThT was measured in 
10-minute intervals at 495nm after excitation at 438nm. (B) Circular dichroism analysis 
of 10 μM CsgA immediately after purification, 2 days post-purification, 7 days 
post-purification and 15 days post-purification. CsgA was incubated at room temperature 
without shaking after purification. (C-E) Transmission Electron Microscopy (TEM) 
micrographs of 30 μM CsgA after incubation at room temperature for the indicated times. 
(Scale bar: 500nm)  
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Figure 2.2. Detection of transient conserved intermediate species during CsgA 
polymerization.  
(A) ThT fluorescence (top) and immunoblotting (bottom) of 80 μM CsgA incubated for 
the indicated time post-purification. At the indicated times, samples were removed, ThT 
was added to a final concentration of 20 μM, and fluorescence was measured. Samples 
were blotted onto nitrocellulose membrane and probed with the A11 antibody, and after 
stripping, with the anti-CsgA antibody. (B) CsgA denatured with 8 M GdnHCl was 
blotted onto nitrocellulose and probed with the A11 and anti-CsgA antibodies (left). 
GdnHCl was removed using a Sephadex G25 column (final buffer: 50 mM KPi pH 7.2) 
and then immediately blotted onto nitrocellulose and probed with the A11 and anti-CsgA 
antibodies (right). (C) Amicon ultra filters were used to separate CsgA solutions prior to 
probing with the A11 and anti-CsgA antibodies. The molecular weight cutoff of the filters 
is indicated. Retentates and filtrates were immediately blotted onto nitrocellulose and 





























Figure 2.3. CsgA fibers can catalyze self-polymerization.  
(A) CsgA (40 μM) fluorescence in the absence (solid line) or presence of 2.5% by weight 
of sonicated CsgA fibers (dashed line). Samples were incubated at room temperature, 
collected at the indicated times and amended with 20 μM ThT prior to excitation at 
438nm and measurement at 495nm. (B) Samples were removed at the indicated times and 
immediately blotted to nitrocellulose. Blots were probed with the A11 antibody and after 













Figure 2.4. Three CsgA intramolecular peptide repeats can assemble into amyloid 
fibers.  
(A) Alignment of internally conserved residues. CsgA primary sequence shows the 
repeated consensus sequences. The identical amino acid residues of five repeats are in 
gray color and the conserved polar amino acid residues are enclosed in 4 boxes.  
(B) Oligopeptides of R1, R2, R3, R4 and R5 at 0.2 mg/ml in KPi were incubated at room 
temperature for 5 days before ThT fluorescence measurements were taken. Error bar 
indicates the standard error mean for at least three separate experiments. CsgA fibers 
were diluted to 0.2 mg/ml and assayed for ThT fluorescence. (C-E) Transmission 
Electron Microscopy (TEM). 0.5 mg/ml of R1, R3 and R5 in pH7.2 KPi were incubated 
at room temperature for 5 days. Samples of different peptide solutions were directly 
applied on formvar-coated grids and visualized with negative staining electron 
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N- and C-terminal Repeating Units Govern CsgA  
Nucleation and Seeding Responsiveness3 
 
Abstract 
Amyloid fibers are filamentous proteinaceous structures commonly associated 
with mammalian neurodegenerative diseases. Nucleation is the rate-limiting step of 
amyloid propagation and its nature remains poorly understood. E. coli assembles 
functional amyloid fibers called curli on the cell surface using an evolved biogenesis 
machine. In vivo, amyloidogenesis of the major curli subunit protein, CsgA, is dependent 
on the minor curli subunit protein, CsgB. In this chapter, I directly demonstrated that 
CsgB+ cells efficiently nucleated purified soluble CsgA into amyloid fibers on the cell 
surface. CsgA contains five imperfect repeating units that fulfill specific roles in directing 
amyloid formation. Deletion analysis revealed that the N- and C-terminal most repeating 
units were required for in vivo amyloid formation. I found that CsgA nucleation 
specificity is encoded by the N- and C-terminal most repeating units using a blend of 
genetic, biochemical and electron microscopic analyses. In addition, I found that 
C-terminal most repeat was most aggregation-prone and dramatically contributed to 
CsgA polymerization in vitro. This work defines the elegant molecular signatures of 
bacterial amyloid nucleation and polymerization, thereby revealing how nature directs 
amyloid formation to occur at the correct time and location. 
 
3 A version of this chapter has been published as Wang et al., 2008, J Biol Chem 283, 21530-21539. 
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Introduction 
Amyloid formation is most readily recognized as the underlying cause of 
neurodegenerative diseases and prion-based encephalopathies (Chiti and Dobson, 2006). 
At the root of these diseases is the uncontrolled conversion of soluble proteins into an 
insoluble fiber known as amyloid. Amyloid fibers are 4-10 nm wide, unbranched 
filaments possessing a characteristic cross-β sheet structure, and specific tinctorial 
properties when stained with Congo red and thioflavin T (ThT) (Chiti and Dobson, 2006). 
The disease-associated amyloid forming proteins have little similarity at amino acid level, 
although the resulting fibers are biochemically and structurally similar (Chiti and Dobson, 
2006). Although the pathology of amyloid diseases is incompletely understood, there is 
growing evidence that soluble folding intermediates are key to cytotoxicity and disease 
development (Bucciantini et al., 2002; Hartley et al., 1999; Lambert et al., 1998; Lesne et 
al., 2006; Roher et al., 1996; Walsh et al., 2002). 
An increasing number of examples suggest that amyloid fibers, or amyloidogenic 
intermediates, can be utilized to facilitate a particular physiological task (Fowler et al., 
2007). These ‘functional amyloids’ have been found in many organisms, including 
bacteria, fungi and mammals (Fowler et al., 2007). The functional amyloids provide a 
unique perspective on amyloidogenesis, since it is assumed that the cell has evolved 
mechanisms to control and propagate functional amyloid formation so that the 
cytotoxicity normally associated with amyloid formation is minimized. A compelling 
example of a functional amyloid is curli, a bacterially produced extracellular fiber that is 
required for biofilm formation and other community behaviors (Barnhart and Chapman, 
2006; Gerstel and Romling, 2003). Curli fibers exhibit the biochemical and structural 
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properties of amyloids (Chapman et al., 2002). E. coli possesses at least six proteins, 
encoded by the csgBA and csgDEFG (csg, curli specific genes) operons, that are 
dedicated to curli biogenesis. This highly regulated assembly machine ensures that the 
curli subunits interact at the correct time and location. 
In E. coli, the polymerization of the major curli fiber subunit protein CsgA into an 
amyloid fiber depends on the minor curli subunit protein, CsgB (Hammar et al., 1996). 
The mature CsgA protein has a predicted molecular weight of 13.1 kDa, and at least two 
distinct functional domains, an N-terminal outer membrane secretion domain (Robinson 
et al., 2006) and an amyloid core domain. The N-terminal domain is 22 amino acids long 
(residues 21 to 42 as shown in Figure 3.1A, as the first 20 amino acids are cleaved during 
translocation by the Sec inner membrane secretion complex) (Collinson et al., 1999). The 
amyloid core domain (residues 43 to 151) contains five imperfect repeating units, each 
19-23 amino acids (Figure 3.1A). The five repeating units form a protease-resistant 
structure (Collinson et al., 1999) that is proposed to be the amyloid core of CsgA (Wang 
et al., 2007). These repeats are distinguished by the consensus sequence 
Ser-X5-Gln-X4-Asn-X5-Gln linked by 4 or 5 residues, which is found in all known CsgA 
homologs from Enterobacteriaceae (Wang et al., 2007). Each repeat is predicted to form 
a β strand-loop-strand motif and five repeated motifs compose cross-β structure 
(Collinson et al., 1999). In vitro, chemically synthesized oligopeptide repeating unit 1 
(R1), R3 and R5 can efficiently assemble into amyloid-like fibers, suggesting that the 
individual repeats are amyloidogenic as presented in Chapter 2 (Wang et al., 2007). It is 
plausible that these five repeating units are critical for CsgA polymerization into an 
amyloid fiber in vivo. But how these repeat sequences direct CsgA polymerization remain 
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elusive. 
Most amyloids have the ability to promote their own polymerization in a process 
called seeding where preformed fibers provide templates for fiber elongation. This 
process potentially drives prion infectivity and the development of noninfectious amyloid 
diseases (Harper and Lansbury, 1997; Prusiner et al., 1998; Shorter and Lindquist, 2005). 
Likewise, CsgA polymerization is seeded by preformed CsgA amyloid fibers (Wang et al., 
2007). In vivo the nucleator protein CsgB initiates the polymerization of CsgA (Hammar 
et al., 1996). Because CsgB presents an amyloid-like template to CsgA, it was proposed 
that fiber-mediated self-seeding and CsgB-mediated heteronucleation are mechanistically 
similar processes (Hammer et al., 2007). As seeding/nucleation underlies the limiting step 
of amyloid propagation, understanding the nature of this mechanism will shed light on 
how to control amyloid formation. Here, I use a powerful blend of genetics, biochemistry 
and electron microscopy analysis to elucidate the sequence determinants and specificity 
of curli nucleation and polymerization. Although five repeats of CsgA share high 
sequence similarity, I found that only N- and C- terminal repeats are indispensable and 
responsive to CsgB-mediated heteronucleation and CsgA seeding. This work provides 
unique insights into the in vivo nucleated amyloid polymerization. 
 
Experimental Procedures 
Bacterial Growth  
To induce curli production, bacteria were grown on YESCA plates (1 g yeast 
extract, 10 g Casamino Acids and 20 g agar per liter) at 26°C for 48 hours (Chapman et 
al., 2002). When needed, antibiotics were added to plates at the following concentrations: 
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kanamycin 50 μg/ml, chloramphenicol 25 μg/ml, or ampicillin 100 μg/ml. 
Strains and Plasmids  
Strains and plasmids used in this study are listed in Table 3.1. Primer sequences 
used in this study are listed in Table 3.2. Plasmids containing repeat deletions were 
constructed by site-specific mutagenesis using overlapping PCR extension. The PCR 
products contained the relevant mutations and NcoI/BamHI sites at the 5’/3’ ends. PCR 
products were cloned downstream of the csgBA promoter into NcoI/BamHI sites of 
control vector pLR2 (Robinson et al., 2006). The csgA strain LSR10 (MC4100 ΔcsgA) 
and expression vector pMC3 were generated previously (Chapman et al., 2002). To 
express and purify CsgA mutant proteins, PCR amplified mutant sequences including 
sequence encoding 6 histidine residues at C-terminus were subcloned into pMC3 to 
replace sequence encoding CsgA-his. The truncated CsgA proteins and the plasmids 
encoding them were named to reflect the particular deletion. For example, CsgA lacking 
R1 was named ΔR1, and the plasmid encoding ΔR1 was named pΔR1. 
Western Blot Analysis  
Whole-cell and plug western blot analysis of CsgA were described previously 
(Chapman et al., 2002). Briefly, for whole-cell western analysis, bacteria were grown on 
YESCA plates at 26°C for 48 hours. Cells were scraped off the plates and normalized by 
optical density at 600 nm. Cell pellets (including cell associated protein aggregates) were 
resuspended in 2X SDS loading buffer either with or without prior formic acid (FA) 
treatment. Wild-type curli fibers require brief FA treatment prior to SDS PAGE in order 
to depolymerize CsgA monomers from the fiber (Collinson et al., 1991). For plug western 
analysis, cultures were normalized by optical density at 600 nm and spotted on the 
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YESCA plate. After growth at 26°C for 48 hours, 8 mm circular plugs that included cells 
and the underlying agar (plugs) were collected and resuspended in 2X SDS loading buffer 
either with or without prior FA treatment. Samples were electrophoresed on a 15% 
sodium dodecyl sulfate (SDS)-polyacrylamide gel and blotted onto polyvinylidene 
difluoride membrane using standard techniques. Western blots were probed by anti-CsgA 
polyclonal antibody that was raised in rabbits against purified CsgA (Proteintech, 
Chicago, IL) and was used at a dilution of 1:10,000. The secondary antibody was 
anti-rabbit antibodies conjugated to horseradish peroxidase (Sigma, St. Louis, MO) and 
was used at a dilution of 1:7,000. The blots were developed using the Pierce super signal 
detection system as previously described (Hammer et al., 2007). 
Transmission Electron Microscopy 
A Philips CM10 Transmission Electron Microscope was used to visualize the 
curliated cells and protein fiber aggregates. Samples (10 μl) were placed on 
Formvar-coated copper grids (Ernest F. Fullam, Inc., Latham, NY) for 2 min, washed 
with deionized water, and negatively stained with 2% uranyl acetate for 90 sec. 
Purification of Mutant Proteins 
C-terminal hexahistidine tagged CsgA or CsgA mutant proteins were 
overexpressed along with CsgG by induction with 0.25 mM isopropyl 
β-D-1-thiogalactopyranoside (IPTG) in LSR12 (C600 ΔcsgBAC and ΔcsgDEFG). In this 
strain, CsgA or CsgA mutant proteins were secreted to the medium and purified as 
previously described in Chapter 2 (Wang et al., 2007). Cell-free medium containing CsgA 
or CsgA mutant proteins was passed through a HIS-selectTM HF nickel-nitrilotriacetic 
acid column (Sigma, St. Louis, MO). His-tagged CsgA or CsgA mutant proteins were 
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eluted with 100 mM imidazole in 10 mM potassium phosphate (pH 7.2). Sephadex G25 
(balanced in 50 mM potassium phosphate, pH7.2) was used to remove the imidazole in 
the CsgA-containing fractions. Immediately after removal of imidazole, freshly purified 
proteins in 50 mM potassium phosphate (pH7.2) were soluble and unstructured as 
reported previously (Wang et al., 2007). CsgA and CsgA mutant proteins were purified to 
homogeneity by this approach as evidenced by single monomer band on SDS-PAGE 
stained by Coomassie blue. Plasmids encoding CsgA-His (Chapman et al., 2002) or 
ΔR2-His can complement a csgA mutant in vivo (data not shown), suggesting that His tag 
does not disrupt amyloidogenecity of CsgA and its mutants.  
In vitro polymerization assay  
For ThT assays, freshly purified CsgA or CsgA mutant proteins were passed 
through a 0.02-μm Anotop 10 filter (Whatman, Maidstone, UK) before being loaded on 
96-well opaque plate. ThT was added to a concentration of 20 μM. Fluorescence was 
measured every 10 min after shaking 5 sec by a Spectramax M2 plate reader (Molecular 
Devices, Sunnyvale, CA) set to 438 nm excitation and 495 nm emission with a 475 nm 
cutoff. ThT fluorescence was normalized by (Fi-F0)/(Fmax-F0). Fi was the ThT intensity 
(fluorescence arbitrary unit) of samples and F0 was the ThT background intensity. For the 
measurements of polymerization at different concentrations, Fmax was the maximum ThT 
intensity of samples at the highest concentration. For seeding reactions, Fmax was the 
maximum ThT intensity of the reaction in the absence of seeds. CsgA polymerization can 
be described as a triphasic process with a lag, growth and stationary phase (Wang et al., 
2007). We used the time intervals of lag phase (T0) and fiber growth phase (Tc) to 
describe the efficiency of polymerization. T0 and Tc were previously used to compare the 
 85
polymerization of yeast prion Sup35p and its mutants (DePace et al., 1998). Here, the T0 
was obtained by measuring the time interval between the starting point (0 hour) and the 
intersection point of the extrapolation line from the lag phase and extrapolation line of the 
major portion of the growth phase. The length of the growth phase (Tc) was calculated by 
subtracting T0 from the time at the beginning of the stationary phase, which includes the 
major portion of growth phase. 
Peptide preparation 
Peptides were chemically synthesized by Proteintech Group Inc., Chicago, IL. 
The peptides were dissolved in hexafluoroisopropanol (HFIP)/trifluoroacetic acid (TFA) 
(1:1 v/v) as previously described in Chapter 2 (Wang et al., 2007). Alternatively, peptides 
were dissolved in 8.0 M guanidine hydrochloride (GdnHCl) buffered by 50 mM 
potassium phosphate buffer at pH 7.2 to fully denature the sample. After at least 1 hour 
incubation, GdnHCl was quickly removed by a Sephadex G10 column that was balanced 
in 50 mM potassium phosphate, pH7.2 at room temperature. Peptides in potassium 
phosphate buffer (50 mM, pH7.2) were passed through a 0.02-μm Anotop 10 filter 
(Whatman, Maidstone, UK) and their polymerization was measured using ThT 
fluorescence as described for CsgA and mutant proteins. Similar results were obtained 
using either denaturing protocol and the HFIP/TFA denaturing protocol was used, unless 
indicated otherwise. 
In vitro seeding  
Mature fibers (2-week-old fibers) were sonicated using a Fisher Model 100 sonic 
dismembrator (Fisher, Pittsburgh, PA) for three 15-sec bursts on ice to produce seeds. 
Seeds were added to freshly purified or prepared samples immediately before the start of 
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ThT florescence assay. 
Overlay assay 
10 μl freshly prepared proteins or peptides were dripped on a lawn of the CsgB+ 
(csgA mutant strain LSR10) and CsgB- (csgAB mutant strain LSR13) cells which were 
grown on YESCA plates at 26°C for 48 hours. Samples were incubated on cells for 10 
min at room temperature unless otherwise specified, stained with 0.5 mg/ml Congo red 
solution (50 mM potassium phosphate, pH 7.2) for 5 min, and then washed with 
potassium phosphate buffer. Cells incubated with protein or peptide solution were 
collected for TEM analysis. 
 
Results 
R1 and R5 are critical for CsgA polymerization in vivo  
The amyloid core domain of CsgA (residues 43 to 151) contains five imperfect 
repeating units (Figure 3.1A). Using a series of csgA alleles that contained precise 
in-frame deletions, the role of each repeating unit was determined. The ability of csgA 
alleles to complement a non-amyloidogenic csgA mutant strain was assessed by western 
blotting and transmission electron microscopy (TEM). A csgA-/pCsgA strain produced 
curli fibers that were microscopically similar to those assembled by wild-type strain 
MC4100 as shown by TEM (Figure 3.2). Wild type curli are SDS insoluble and require 
brief treatment with formic acid (FA) to liberate CsgA monomers from the fiber 
(Collinson et al., 1991). Similarly, the CsgA produced by csgA-/pCsgA was SDS 
insoluble and did not migrate into an SDS PAGE gel without FA pretreatment (Figure 
3.1B, lanes 1 and 2). A csgA mutant transformed with pΔR2 produced curli fibers that 
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were similar to those produced by csgA-/pCsgA, suggesting that R2 is dispensable for 
curli formation (Figure 3.1B, lanes 7-8, Figure 3.1D and Figure 3.2). Fibers assembled by 
csgA-/pΔR3 and csgA-/pΔR4 appeared shorter than wild-type fibers (Figure 3.1D and 
Figure 3.2). Also, ΔR3 and ΔR4 fibers were less SDS resistant and migrated into an 
SDS-PAGE gel without FA treatment (Figure 3.1B, lanes 9, 10, 11 and 12). Deletion of 
R1 or R5 resulted in the most defective csgA alleles. Nearly no fibers were produced by 
csgA-/pΔR1 or csgA-/pΔR5 when analyzed by TEM (Figure 3.1D). Furthermore, ΔR1 and 
ΔR5 proteins were nearly undetectable in whole cell lysates scraped off YESCA plates 
(Figure 3.1B, lanes 5 and 6; lanes 13 and 14). To test the possibility that ΔR1 and ΔR5 
were secreted away from the cell as soluble proteins, cells and the underlying agar were 
collected and analyzed by western blotting. Both ΔR1 and ΔR5 were readily detected in 
samples that included the underlying agar, demonstrating that, like wild-type CsgA, ΔR1 
and ΔR5 were stable and secreted to the cell surface (Figure 3.1C, lanes 5, 6, 7 and 8). 
However, unlike CsgA, ΔR1 and ΔR5 were not assembled into an SDS-resistant fiber 
after secretion (Figure 3.1B and 3.1D). I also asked if ΔR1 and ΔR5 could form fiber 
aggregates if cells were incubated for 100 hours instead of our standard incubation time 
of 48 hours. A small number of fibril aggregates were observed in csgA-/pΔR1 samples 
incubated for 100 hours, although the fibers were rarely detected and they did not 
associate with cells (Figure 3.3). In contrast to ΔR1, ΔR5 did not form any detectable 
fiber aggregates, even after 100 hours of incubation (Figure 3.3).  
We noted that ΔR1 and ΔR3 migrated more slowly than other mutant proteins on 
SDS-PAGE even though they are all of similar predicted molecular weights. Purified 
homogeneous proteins ΔR1 and ΔR3 also migrated more slowly than other repeat 
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deletion mutant proteins, suggesting the different migration rates resulted from the 
intrinsic properties of mutant proteins. The nature of these aberrant mobilities was not 
investigated further in this study. 
R5 is critical for in vitro self-polymerization of CsgA  
At least two possibilities existed as to why ΔR1 and ΔR5 did not assemble into 
amyloid fibers in vivo. The first possibility is that ΔR1 and/or ΔR5 were missing 
CsgB-responsive domains that prevented them from participating in nucleation. 
Alternatively, ΔR1 and ΔR5 might inefficiently participate in intermolecular interactions 
with themselves. To test the ability of mutant proteins to self-assemble into an amyloid 
fiber, I utilized an in vitro polymerization assay that is CsgB-independent as presented in 
Chapter 2 (Wang et al., 2007). ΔR1, ΔR2, ΔR3, ΔR4 and ΔR5 were purified and their 
polymerization was compared to wild-type CsgA using a ThT assay described in our 
previous work (Wang et al., 2007). In vitro wild-type CsgA polymerization is 
characterized by three distinct phases: lag, growth and stationary as shown in Chapter 2 
(Wang et al., 2007). When comparing the polymerization of CsgA mutant proteins I 
utilized two simple parameters that were previously used to describe the polymerization 
of yeast prion Sup35p (DePace et al., 1998). The first kinetic parameter was the time 
period preceding rapid fiber growth, called lag phase, or T0. The second parameter was 
the time period encompassing fiber growth phase (Tc) (DePace et al., 1998). Interestingly, 
when the samples were incubated at room temperature with intermittent shaking, T0 and 
Tc for ΔR1, ΔR2, ΔR3 and ΔR4 were similar to those of wild-type CsgA (Figure 3.4A and 
4B). However, both T0 and Tc for ΔR5 were dramatically increased (Figure 3.4A and 4B). 
TEM analysis confirmed that the ThT positive aggregates formed by CsgA mutant 
 89
proteins were ordered fibers (Figure 3.5). Furthermore, the T0 values of CsgA, ΔR1, ΔR2, 
ΔR3 and ΔR4 were concentration independent above 10 μM, while the T0 value for ΔR5 
was inversely correlated to concentration up to 200 μM (Figure 3.4A and data not shown). 
When the proteins were incubated without intermittent shaking, ΔR5 polymerization was 
even more defective relative to wild-type CsgA. At a concentration of 50 μM T0 and Tc 
values of ΔR5 polymerization were two orders of magnitude greater than those of CsgA 
(Figure 3.6). ΔR5 incubated at 10 μM without shaking did not assemble into fibers within 
800 hours (Figure 3.6). These results suggest that R5 plays a critical role in CsgA 
self-polymerization. Peptides corresponding to each repeating unit were synthesized 
(Wang et al., 2007) and their polymerization kinetics was determined by ThT 
fluorescence (Figure 3.4C and 3.4D). The strong denaturing reagents, 8.0 M GdnHCl or 
HFIP/TFA (1:1 v/v), were employed to remove possible seeds that would unpredictably 
influence polymerization kinetics. Chemically synthesized R1, R3 and R5 peptides 
efficiently assembled into ThT-positive fibers in vitro as shown in Chapter 2 (Wang et al., 
2007). Like CsgA, R1 and R3 peptides polymerized into ThT-positive fibers in a triphasic 
fashion that included a discernable lag, growth and stationary phase (Figure 3.4C). At a 
concentration of 0.6 mg/ml (~240 μM), T0 values of R1 and R3 were approximately 7.5 
and 15 hours, respectively (Figure 3.4C). Unlike R1 and R3, the R5 polymerized with no 
apparent lag phase, becoming ThT-positive immediately after removal of the denaturant 
(Figure 3.4C). Even when R5 was incubated at relatively low concentrations (15 μM), 
there was no detectable lag phase (Figure 3.4D). The Tc value of R5 was also shorter than 
that of R1 and R3 (Figure 3.4C). Under the same conditions, R2 and R4 were never 
observed to polymerize as measured by ThT fluorescence and TEM (Figure 3.4C and 
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data not shown). Collectively, these results demonstrate that R5 is the most 
aggregation-prone of the repeating unit peptides.  
CsgA efficiently responds to CsgB nucleation to assemble into amyloid fibers 
Although CsgA can self-assemble into amyloid fibers in vitro, CsgA 
polymerization in vivo is dependent on the CsgB nucleator. Direct evidence that soluble 
CsgA can be converted to an amyloid fiber by wild-type CsgB is missing. To test whether 
the cell surface-exposed CsgB can nucleate the polymerization of purified CsgA, I 
developed an overlay assay using CsgB+ or CsgB- cells and freshly purified soluble CsgA 
protein (Figure 3.7A). Different concentrations of CsgA were overlaid on CsgB+ (csgA) 
or CsgB- (csgAB) cells and CsgA polymerization was detected using the amyloid specific 
dye Congo red and TEM (Figure 3.7B-E). CsgA overlaid on CsgB+ cells efficiently 
assembled into amyloid-like fibers as shown by Congo red staining and TEM (Figure 
3.7B and 3.7D), while CsgA overlaid on CsgB– cells did not induce Congo red binding 
and did not assemble into fibers shown by TEM (Figure 3.7C and 3.7D). CsgA fibers 
formed on CsgB+ cells in the overlay assay were similar to wild-type curli fibers formed 
by csgA-/pCsgA (Compare Figure 3.7B and 3.1D). The CsgB-mediated polymerization of 
purified CsgA occurred in as little as 6 minutes (1 min incubation and 5 min Congo red 
staining) (Figure 3.7E).  
Mapping the CsgB-responsive sequences in CsgA  
The CsgB-responsive repeating units in CsgA were mapped using the overlay 
assay and peptides corresponding to each repeating unit. 2.0 mg/ml of freshly prepared 
R1, R2, R3, R4 or R5 peptides was overlaid onto CsgB+ and CsgB- cells. When either R1 
or R5 was overlaid on CsgB+ cells, amyloid-like fibers were detected by Congo red 
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binding and TEM (Figure 3.8A and 3.8B). When either R1 or R5 was overlaid on CsgB- 
cells for the same incubation time, no Congo red binding was observed and no fibers 
were detected by TEM (Figure 3.8A and data not shown). The R1 and R5 fibers formed 
on CsgB-presenting cells were shorter and thinner than fibers assembled by wild-type 
CsgA polymerization on the surface of the cell (Compare Figure 3.8B, 3.7B, 3.1D and 
3.2). When 2.0 or 4.0 mg/ml R2, R3 and R4 were overlaid on CsgB+ or CsgB- cells, no 
fibers were formed as evidenced by the lack of Congo red binding and by TEM analysis. 
This suggested that R2, R3 and R4 were unable to interact with CsgB to promote fiber 
assembly (Figure 3.8A and data not shown). Therefore, we concluded that R1 and R5 
were the CsgB heteronucleation-responsive domains of CsgA. 
To further test the notion that R1 and R5 were the only CsgB-responsive domains 
of CsgA, a csgA allele without both R1 and R5 (ΔR1&5) was engineered and its CsgB 
responsiveness was measured. ΔR1&5 was unable to complement a csgA mutant for curli 
biogenesis (data not shown). Unlike CsgA, ΔR1&5 did not respond to CsgB nucleation 
on CsgB+ cells measured with the overlay assay even after extended incubation (Figure 
3.8C). In vitro, ΔR1&5 polymerized into ThT-positive fibers, with T0 and TC values 
comparable to those of ΔR5 (compare Figure 3.4A and 3.8D). Fiber aggregates formed by 
ΔR1&5 in vitro were short and protofibril-like, similar to fibers assembled by peptide R3 
by TEM (data not shown). A nucleation-competent CsgB truncation mutant (CsgBtrunc) 
was purified as previously described (Hammer et al., 2007). CsgBtrunc has been 
demonstrated to seed wild-type CsgA (Hammer et al., 2007). Unlike CsgA, the 
polymerization of ΔR1&5 was not stimulated by CsgBtrunc in vitro (Figure 3.8D). 
Collectively, these results demonstrate that a csgA allele missing R1 and R5 is not 
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responsive to CsgB-mediated heteronucleation in vivo and in vitro. 
R1 and R5 are CsgA seeding responsive domains 
CsgA polymerization is a self-propagating process in which CsgA seeds can 
completely eliminate the lag phase as presented in Chapter 2 (Wang et al., 2007). 
However, the determinants of CsgA seeding specificity are poorly understood. Our results 
demonstrate R1 and R5 are CsgB-responsive domains. To test whether R1 and R5 also 
play an important role in growth of CsgA fibers, I tested CsgA seeding on ΔR1, ΔR5 and 
ΔR1&5 in vitro. CsgA seeds eliminated the lag phase of ΔR1 and ΔR5 polymerization 
(Figure 3.9A and 3.9B), while ΔR1&5 polymerization was not promoted by CsgA 
seeding (Figure 3.9C). These findings demonstrated that both R1 and R5 are involved in 
the response to CsgA seeding and specificity is encoded in R1 and R5 sequences. 
In support of the hypothesis that only R1 and R5 are CsgA seeding-responsive domains, 
each repeating unit peptide was incubated with wild-type CsgA fiber seeds. The lag phase 
of R1 polymerization was completely eliminated when 2% preformed CsgA fibers were 
added to the reaction (Figure 3.9D). In order to test the responsiveness of R5 to CsgA 
seeding, I needed to slow the aggregation of R5 so that a discernable lag phase could be 
observed. In the presence of 1.0 M GdnHCl, 0.2 mg/ml R5 remained unpolymerized for 
over 40 hours (Figure 3.9E). CsgA seeds eliminated the lag phase of R5 even under these 
mildly denaturing conditions (Figure 3.9E). However, CsgA seeds did not accelerate R3 
polymerization (Figure 3.9F). CsgA seeds were also unable to stimulate the 
polymerization of R2 and R4 peptides, as both R2 and R4 remained unpolymerized for 
48 hours detected by ThT assay and TEM (data not shown). 
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Discussion 
Amyloid formation has been associated with neurodegenerative diseases for over 
a century, yet very little is known about the mechanism of nucleated polymerization in 
vivo. Curli provide a sophisticated genetic and molecular tool set with which to explore 
amyloid nucleation and polymerization. I have described the molecular determinants of a 
highly evolved and elegant amyloid assembly pathway. CsgB-mediated heteronucleation 
is requisite for in vivo curli fiber assembly. I extensively investigated the CsgA sequence 
determinants for nucleation and polymerization. I found that the N- and C- terminal 
repeats (R1 and R5) are indispensable for curli biogenesis in vivo. R5 is the most 
aggregation-prone repeating unit and it contributes dramatically to CsgA polymerization 
in vitro. R1 and R5 play critical roles in CsgA seeding and CsgB heteronucleation 
response.  
Molecular details of curli assembly 
Curli biogenesis occurs via a nucleation-precipitation mechanism, where 
surface-exposed CsgB nucleates secreted CsgA into an insoluble fiber (Hammar et al., 
1996; Hammer et al., 2007). I found that R1 and R5 are indispensable for in vivo curli 
assembly (Figure 3.1). I have provided direct evidence that surface-exposed CsgB 
promotes the transition of CsgA from a soluble protein to an insoluble amyloid-like fiber 
(Figure 3.7). Both R1 and R5 of CsgA were demonstrated to respond to CsgB 
heteronucleation (Figure 3.8). Similarly, preformed CsgA fibers (in the absence of CsgB) 
were able to recruit soluble CsgA into the fiber in a process called seeding (Wang et al., 
2007). Seeding was also dependent on R1 and R5 (Figure 3.9). Based on these results I 
propose a promiscuous nucleation model to describe the molecular details of curli 
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assembly (Figure 3.10). CsgA is not amyloidogenic within or outside the cell until it 
encounters outer membrane-localized CsgB. This temporal and spatial control might 
prevent the proteotoxicity of amyloid formation. After CsgA is secreted from cells, either 
R1 or R5 of CsgA interacts with CsgB or the growing fiber tip, facilitating CsgA 
polymerization (Figure 3.10). Collectively, the curli fiber assembly machinery on the cell 
surface is composed of multiple nucleation templates (CsgB and CsgA fiber tip) and 
multiple responsive domains of fiber subunit CsgA (R1 and R5), which makes nucleation 
polymerization an efficient process in vivo. 
Microbes assemble many proteinaceous fibers on their cell surface. One challenge 
to assembling extracellular fibers is prevention of subunit diffusion to the extracellular 
milieu. Therefore, the assembly of curli, pili and flagella must be regulated so that 
efficient subunit incorporation into the fiber occurs. P and type-I pilus assembly is 
dependent on the chaperone/usher pathway, where periplasmic chaperone proteins deliver 
the pilus subunits to the outer membrane-localized usher protein. On the periplasmic side 
of the usher, pilus subunits are added to the base of the growing pilus. Because pilus 
subunits never leave the periplasmic space before incorporation into the pilus, there is no 
chance for diffusion of unassembled subunits to the extracellular space (Sauer et al., 
2004). Flagella are another common extracellular fiber assembled by Gram-negative 
bacteria. Soluble flagellin is secreted through the growing fiber until it is bound by the 
cap protein and polymerized onto the distal end (Yonekura et al., 2002). In contrast to 
flagella and pili assembly, the major curli subunit CsgA is secreted from the cell as a 
soluble protein, which subsequently polymerizes into a fiber. To ensure that secreted 
subunits are efficiently incorporated into an amyloid fiber, curli assembly is dependent on 
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the CsgB nucleator and multiple CsgA responsive domains. Nucleation, the stalwart of 
curli formation, is also important for disease-associated amyloid formation. 
Understanding the molecular signatures of nucleation will lead to new insights into 
disease-associated protein aggregation.   
Distinction between in vivo and in vitro bacterial amyloid formation  
Even though CsgA is amyloidogenic in vitro, it remains soluble in the 
extracellular milieu in the absence of nucleator CsgB in vivo (Hammar et al., 1996). Like 
a csgB mutant, csgA alleles missing one or both CsgB-responsive domains (R1 and R5) 
are unable to efficiently polymerize in vivo. For example, ΔR1 is completely defective in 
curli assembly in vivo, even though ΔR1 polymerizes with similar kinetics as wild-type 
CsgA in vitro (Figure 3.1 and Figure 3.4). ΔR1 was mostly incapable of forming fiber 
aggregates in vivo, even if cells were incubated for over 100 hours instead of the standard 
48 hours. A small amount of ΔR1 short fibril aggregates not associated with cells were 
observed by TEM, while ΔR5 was never observed to form fiber aggregates by TEM 
( Figure 3.3). These observations were consistent with the in vitro polymerization results: 
ΔR1 polymerization was much more efficient than ΔR5 polymerization (Figure 3.4A and 
4B). This suggests that within natural cellular environments the amyloidogenecity of 
CsgA is tightly controlled by the CsgB heteronucleator. Therefore, these intermolecular 
interactions between CsgA and CsgB initiate bacterial amyloid formation at the correct 
place and time.  
Nucleation specificity of amyloid formation 
Nucleation/seeding is the rate-limiting step of amyloid formation (Jarrett and 
Lansbury, 1993). The mechanism and specificity of nucleation is poorly understood. 
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Nucleation specificity is arguably the best understood in the yeast prion Sup35p. One 
small region (amino acids 9-39) located in the N-terminal prion domain of Sup35p 
governs self-recognition and species-specific seeding activity (Tessier and Lindquist, 
2007). The residues located in this region are critical for prion propagation (DePace et al., 
1998). Here, I demonstrated that bacterial amyloid protein CsgA also contains two small 
regions (R1 and R5) that control nucleation response. It may be a general rule that only 
small portions (nucleation sites) of amyloid proteins govern the nucleation response and 
specificity. The residues contained in the nucleation site determine the nucleation 
response and specificity. Mutagenesis analyses on Sup35p (DePace et al., 1998) and 
CsgA support this notion. The nucleation sites of Sup35p and CsgA are located within the 
protease-resistant amyloid core of the proteins, and peptides containing the nucleation 
sites of Sup35p and CsgA are sufficient to form amyloid fibers in vitro (Glover et al., 
1997; Wang et al., 2007).  
CsgA homologues from different bacteria share high sequence similarity 
suggesting cross-species nucleation might occur. Salmonella typhimurium CsgA and 
CsgB homologues are 74.8% and 82.1% identical to E.coli CsgA and CsgB, respectively. 
Salmonella typhimurium csgA and csgB genes can complement E.coli csgA and csgB 
mutations in terms of fiber assembly (Romling et al., 1998). Because curli subunits are 
secreted into the extracellular milieu prior to incorporation into the fiber, complex 
bacterial communities may have members that secrete CsgA-like molecules and others 
that produce CsgB-like nucleators. It is plausible that nucleation promiscuity facilitates 
interspecies fiber formation in complex communities, allowing curli to act as a structural 
signal that links different species together. 
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Figures and Tables 
Figure 3.1. R1 and R5 are critical for CsgA in vivo polymerization into an amyloid 
fiber. (A) Schematic of CsgA including an N-terminal Sec signal peptide and the 
N-terminal 22 residues that precede the five repeating units. (B) Whole-cell western blots 
of csgA mutant strains harboring the following plasmids: pCsgA (lanes 1 and 2), vector 
control (VC) (lanes 3 and 4), pΔR1 (lanes 5 and 6), pΔR2 (lanes 7 and 8), pΔR3 (lanes 9 
and 10), pΔR4 (lanes 11 and 12) and pΔR5 (lanes 13 and 14). Samples were treated with 
(+) or without (-) FA. The blot was probed with anti-CsgA antibody. (C) Western blot of 
whole-cells and underlying agar (agar plugs) from csgA strains containing constructs 
pCsgA (lanes 1 and 2), vector control (lanes 3 and 4), pΔR1 (lanes 5 and 6) and pΔR5 
(lanes 7 and 8) grown 48 hours at 26°C on YESCA plates. Samples were treated with (+) 
or without (-) FA. The blots were probed with anti-CsgA antibody. (D) Negative-stain 
EM micrographs of csgA mutant cells containing the indicated plasmids. Cells were 
grown on YESCA plates for 48 hrs at 26°C prior to staining with uranyl acetate. Scale 






Figure 3.2. Negative-stain EM micrographs of CsgA, ΔR2, ΔR3 and ΔR4 fibers 
assembled in vivo at high magnification. 
Negative-stain EM micrographs of wild-type strain MC4100 and csgA mutant cells 
containing the indicated plasmids. Cells were grown on YESCA plates for 48 hrs at 26°C 





















Figure 3.3. Negative-stain EM micrographs of csgA cells expressing CsgA, ΔR1 or 
ΔR5 for a long-term growth. 
Negative-stain EM micrographs of csgA mutant cells containing the indicated plasmids. 
Cells were grown on YESCA plates for 100 hrs at 26°C prior to staining with uranyl 



















Figure 3.4. In vitro polymerization of CsgA, mutant CsgA proteins and peptides.  
(A) The normalized fluorescence intensity of freshly purified CsgA and repeat deletion 
analogues was measured at 495 nm after excitation at 438 nm in the presence of 20 μM 
ThT. Samples were shaken for 5 seconds prior to fluorescence measurements in 10 
minute intervals. The protein used in the assay is indicated at the top of the graph and the 
protein concentration is above the relevant data points. The X-axis of each graph spans 
from 0 hr to 10 hrs, except for ΔR5 which spans from 0 hr to 35 hrs. (B) Lag time (T0) of 
freshly purified CsgA and CsgA analogues incubated at 10 μM. Data were expressed as 
the mean ± SEM of three independent experiments. (C) The polymerization of 0.6 mg/ml 
(~240 μM) chemically synthesized peptides R1, R2, R3, R4 and R5 was measured by 
ThT fluorescence. (D) The polymerization of 15 μM and 30 μM R5 peptide was 







Figure 3.5. EM Micrographs of in vitro polymerized fibers from CsgA and mutant 
proteins.  
(A-F) Negative-stain EM micrographs of in vitro polymerized fibers of CsgA (A), 





















Figure 3.6. In vitro polymerization of CsgA mutant proteins under the quiescent 
condition. 
13 μM CsgA (A) and ΔR5 at various concentrations (B) were incubated at room 
temperature without agitation in the presence of 0.02% NaN3. At the indicated time 
points, samples were withdrawn, ThT was added at a concentration of 20 μM and 
fluorescence was measured at 495 nm after excitation at 438 nm by a Spectramax M2 
plate reader (Molecular Devices, Sunnyvale, CA). ThT fluorescence was normalized as 




























Figure 3.7. Purified CsgA is efficiently nucleated when overlaid on CsgB-expressing 
cells.  
(A) A schematic presentation of the overlay assay in which freshly purified and soluble 
CsgA is dripped onto cells expressing the nucleator protein, CsgB. In the presence of 
CsgB, CsgA (shown as a circle) undergoes a conformational change and polymerizes into 
a fiber (shown as a chevron). In the absence of CsgB, CsgA remains soluble and does not 
assemble into an amyloid fiber. (B-C) Negative-stain EM micrographs of CsgA-B+ (B) 
and CsgA-B- (C) cells grown on YESCA plates for 48 hours at 26°C that were overlaid 
with freshly purified 40 μM CsgA. Scale bars are equal to 500 nm. (D) Congo red 
staining of CsgA-B+ and CsgA-B- cells after being overlaid with different concentrations 
of soluble CsgA. (E) 72 μM CsgA was overlaid on CsgA-B+ and CsgA-B- cells and 











Figure 3.8. R1 and R5 are responsive to CsgB heteronucleation.  
(A) 2.0 mg/ml of freshly prepared peptide solution was overlaid on CsgA-B+ and CsgA-B- 
cells. After a 5-minute incubation, cells were stained with 0.5 mg/ml Congo red solution 
for 5 min and washed once by 50 mM potassium phosphate buffer. 
(B) Negative-stain EM micrographs of CsgA-B+ cells overlaid with freshly prepared R1 
(left) and R5 (right). Conditions are the same as in (A). Scale bars are equal to 200 nm. 
(C) Freshly purified 105 μM ΔR1&5 was overlaid onto CsgA-B+ and CsgA-B- cells. 
ΔR1&5 was incubated on cells for 10 hours before staining with Congo red. (D) 3% and 
6% CsgBtrunc by weight was added to freshly purified 50 μM ΔR1&5. The polymerization 




















Figure 3.9. R1 and R5 are responsive to CsgA seeding.  
(A)-(C) Indicated percentages of sonicated CsgA fibers were added to freshly prepared 17 
μM ΔR1 (A), 50 μM ΔR5 (B) and 50 μM ΔR1&5 (C). The polymerization was measure 
by ThT fluorescence. (D) 2% sonicated CsgA fibers were added to freshly prepared 1.0 
mg/ml R1 peptide solution. The polymerization was measured by ThT fluorescence. (E) 
R5 was solubilized in HFIP/TFA. Upon removal of HFIP/TFA, R5 was resuspended in 
1.0 M GdnHCl buffered by 50 mM potassium phosphate buffer at pH 7.2. 4% and 8% 
sonicated CsgA fibers were added to 0.2 mg/ml R5 solution in the presence of 1.0 M 
GdnHCl, mixed with ThT at 20 μM and fluorescence was measured. (F) Indicated 
percentages of sonicated CsgA fibers were added to freshly prepared 1.0 mg/ml R3 



















Figure 3.10. The promiscuous nucleation model of CsgA in vivo polymerization.  
Curli assembly is governed by surface-localized CsgB (heteronucleation) and by the 
growing fiber tip (homonucleation). After secretion from the periplasm to extracellular 
































a Vectors used for expression and purification are not listed. These vectors were 
constructed by insertion of PCR amplified mutant csgA sequences with C-terminal 
hexahistidine tag into NdeI/EcoR1 sites in pMC3 (Chapman et al., 2002) replacing 
sequence encoding CsgA-his. 
b pΔR1 was used as template for PCR to make pΔR1&5. 
Strains or 
Plasmids Relevant characteristics References Primer used 
Strains      
csgA (LSR10) MC4100 ΔcsgA (Chapman et al., 2002)  
csgBA 
(LSR13) MC4100 ΔcsgBA (Hammer et al., 2007)  
LSR12 C600 ΔcsgBA andΔcsgDEFG (Chapman et al., 2002)  
Plasmids    
pCsgA (pLR5)  csgA sequence in pLR2 Hultgren lab  
pLR2 
 
Control vector containing 






































































Table 3.2.  Sequence of primers used in Chapter 3 
 
a FpLR5 is paired to noncoding strand immediately upstream of the start codon of csgA in 
pLR5. 
b RpLR5 is paired to coding strand immediately downstream of the stop codon of csgA in 
pLR5. 
C The primers with odd number such as pΔR1 P1 are paired to the coding strand of csgA  
template. 


















Primer Name Sequence 
FpLR5a 5’ CATGCCATGGCGAAACTTTTAAAAGTAGC 3’ 
RpLR5b 5’ CGGGATCCTGTATTAGTACTGAT 3’ 
PΔR1 P1c 5’ AATAGTCAAGTCAGAATTTGGGCCGCTATT 3’ 
PΔR1 P2d 5’ AATAGCGGCCCAAATTCTGACTTGACTATT 3’ 
PΔR2 P1  5’ GATCGATTGAGCTGTTACGGGCATCA 3’ 
PΔR2 P2 5’ TGATGCCCGTAACAGCTCAATCGATC 3’ 
PΔR3 P1 5’ CCGTCATTTCAGAGTCATCTGAGCCCT 3’ 
PΔR3 P2 5’ AGGGCTCAGATGACTCTGAAATGACGG 3’ 
PΔR4 P1  5’ CGTTGACGGAGGAATTTTTGCCGTTC 3’ 
PΔR4 P2 5’ GAACGGCAAAAATTCCTCCGTCAACG 3’ 
PΔR5 P1 5’ CGGGATCCTGTATTAGTTAGATGCAG 3’ 
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The Critical Roles of the Conserved Glutamine and Asparagine 
Residues in CsgA Nucleation and Polymerization4 
 
Abstract 
Amyloids are proteinaceous fibers commonly associated with neurodegenerative 
diseases and prion-based encephalopathies. Many different polypeptides can form 
amyloid fibers, leading to the suggestion that amyloid is a primitive main-chain-
dominated structure. A growing body of evidence suggests that amino acid side chains 
dramatically influence amyloid formation. The specific role fulfilled by side chains in 
amyloid formation, especially in vivo, remains poorly understood. In this chapter, I 
determined the role of internally conserved polar and aromatic residues in promoting 
amyloidogenesis of the functional amyloid protein, CsgA. CsgA is the major protein 
component of curli fibers assembled by enteric bacteria such as Escherichia coli and 
Salmonella spp. In vivo CsgA polymerization into an amyloid fiber requires the CsgB 
nucleator protein. The CsgA amyloid core region is composed of five repeating units, 
defined by regularly spaced Ser, Gln and Asn residues. The results of a comprehensive 
alanine scan mutagenesis screen showed that Gln and Asn residues at positions 49, 54, 
139 and 144 were critical for curli assembly. Alanine substitution of Q49 or N144 
impeded the ability of CsgA to respond to CsgB-mediated heteronucleation, and the 
ability of CsgA to self-polymerize in vitro. However, CsgA proteins harboring these 
 
4 A version of this chapter has been published as Wang et al., 2008, J Mol Biol 380, 570-580. 
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mutations were still seeded by preformed wild-type CsgA fibers in vitro. This suggests 
that CsgA-fibril-mediated seeding and CsgB-mediated heteronucleation have 
distinguishable mechanisms. Remarkably, Gln residues at positions 49 and 139 could not 
be replaced by Asn residues without interfering with curli assembly, suggesting that the 
side chain requirements were especially stringent at these positions. This analysis 
demonstrates that bacterial amyloid formation is driven by specific side chain contacts 




Amyloid formation is readily associated with neurodegenerative diseases and 
prion-based encephalopathies (Chiti and Dobson, 2006). Amyloid fibers are 4-10 nm 
wide, unbranched proteinaceous filaments (Chiti and Dobson, 2006). Amyloid fibers 
possess a characteristic cross-β sheet quaternary structure, in which β strands are 
perpendicular to fibril axis.1 These fiber structures have specific tinctorial properties, 
binding to dyes such as Congo red and thioflavin T (ThT) (Chiti and Dobson, 2006). 
Amyloid toxicity is complex, but a growing body of work suggests that pre-fiber 
aggregates are cytotoxic, while mature fibers are relatively benign (Hardy and Selkoe, 
2002). Therefore, understanding the folding cascades involved in amyloid formation is 
necessary for developing new therapies to target these processes. 
A newly described class of ‘functional’ amyloids suggest that amyloid formation 
can be an integral part of normal cellular physiology (Fowler et al., 2007; Hammer et al., 
2008). Functional amyloids provide a unique perspective on amyloidogenesis because the 
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cell must have coevolved mechanisms to prevent the toxicity normally associated with 
amyloid formation. One of the best understood functional amyloids is curli, a bacterially 
produced extracellular fiber required for biofilm formation and other community 
behaviors (Barnhart and Chapman, 2006). In E. coli, the polymerization of the major 
curli fiber subunit protein CsgA into an amyloid fiber is dependent on the minor curli 
subunit protein, CsgB (Hammar et al., 1996). CsgA remains soluble until it encounters 
outer membrane-localized CsgB (Barnhart and Chapman, 2006). CsgB has also been 
demonstrated to have amyloid-forming properties and apparently serves as a template for 
CsgA polymerization (Hammer et al., 2007).  
We previously showed that, like many other amyloids, preformed CsgA fibers 
could seed soluble CsgA polymerization in vitro as presented in Chapter 2 (Wang et al., 
2007). Therefore, we proposed that the growing CsgA fiber on the cell surface could 
serves as a template promoting soluble CsgA polymerization in a process akin to seeding 
(Wang et al., 2007). The molecular details of CsgA fiber-mediated seeding and CsgB-
mediated heteronucleation remain poorly described. Because nucleation underlies the 
rate-limiting step of amyloid propagation, understanding the nature of this mechanism 
will shed light on how cells control amyloid formation. 
The primary sequence of CsgA can be divided into three functional domains: an 
N-terminal Sec signal sequence (cleaved after translocation into the periplasmic space), 
an N-terminal 22 amino acid segment (N22) that directs CsgA secretion across the outer 
membrane (Robinson et al., 2006), and an amyloid core region (residues 43 to 151) that 
contains five imperfect repeating units, each 19-23 amino acids in length (Figure 4.1A) 
(Barnhart and Chapman, 2006). The five repeating units form a protease-resistant 
 116
structure (Collinson et al., 1999), which is proposed to be the amyloid core of CsgA 
(Wang et al., 2007). These repeats are distinguished by the consensus sequence Ser-X5-
Gln-X4-Asn-X5-Gln and are linked by 4 or 5 residues (Collinson et al., 1999). These Ser, 
Gln and Asn residues are conserved among CsgA homologs of many enteric bacteria 
(Wang et al., 2007). This high degree of amino acid sequence conservation suggests that 
these residues may play an important role in curli assembly.  
     Many polypeptides, if not all, can assemble into an amyloid fiber in vitro even though 
amyloid-forming proteins do not necessarily share amino acid similarities (Chiti and 
Dobson, 2006). Therefore, it has been proposed that amyloid formation is an inherent 
property of polypeptide main chains (Chiti and Dobson, 2006). However, specific 
residues likely play a role in promoting both disease-associated and functional amyloid 
formation. Yeast prion protein Sup35p has a Gln/Asn rich domain at N-terminus that has 
been implicated in prion propagation (DePace et al., 1998; Liu and Lindquist, 1999; 
Osherovich et al., 2004). Moreover, the specific sequences in this Gln/Asn rich domain 
govern self-recognition and species-specific seeding activity (Tessier and Lindquist, 
2007). Aromatic residues in the islet amyloid polypeptide fragment positively contribute 
to its polymerization into amyloid fibers in vitro (Gazit, 2002). Structural analysis of Aβ 
40 and Aβ42 revealed that two β sheets form a parallel β-sandwich stabilized by specific 
intermolecular side chain contacts and changes of these side chains resulted in defective 
fiber assembly (Luhrs et al., 2005; Petkova et al., 2002). Therefore, it is clear that side 
chains can influence amyloid polymerization, but the contribution of side chains to in 
vivo amyloidogenesis and the exact roles of amino acid side chain contacts remain poorly 
understood. Here, I performed a comprehensive mutagenesis study on CsgA and 
 117
identified the residues that promote CsgA amyloidogenesis. I showed that CsgA 
amyloidogenesis is driven by the side chain contacts of four Gln and Asn residues in N- 
and C-terminal repeats. These Gln and Asn residues play essential roles in the response to 
CsgB-mediated heteronucleation and the initiation of efficient self-assembly in vitro. 
Strikingly, these four Gln and Asn residues are not required for CsgA seeding suggesting 
CsgA seeding and CsgB-mediated heteronucleation have distinct mechanisms.  
 
Experimental Procedures 
Bacterial Growth  
To induce curli production, bacteria were grown on YESCA plates (1.0 g yeast 
extract, 10 g casamino acids and 20 g agar per liter) at 26°C for 48 h (Chapman et al., 
2002). Antibiotics were added to plates at the following concentrations: kanamycin 50 
μg/ml, chloramphenicol 25 μg/ml, or ampicillin 100 μg/ml. Curli production was 
monitored by using Congo red-YESCA (CR-YESCA) plate (Chapman et al., 2002). 
Strains and Plasmids  
Strains LSR10 (MC4100::csgA), LSR12 (C600::csgBAC and csgDEFG), LSR13 
(MC4100::csgBA) and MHR261 (MC4100::csgB) and plasmids pLR5 (encoding CsgA), 
pLR2 (vector control) and pMC1(encoding CsgG) were previously constructed 
(Chapman et al., 2002; Hammar et al., 1996; Hammer et al., 2007; Robinson et al., 2006). 
Plasmids containing CsgA mutations were constructed by site-specific mutagenesis using 
standard overlapping PCR extension. PCR products containing relevant mutations and 
NcoI/BamHI restriction endonuclease sites at 5’/3’ ends were cloned downstream of the 
csgBA promoter into NcoI/BamHI sites of vector pLR2. The expression vector pMC3 
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was generated previously (Chapman et al., 2002). To express and purify CsgA mutant 
proteins, PCR amplified mutant sequences including C-terminal hexahistidine tag were 
cloned into pMC3, replacing the sequence encoding CsgA-his. Sequences of constructs 
were verified by DNA sequencing. 
Western analysis 
The immunoblotting of CsgA in whole-cells and plugs was performed as 
previously described (Chapman et al., 2002). Briefly, bacterial cells grown on YESCA 
plate for 48 h were scraped off and normalized by optical density at 600 nm. Cell pellets 
were resuspended in 2X SDS loading buffer either with or without prior formic acid (FA) 
treatment as previously described (Chapman et al., 2002). Alternatively, 8 mm circular 
plugs including cells and underlying agar were resuspended in 2X SDS loading buffer 
either with or without prior FA treatment. Samples were electrophoresed on 15% sodium 
dodecyl sulfate (SDS)-polyacrylamide and transferred onto polyvinylidene difluoride 
membrane using standard techniques. Western blots were probed and developed as 
previously described (Hammer et al., 2007). 
Transmission Electron Microscopy  
A Philips CM10 Transmission Electron Microscope was used to visualize the cell 
samples and protein fiber aggregates. Samples (10 μl) were placed on Formvar-coated 
copper grids (Ernest F. Fullam, Inc., Latham, NY) for 2 min, washed with deionized 
water, and negatively stained with 2% uranyl acetate for 90 sec. 
In vitro polymerization and nucleation assay  
CsgA or CsgA mutant proteins and CsgG were co-overexpressed by induction 
with isopropyl β-D-1-thiogalactopyranoside (IPTG) in LSR12 (C600::csgBAC and 
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csgDEFG) strain. CsgA or CsgA mutant proteins were secreted to the supernatant and 
purified as previously described (Wang et al., 2007). After removal of imidazole by a 
desalting column, purified proteins were passed through a 30 kD cutoff filter (Amicon® 
Ultra, MA) to remove possible aggregates or seeds that might alter polymerization 
kinetics. Purified homogeneous proteins were loaded on 96-well opaque plate and ThT 
was added to a concentration of 20 μM. ThT fluorescence was measured every 10 min 
after shaking 5 sec by a Spectramax M2 plate reader (Molecular Devices, Sunnyvale, CA) 
set to 438 nm excitation and 495 nm emission with a 475 nm cutoff. Alternatively, 
samples were kept at room temperature in the presence of 0.02% NaN3. At the indicated 
times, aliquots were removed, ThT was added at a concentration of 20 μM and 
fluorescence intensity was measured as described above. For seeding reactions, CsgA 
fiber seeds, prepared as previously described in Chapter 2 (Wang et al., 2007), were 
added to freshly purified CsgA mutant proteins immediately before the start of ThT 
fluorescence assay. 
Overlay assay 
10 μl freshly purified proteins were spotted onto a lawn of csgA (LSR10) or 
csgBA (LSR13) cells grown on YESCA plates at 26°C for 48 h. Samples were incubated 
on cells for 10 min at room temperature, stained with a 0.5 mg/ml Congo red in 50 mM 
potassium phosphate (pH 7.2) for 5 min, then washed with potassium phosphate buffer 
and photographed. 
Interbacterial complementation 
Cells that secrete CsgA or CsgA mutant proteins were streaked adjacently to csgA cells 
on a CR-YESCA plate. The plates were photographed after 48 h growth at 26°C. 
 120
Results 
Ala scan mutagenesis of internally conserved polar residues 
The amyloid core of CsgA is composed of five repeating units, defined by 
internally conserved and regularly spaced Ser, Gln and Asn residues conserved among 
many enteric bacteria (Figure 4.1A) (Wang et al., 2007). We performed an Ala scan 
mutagenesis on these 20 polar residues to test their importance in directing bacterial 
amyloid formation. Amyloid formation of each CsgA mutant was initially assessed by 
growing bacteria on plates amended with Congo red, as cells expressing wild-type CsgA 
will stain a deep red color on this medium (Figure 4.1B). Only two mutations, Q49A and 
N144A, significantly reduced Congo red binding relative to wild-type CsgA (Figure 
4.1B). Transmission electron microscopy (TEM) was used to validate the Cong red 
binding phenotypes. csgA cells (LSR10) transformed with pLR5 (encoding CsgA) 
produced curli fibers that were indistinguishable from those assembled by wild-type 
strain MC4100 by TEM. Cells expressing CsgAQ49A or CsgAN144A assembled fewer fibers 
than cells expressing wild-type CsgA observed by TEM (Figure 4.1C). 
CsgA polymerization into an amyloid fiber in vivo can also be monitored by its 
ability to migrate as a monomer on SDS PAGE gels after dissociation by a strong acid, 
formic acid (FA) (Chapman et al., 2002). For example, CsgA produced by wild-type cells 
is whole cell-associated and SDS insoluble (Collinson et al., 1991). Brief treatment with 
FA liberates CsgA monomers from curli fibers produced by wild-type strain 
MC4100(Hammar et al., 1996). Similar to the wild-type strain, CsgA produced by 
csgA/pLR5 was SDS insoluble and required brief pretreatment with FA to migrate into 
the gel (Figure 4.2A, lanes 1 and 2). All of the Ser mutants (S43A, S66A, S88A, S111A 
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and S133A) were also SDS insoluble and associated with the whole cell fraction (Figure 
4.2A, lanes 5, 6, 13, 14, 21, 22, 29, 30, 37 and 38). However, 13 of 15 Ala substitution 
mutants of Gln/Asn residues (Q49A, N54A, Q60A, Q72A, N77A, Q94A, N99A, Q105A, 
Q117A, N122A, Q128A, Q139A and N144A) showed different levels of SDS solubility 
by whole-cell western analysis, suggesting these polar residues help stabilize the amyloid 
structure (Figure 4.2A). CsgAQ49A and CsgAN144A were unable to complement Congo red 
binding to a csgA mutant (Figure 4.1B), and very little of these mutant proteins could be 
recovered from whole cell lysates scraped off YESCA plates (Figure 4.2A, lanes 7, 8, 41 
and 42).  
To test the possibility that CsgAQ49A and CsgAN144A were secreted away from the 
cell as soluble proteins, cells and the underlying agar were collected and analyzed by 
western blotting. In these samples, called ‘plugs’, both CsgAQ49A and CsgAN144A were 
readily detected and SDS soluble, demonstrating that CsgAQ49A and CsgAN144A were 
stable, secreted to the cell surface and unpolymerized (Figure 4.2B, lanes 2, 3, 11 and 12). 
CsgAN54A and CsgAQ139A were also significantly different from other mutants in the 
whole cell SDS solubility assays. CsgAN54A was completely SDS soluble (Figure 4.2A, 
lanes 9 and 10) and CsgAQ139A was not predominately cell associated (Figure 4.2A, lanes 
39 and 40). CsgAN54A and CsgAQ139A were SDS soluble detected by western analysis of 
cells and the underlying agar (Figure 4.2B, lanes 4, 5, 8 and 9), suggesting CsgAN54A and 
CsgAQ139A were not assembled into wild-type like fibers in vivo. Collectively, Q49A and 
N144A were the most defective mutants in curli formation of the 20 mutants examined. 
In addition, the N54A and Q139A mutants were also significantly defective in curli 
assembly as measured by western analysis. 
 122
Ala scan mutagenesis of the aromatic residues 
It was reported that aromatic residues may play an important role during 
amyloidogenesis (Azriel and Gazit, 2001; Gazit, 2002). We tested the contribution of 
aromatic residues in the CsgA amyloid core region by Ala scan mutagenesis. Except for 
CsgAY151A, Ala substitutions in the aromatic residues resulted in proteins that were 
phenotypically identical to wild-type CsgA as detected by Congo red binding and whole-
cell western analysis (Figure 4.3A and 4.3B). CsgAY151A was undetectable by western 
analysis of cells and the underlying agar, indicating that Y151A was unstable (Figure 
4.3C, lanes 5 and 6). When Tyr151 was changed to Phe, Trp, Lys or Asp, curli formation 
was restored as evidenced by Congo red binding and whole-cell western analysis, 
suggesting Tyr residue at position 151 is not absolutely required (Figure 4.3D and data 
not shown). 
CsgAQ49A and CsgAN144A are defective in self-polymerization in vitro  
To further characterize the most defective CsgA mutant proteins, we purified 
CsgAQ49A and CsgAN144A and compared their polymerization to wild-type CsgA using the 
ThT assay described in Chapter 2 (Wang et al., 2007). Wild-type CsgA assembles into an 
amyloid fiber in vitro at concentrations above 2.0 μM in the absence of CsgB (Wang et 
al., 2007). Two parameters were used to compare the polymerization kinetics of CsgA 
and its mutant analogues as presented in Chapter 3. The first kinetic parameter was the 
time period preceding rapid fiber growth, called lag phase or T0. The second parameter 
was the time period encompassing the fiber growth phase from initiation of rapid 
polymerization to its completion, called conversion time (Tc) (DePace et al., 1998). At a 
concentration of 40 μM, the T0 of CsgAQ49A was similar to that of CsgA, while the Tc was 
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much greater than that of CsgA (Figure 4.4A). CsgAN144A polymerization had much 
greater T0 and Tc than those of CsgA, suggesting the amido group of Asn at position 144 
is critical for aggregation (Figure 4.4A). After 120 hrs, both CsgAQ49A and CsgAN144A had 
assembled into amyloid fibers with similar fiber morphology to wild-type CsgA fibers 
(Figure 4.4B, 4.4C and 4.4D). 
CsgAQ49A and CsgAN144A are defective in heteronucleation response  
Even though CsgAQ49A and CsgAN144A were defective in self-polymerization, in 
the presence of wild-type CsgA seeds they polymerized with efficiency similar to wild-
type CsgA (data not shown). To test of the ability of CsgAQ49A and CsgAN144A to respond 
to CsgB-mediated heteronucleation, two different approaches were employed. The first 
was an overlay assay using freshly purified CsgA or CsgA mutant proteins and cells 
expressing the CsgB nucleator protein (Wang et al., 2008). In a CsgB-dependent manner, 
soluble wild-type CsgA was converted into an amyloid fiber within 1 minute of the 
overlay as evidenced by Congo red staining, or by TEM as shown in Chapter 3 (Wang et 
al., 2008). Various concentrations of CsgA, CsgAQ49A and CsgAN144A were overlaid on 
csgA cells (CsgB+). At a concentration of 10 μM or higher, CsgA polymerized into an 
amyloid fiber in a CsgB-dependent fashion detected by Congo red staining (Figure 4.5A). 
However, 10 μM CsgAQ49A and CsgAN144A did not polymerize into amyloid-like fibers 
under the same conditions (Figure 4.5A). When the concentration of CsgAQ49A and 
CsgAN144A was increased to 40 μM, a Congo red-binding structure on the surface of 
CsgB-expressing cells was detected (Figure 4.5A).  
Curli fibers are proposed to assemble after CsgA is secreted to the extracellular 
space. This can be illustrated by interbacterial complementation where a csgA mutant 
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strain (CsgB+) is grown in close proximity to a csgB mutant strain (CsgA+). CsgA 
molecules secreted by csgB donor cells polymerize into amyloid fibers on the csgA 
acceptor cells, as shown in Figure 4.5B (Hammar et al., 1996). We performed an 
interbacterial complementation assay to test CsgB-mediated heteronucleation 
responsiveness of CsgA, CsgAQ49A and CsgAN144A in vivo. CsgA secreted from 
csgBA/pLR5 (donor) responded to the heteronucleation of CsgB on the csgA cells 
(acceptor), and formed an amyloid fiber on the surface of csgA cells as demonstrated by 
Congo red (Figure 4.5B) (Hammar et al., 1996). There was reduced Congo red binding 
on the surface of csgA cells when csgBA cells containing plasmid encoding CsgAQ49A or 
CsgAN144A were grown adjacently to csgA cells (Figure 4.5B). The protein levels of CsgA, 
CsgAQ49A and CsgAN144A produced in the csgBA genetic background were similar as 
detected by western analysis of cells and the underlying agar (data not shown). These 
data collectively demonstrate that CsgAQ49A and CsgAN144A were defective in responding 
to the heterogeneous nucleator CsgB. 
Ala substitutions of Q49, N54, Q139 and N144 result in the dramatic loss of 
heteronucleation response to CsgB 
In order to abolish the four critical Gln/Asn residues identified by our Ala scan 
mutagenesis, we constructed the mutant Q49A/N54A/Q139A/N144A. In vivo 
CsgAQ49A/N54A/Q139A/N144A (CsgAslowgo) completely lost the ability to assemble into 
amyloid fibers as detected by Congo red binding, TEM and whole-cell western analysis 
(data not shown). We tested the competence of CsgAslowgo to respond to CsgB-mediated 
heteronucleation by overlay assay. Purified homogeneous CsgAslowgo could not be 
promoted to form amyloid fibers by cell-associated CsgB as evidenced by the lack of 
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Congo red binding in the overlay assay even at a concentration of 100 μM (Figure 4.6A). 
There was no Congo red binding on the surface of csgA cells when csgBA cells 
containing plasmid encoding CsgAslowgo were grown adjacently to csgA cells shown in 
Figure 4.6B, suggesting that CsgAslowgo completely lost the response to CsgB-mediated 
heteronucleation in the interbacterial complementation. The protein level of CsgAslowgo 
was similar to wild-type CsgA in this genetic background (data not shown). Collectively, 
these results demonstrate that CsgAslowgo remains unpolymerized even in the presence of 
the heteronucleator CsgB, suggesting these four polar residues are required in CsgB-
mediated heteronucleation.  
Q49, N54, Q139 and N144 are required for efficient self-polymerization and 
CsgBtrunc cross-seeding not for CsgA seeding 
CsgAslowgo was purified and its polymerization kinetics was analyzed in vitro. The 
T0 and Tc of CsgAslowgo were much higher than CsgA (Figure 4.7A), suggesting that Q49, 
N54, Q139 and N144 play critical roles in self-polymerization in vitro. Self-assembled 
CsgAslowgo fibers were similar to CsgA fibers shown by TEM (Figure 4.7B). Interestingly, 
wild-type CsgA seeds efficiently eliminated the lag phase of the polymerization of 
CsgAslowgo as detected by ThT assay (Figure 4.7C). In the presence of CsgA seeds, the 
polymerization rate CsgAslowgo is very similar to wild-type CsgA as shown in Chapter 2 
(Wang et al., 2007) and ThT signal reached stationary phase within 5 hours (Figure 4.7C). 
Polymerized CsgAslowgo fibers promoted by wild-type CsgA were similar to CsgA fibers 
shown by TEM (Figure 4.7D). A nucleation-competent CsgB truncation mutant (called 
CsgBtrunc) was purified as previously described (Hammer et al., 2007). CsgBtrunc has been 
demonstrated to efficiently seed the polymerization of wild-type CsgA (Hammer et al., 
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2007). Unlike CsgA seeds, CsgBtrunc seeds did not efficiently promote the polymerization 
of CsgAslowgo under the same condition shown in Figure 4.7C. Self-assembled CsgAslowgo 
fibers were able to seed wild-type CsgA polymerization, suggesting CsgAslowgo fibers are 
similar to wild-type CsgA fibers in terms of seeding specificity (data not shown).  
Conservative Q/N substitutions 
It was proposed that in vitro amyloid formation is strongly influenced by simple 
physicochemical factors of polypeptides such as hydrophobicity, charge and secondary 
structure propensity. (Chiti and Dobson, 2006; Chiti et al., 2003) Ala substitutions at 
positions 49, 54, 139 and 144 decreased CsgA polymerization in vivo. To test the 
stringency of the amino acid present at these critical positions, I constructed four mutants 
(Q49N, N54Q, Q139N and N144Q) that contained relatively conservative amino acid 
changes. Gln and Asn residues have similar physicochemical features, including the same 
amido group. Surprisingly, even though the side chain of Asn is only one carbon distance 
shorter than that of Gln, CsgAQ49N had dramatically reduced Congo red binding and was 
almost undetectable in lysates of whole cells scraped off YESCA plate (Figure 4.8A and 
4.8B, lanes 7 and 8). CsgAQ49N was stable and secreted into the agar as detected by 
western analysis of cells and the underlying agar (Figure 4.8C, lanes 7 and 8). In addition, 
whole-cell western analysis showed that Q139N (Figure 4.8B, lanes 15 and 16) was as 
defective as Q139A (Figure 4.2A, lanes 39 and 40). The sequence requirements at 
positions 49 and 139 appear extremely stringent during fiber assembly since either Ala or 
Asn was not tolerated at these positions. The Congo red binding of CsgAN144Q and 
CsgAN54Q was similar to that of wild-type CsgA (Figure 4.8A). In addition, CsgAN144Q 
and CsgAN54Q were predominately SDS insoluble as shown by whole-cell western 
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analysis (Figure 4.8B, lanes 11, 12, 13 and 14). The SDS insolubility of CsgAN144Q and 
CsgAN54Q was similar to wild-type CsgA as detected by western analysis of cells and the 
underlying agar (Figure 4.8C, lanes 11, 12, 15 and 16). We observed wild-type like fibers 
assembled by the csgA strain that contained plasmid encoding CsgAN144Q by TEM, while 
relatively few fibers were observed on the csgA strain expressing CsgAQ49N (Figure 4.8D). 
Collectively, in vivo Gln residues at positions 49 and 139 could not be replaced by Asn, 
while Asn residues at position 54 and 144 could be replaced by Gln and function like 
wild-type CsgA. In vitro CsgAQ49N was as defective as CsgAQ49A in both 
heteronucleation responsiveness and self-polymerization. CsgAQ49N polymerization had 
greater Tc than that of CsgA at the same concentration measured by ThT assay (Figure 
4.8E). CsgAQ49N did not respond to CsgB nucleation at 10 μM as detected by overlay 
assay (Figure 4.8E insert). It has been proposed that amino acid content can be an 
important factor in promoting amyloid formation (Ross et al., 2004; Ross et al., 2005). To 
test whether N144Q can suppress the polymerization defect of Q49N, we constructed the 
mutant Q49N/N144Q. Like Q49N, Q49N/N144Q had significantly reduced Congo red 
binding relative to wild-type CsgA (Figure 4.8F). Collectively, these findings suggest that 
CsgB-mediated heteronucleation and CsgA self-polymerization require spatially 
constrained contacts between certain amino acid side chains.        
 
Discussion  
Curli function as part of the extracellular matrix produced by many Gram-
negative enteric bacteria. Curli assembly is a precisely coordinated process that is highly 
amenable to study because of the sophisticated genetic and biochemical tools afforded by 
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E. coli. Here, I elucidated the CsgA sequence determinants that drive amyloid formation. 
I found that Gln and Asn residues at the N- and C- terminal repeats are critical for curli 
assembly. These Gln and Asn residues are necessary for CsgA to respond to CsgB-
mediated heteronucleation and to initiate efficient CsgA self-assembly in vitro. 
The contribution of amino acid side chains to functional amyloid formation 
Unlike amorphous aggregates formed by nonspecific hydrophobic interactions, 
amyloid fibers are highly ordered proteinaceous polymers that are stabilized by specific 
interactions. The side chains can clearly influence amyloidogenesis (Chiti and Dobson, 
2006). But how specific sequences influence amyloid formation in vivo remains poorly 
understood. We demonstrated that four internally conserved Gln and Asn residues were 
required to respond to CsgB-mediated heteronucleation. When these four residues are 
changed to Ala, the resulting protein, CsgAslowgo, cannot efficiently initiate self-assembly 
in vitro as indicated by an extremely long lag phase before polymerization (Figure 4.7A). 
CsgAslowgo also cannot efficiently respond to CsgB-mediated heteronucleation (Figure 
4.6). These results suggest that the specific side chain interactions are the driving forces 
to efficiently initiate bacterial amyloid formation in vivo and in vitro. Interestingly, we 
found that these Gln/Asn residues required for CsgB-mediated heteronucleation are not 
necessary for CsgA fiber-mediated seeding, suggesting that CsgA seeding and CsgB-
mediated heteronucleation may have somewhat distinct mechanisms (Figure 4.7C). 
CsgAslowgo is completely defective in amyloid formation in vivo, although it can 
inefficiently assemble into amyloid fibers in vitro (Figure 4.7A and 4.7B). This 
distinction between in vitro and in vivo behaviors suggests that in vivo amyloid formation 
has highly stringent requirements that limit initiation of amyloid formation to CsgB-
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mediated heteronucleation. For example, CsgA remains soluble in the extracellular milieu 
in the absence of nucleator CsgB even though CsgA is amyloidogenic in vitro (Wang et 
al., 2007). This indicates that CsgA may diffuse into the extracellular milieu if it cannot 
participate in efficient nucleation. Curli also provides an elegant example how 
amyloidogenecity can be temporally and spatially controlled. It is possible that an 
evolved functional amyloid such as curli capitalizes on specific side-chain interactions to 
tightly regulate and control amyloidogenecity. 
The diverse sequence determinants of amyloid formation 
The sequence-specific determinants of amyloid formation have been most studied 
in vitro. Clearly, different amyloid proteins employ various interactions such as hydrogen 
bonding, hydrophobic and electrostatic interactions to promote intra- and inter-molecular 
associations. For example, the hydrophobic stretches in Aβ42, rather than specific side 
chains, are sufficient to promote aggregation (Kim and Hecht, 2006). Yeast prion 
proteins Sup35p, Ure2p and Rnq1p all have Gln/Asn rich domains that are essential for 
prion propagation in vivo and in vitro (DePace et al., 1998; Michelitsch and Weissman, 
2000; Sondheimer and Lindquist, 2000; Taylor et al., 1999). In Huntington’s disease, 
polyglutamine peptides play an essential role in molecular etiology. In addition, the 
length of polyglutamine peptides is positively correlated to in vitro aggregation (Chen et 
al., 2002). Gln/Asn rich domains are proposed to have a high potential to be 
amyloidogenic because they can form intramolecular hydrogen bonds (Michelitsch and 
Weissman, 2000). Here, I showed that the internally conserved Gln and Asn residues at 
the N- and C- terminal repeats are critical for CsgA fiber formation. The initiation of 
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CsgA polymerization both in vitro and in vivo appears to be dependent on hydrogen 
bonds formed by these Gln and Asn residues.  
Moreover, I showed that 13 of 15 Ala substitution mutants of Gln/Asn residues 
(Q49A, N54A, Q60A, Q72A, N77A, Q94A, N99A, Q105A, Q117A, N122A, Q128A, 
Q139A and N144A) showed somewhat more sensitive to SDS relative to wild-type CsgA 
(Figure 4.2A), suggesting these polar residues help stabilize the amyloid structure. 
Interestingly, the polar amides of these internally conserved Gln and Asn residues were 
proposed to form hydrogen bonds with backbones to stabilize its fibril structure in a 
CsgA predicted structural model. (Collinson et al., 1999) It is possible that these critical 
Gln/Asn residues not only play an important role to initiate fiber assembly but also 
stabilize the fiber structure when fibers are formed. 
It was proposed that interactions among aromatic residues by π-stacking possibly 
play a critical role in self-assembly of some amyloid fibrils such as islet amyloid 
polypeptide (Gazit, 2002). To assess the role of aromatic residues in guiding in vivo 
CsgA amyloidogenesis, I individually replaced each aromatic residue in the amyloid core 
of CsgA, revealing that aromatic residues do not significantly contribute to curli 
assembly (Figure 4.3). 
Bacterial amyloid formation is influenced by the spatial arrangement of Q/N 
residues 
It has been suggested that amyloid formation is determined by simple 
physicochemical factors of polypeptides such as hydrophobicity, charge and secondary 
structure propensity (Chiti et al., 2003). Furthermore, the amyloidogenecity of yeast 
prions Ure2p and Sup35p appears to be encoded by a particular amino acid composition, 
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rather than specific sequences (Ross et al., 2004; Ross et al., 2005). In contrast, my work 
demonstrates that CsgA amyloidogenesis, especially in vivo, is highly dependent on its 
specific sequence rather than on its overall amino acid composition or the 
physicochemical properties of polypeptide chains. The Gln residue at positions 49 and 
139 of CsgA could not be replaced by Asn residues without interfering with curli 
assembly (Figure 4.8), even though Asn shares many physicochemical features with Gln. 
CsgAQ49N-N144Q and wild-type CsgA share an identical composition of amino acids, but 
CsgAQ49N-N144Q is dramatically defective in curli assembly (Figure 4.8F). Additionally, 
although CsgAQ49A, CsgAQ60A, CsgAQ94A, CsgAQ105A, CsgAQ117A, CsgAQ128A, CsgAQ150A 
have the identical composition of amino acids, CsgAQ49A is dramatically defective than 
other Ala mutants in fiber assembly (Figure 4.1B and 4.2A). We previously showed that 
N- and C-terminal CsgA repeats drive curli assembly in Chapter 3 (Wang et al., 2008). 
Our current study clearly suggests the position of Gln or Asn residues plays an equally 
important role for amyloid assembly.  
Globular protein folding depends on specific side chain contacts. Whether 
amyloid formation, especially in vivo, depends on specific side chain contacts is just 
beginning to be tested. My work demonstrates that the initiation of CsgA amyloid 
formation requires specific amino acid side chains. Specific side chain contacts are likely 








Figure 4.1. Effect of Ala substitutions of conserved Ser, Gln and Asn of CsgA on 
curli assembly.  
(A) Schematic of CsgA including an N-terminal Sec signal sequence and the N-terminal 
22 residues that precede the five repeating units. The regularly-spaced Ser, Gln and Asn 
residues are indicated in red color and the aromatic residues are indicated in blue color. 
The position of highlighted residues is indicated above the residue. (B) CR-YESCA plate 
with csgA cells transformed with the plasmids encoding CsgA with Ala substitution after 
48 h of growth at 26°C. csgA/pLR5 and csgA/pLR2 were used as the positive control (PC) 
and vector control (VC), respectively. The specific Ala substitution is indicated. (C) 
Negative-stain TEM micrographs of csgA cells containing vector control (pLR2) or 
plasmids encoding wild-type CsgA (pLR5), CsgAQ49A and CsgAN144A. Scale bars are 





Figure 4.2. Western analysis of CsgA mutants with Ala substitutions of internally 
conserved Ser, Gln and Asn. 
(A) Western blots of whole-cell lysates from csgA cells containing vector control or 
plasmids encoding wild-type CsgA or indicated Ala substituted mutants. (B) Western blot 
of whole-cells and underlying agar (agar plugs) from csgA strains containing plasmids 
encoding CsgA, CsgAQ49A, CsgAN54A, CsgAQ139A or CsgAN144A. Samples were treated 


























Figure 4.3. Ala scan mutagenesis of aromatic residues in CsgA amyloid core regions. 
(A) CR-YESCA plate with csgA cells transformed with the plasmids encoding CsgA, 
CsgAY48A, CsgAY50A, CsgAF97A, CsgAW106A, CsgAF118A, CsgAF142A or CsgAY151A. (B) 
Western blots of whole-cell lysates from csgB cells and csgA cells containing plasmids 
encoding wild-type CsgA or indicated Ala mutants. (C) Western blot of whole-cells and 
underlying agar (agar plugs) from csgB cells and csgA strains containing plasmids 
encoding CsgA or CsgAY151A. (D) The CR-YESCA plate with csgA cells transformed 

























Figure 4.4. In vitro self-polymerization of CsgAQ49A and CsgAN144A are defective. 
(A) The fluorescence of 40 μM CsgA (solid circle), CsgAQ49A (open circle) and 
CsgAN144A (open square) mixed with 20 µM ThT was measured in 10-minute intervals at 
495nm after excitation at 438nm. a.u., arbitrary units. (B-D) Negative-stain EM 
micrographs of in vitro self-polymerized fibers of CsgA (B), CsgAQ49A (C) and 













Figure 4.5. CsgAQ49A and CsgAN144A are defective in response to CsgB-mediated 
heteronucleation. 
(A) A schematic presentation of the overlay assay in which soluble CsgA is spotted onto 
cells (csgA) expressing the nucleator protein, CsgB, where CsgA polymerization is 
catalyzed by CsgB (top). Freshly purified CsgA, CsgAQ49A or CsgAN144A at the indicated 
concentrations was spotted onto on csgA cells. After 10 min incubation, cells were 
stained with 0.5 mg/ml Congo red solution and washed by potassium phosphate buffer 
(bottom). (B) A schematic presentation of the interbacterial complementation assay in 
which soluble CsgA molecules secreted from csgB cells interact with CsgB on the 
surface of csgA cells to form fibers (top). csgBA cells containing plasmids encoding 
CsgA, CsgAQ49A or CsgAN144A were grown adjacently to csgA cells on a CR-YESCA 

















Figure 4.6. The heteronucleation responsiveness of CsgAslowgo 
(CsgAQ49A/N54A/Q139A/N144A). 
(A) Freshly purified homogeneous CsgAslowgo at the indicated concentrations was spotted 
onto csgA or csgBA cells. After 10 min incubation, cells were stained with 0.5 mg/ml 
Congo red solution and washed by potassium phosphate buffer. (B) csgBA cells 
containing plasmids encoding CsgA or CsgAslowgo were grown adjacently to csgA cells on 


























Figure 4.7. In vitro self-polymerization and seeding responsiveness of CsgAslowgo. 
(A) ThT fluorescence intensity of 40 μM CsgAslowgo incubated for the indicated time 
intervals. a.u., arbitrary units. (B) Negative stain TEM micrograph of in vitro self-
polymerized aggregates of CsgAslowgo. Scale bars are equal to 200 nm. (C) 5% CsgA 
seeds, CsgBtrunc seeds by weight or buffer vehicle were added to 60 μM CsgAslowgo and 
the polymerization was measured by ThT fluorescence assay. The fluorescence intensity 
of nucleated CsgAslowgo samples were shown at the indicated time intervals. The 
contribution to fluorescence intensity by seeds was subtracted. (D) Negative-stain TEM 
micrograph of in vitro polymerized aggregates of CsgAslowgo promoted by CsgA. Scale 
















Figure 4.8. Conservative Q/N substitutions at positions 49, 54, 139 and 144. 
(A) CR-YESCA plate with csgA transformed with the plasmids encoding CsgA, 
CsgAQ49A, CsgAQ49N, CsgAN54A, CsgAN54Q, CsgAQ139A, CsgAQ139N, CsgAN144A or 
CsgAN144Q. (B) Western blots of whole-cell lysates from csgA cells containing plasmids 
encoding wild-type CsgA, CsgAQ49A, CsgAQ49N, CsgAN54Q, CsgAQ139N, CsgAN144A or 
CsgAN144Q. (C) Western blot of whole-cells and underlying agar (agar plugs) from csgA 
strains containing plasmids encoding CsgA, CsgAQ49A, CsgAQ49N, CsgAN54A, CsgAN54Q, 
CsgAN144A or CsgAN144Q. Samples were treated with (+) or without (-) FA. The blots were 
probed with anti-CsgA antibody. (D) Negative-stain TEM micrographs of csgA cells 
containing plasmids encoding CsgAQ49N and CsgAN144Q. Scale bars are equal to 500 nm. 
(E) The polymerization of 56 μM CsgAQ49N was measured by ThT fluorescence. Congo 
red staining of csgA cells overlaid with CsgAQ49N at various concentrations is shown in 
the graph inset. (F) CR-YESCA plate of a csgA strain transformed with the control vector 
pLR2 or the plasmids encoding CsgA, CsgAQ49N or CsgAQ49N/N144Q. 
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Gatekeeper Residues Modulate Bacterial Amyloidogenesis 
 
Abstract 
Amyloid fibers are filamentous protein structures commonly associated with 
neurodegenerative diseases. Unlike disease-associated amyloids that are the products of 
protein misfolding, Escherichia coli assembles membrane anchored extracellular 
functional amyloid fibers called curli using an evolved biogenesis machine. Functional 
amyloids provide a template for understanding controlled amyloid formation. Curli fibers 
are composed of two proteins, CsgA and CsgB. In vivo, the polymerization of the major 
curli subunit protein, CsgA, is dependent on CsgB-mediated nucleation. The amyloid 
core of CsgA is composed of 5 imperfect repeats (R1 to R5). I previously showed that R1 
and R5 govern the ability of CsgA to respond to CsgB nucleation and self-seeding. I 
further characterized the determinants of this specificity in this chapter and found certain 
aspartate and glycine residues in R2, R3 and R4 function as “gatekeepers” of 
polymerization by inhibiting their intrinsic aggregation propensities and responsiveness 
to nucleation. Mutations of the gatekeeper residues in R2, R3 and R4 to the 
corresponding amino acids found in either R1 or R5 rendered these repeats similar to R1 
and R5. Mutations of all gatekeeper residues of CsgA resulted in uncontrolled amyloid 
propagation even in the absence of the nucleation machinery. In addition, the ectopic 
induction of CsgA with mutated gatekeeper residues was cytotoxic, suggesting that 
miss-regulation of CsgA polymerization is detrimental to the cell. This is the first 
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Amyloids are ordered proteinaceous filaments, which are associated with many 
mammalian neurodegenerative diseases and prion-based encephalopathies (Chiti and 
Dobson, 2006). Amyloid fibers have distinct biochemical and biophysical properties such 
as great stability and specific tinctorial properties when bound to Congo red and 
thioflavin T (Chiti and Dobson, 2006). The molecular mechanism of neurodegenerative 
disease development induced by amyloid propagation remains elusive, partially due to 
their erratic and uncontrolled nature. Recently a growing body of research has shown that 
amyloids can also be integral part of physiology found in different organisms including 
bacteria, fungi and mammals (Fowler et al., 2007; Hammer et al., 2008). How nature 
coordinates functional amyloid propagation and reduces the associated cytotoxicity is 
poorly understood. 
Curli, a bacterially produced amyloid, is an important component of extracellular 
matrix and is involved in bacterial community behaviors (Barnhart and Chapman, 2006). 
Due to the amyloid properties of curli fibers, the colonies of curli-producing E. coli stain 
red when grown on Congo red indicator plates, which provides a convenient assay to 
monitor curli assembly in vivo. In E. coli at least six proteins are dedicated to assembling 
curli fibers at correct time and space. Curli fibers are composed of a major subunit CsgA 
and a minor subunit CsgB. CsgA remains unpolymerized until it encounters the 
surface-tethered nucleator CsgB, which initiates CsgA polymerization (Hammar et al., 
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1996). CsgD is a transcriptional activator for the csgBA operon (Barnhart and Chapman, 
2006). CsgG, CsgE and CsgF are non-fiber structural accessory proteins involved in 
subunit stability, secretion of the fiber subunits and modulation of fiber assembly. CsgG 
is proposed to be the curli secretion apparatus that directs the exportation of CsgA and 
CsgB across the outer membrane (Robinson et al., 2006). CsgE and CsgF interact with 
CsgG at the outer membrane (Robinson et al., 2006). CsgF is required for efficient 
CsgB-mediated nucleation and CsgE is critical for CsgA and CsgB stability (Chapman et 
al., 2002; Robinson et al., 2006).  
The CsgA primary amino acid sequence comprises a Sec signal peptide (positions 
1-20), 22 residues (positions 21-42) dedicated to interacting with CsgG secretion 
apparatus and an amyloid core region composed of five imperfect repeats (positions 
43-151), each 19-23 amino acids (Figure 5.1A). Sec signal sequence is cleaved when 
CsgA reaches the periplasmic space (Collinson et al., 1999). The repeats (R1, R2, R3, R4 
and R5) share at least 30% identity at the amino acid level distinguished by the consensus 
sequence Ser-X5-Gln-X4-Asn-X5-Gln. I previously showed that R1 and R5 direct CsgA to 
respond to CsgB-mediated nucleation and are critical for fiber elongation (Wang et al., 
2008). Moreover, internally conserved Gln and Asn residues located in R1 and R5 are 
required for CsgB nucleation and curli assembly (Wang and Chapman, 2008). Because all 
repeats have these critical Gln and Asn residues, the specific determinants for why R1 
and R5 are distinct from other repeats still remain elusive. Here, we elucidate these 
determinants and found certain Asp and Gly residues in R2, R3 and R4 function as 
gatekeeper residues inhibiting their amyloidogenic properties.   
Gatekeeper residues are defined as residues in many globular proteins to cap the 
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aggregation-prone sequences and thereby promote the proteins to fold into their native 
conformations (Monsellier and Chiti, 2007; Otzen et al., 2000; Richardson and 
Richardson, 2002; Rousseau et al., 2006). Herein, I explore the role of gatekeeper 
residues in functional amyloidogenesis. Instead of simply opposing aggregation, I found 
that gatekeeper residues actually play a positive role in harnessing the aggregation of 
CsgA. A CsgA mutant lacking all gatekeeper residues efficiently polymerized into 
amyloid fibers independently of the other curli assembly proteins CsgB and CsgF. In 
addition, the induced expression of CsgA without gatekeeper residues dramatically 




Bacteria were grown at 26 °C on YESCA plates to induce curli production 
(Chapman et al., 2002). When needed, antibiotics were added to the plates in the 
following concentrations, kanamycin 50 μg/ml, chloramphenicol 25 μg/ml, or ampicillin 
100 μg/ml. Curli production was monitored using Congo red-YESCA plates (Chapman et 
al., 2002).  
Bacterial strains and plasmids 
Strains and plasmids used in this study are listed in Table 6.1. Primer sequences 
used in this study are listed in Table 6.2. To study CsgA mutants for in vivo 
polymerization, PCR products containing CsgA mutations and NcoI and BamHI 
restriction endonuclease sites at 5’ and 3’ ends were obtained using standard overlapping 
PCR extension. PCR products were cloned into NcoI/BamHI sites of vector pLR2 that is 
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downstream of csgBA promoter. To purify CsgA and CsgA* from cell pellets, constructs 
pNH11 and pNH12 encoding His6-tagged CsgA and CsgA* without periplasmic Sec 
signal sequence were generated by standard PCR extension. The PCR product containing 
NcoI and BamHI sites at 5’ and 3’ ends was cloned NcoI/BamHI sites into pET11d 
downstream to T7 promoter. The empty vector pNH3, pMC3 and pCsgAslowgoTRC 
containing C-terminal His6-tagged full-length CsgA or CsgAslowgo sequence under the 
control of TRIC promoter were generated previously (Wang and Chapman, 2008; Wang 
et al., 2008). pCsgA*TRC was constructed by replacing His6-tagged CsgA with 
His6-tagged CsgA* in pMC3. 
Purification of CsgA* and CsgA  
C-terminal His6 tagged CsgA* and CsgA without the Sec periplasmic signal 
sequence were purified from cell pellets. NEB C2566 cells harboring a pET11d vector 
encoding His-tagged CsgA (pNH11) or CsgA* (pNH12) were grown to OD600 0.9 in LB 
broth containing 100 μg/ml ampicillin. The expression of CsgA or CsgA* was induced 
with 0.5 mM IPTG and induction proceeded at 37 °C for an hour. Cells were collected by 
centrifugation and the pellets were stored at -80 °C. The cells were resuspended and lysed 
by extraction solution (8 M GdnHCl, 50 mM K2HPO4/KH2PO4, pH 7.2). A total 50 ml of 
extraction solution was used for cell pellets from a 500 ml culture. The lysate was 
incubated at 4 °C with magnetic stirring for 48 hrs. The insoluble portion of the lysate 
was removed by centrifuging at 10,000 g and the supernatant was incubated with 1.2 ml 
HIS-selectTM HF nickel-nitrilotriacetic acid resin (NiNTA) (Sigma, St. Louis, MO) for 1 
hour at room temperature. NiNTA beads that bound His-tagged CsgA or CsgA* were 
loaded on the column and lysis supernatant passed through the column. GdnHCl in 
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NiNTA was washed away by 12 ml potassium phosphate buffer (50 mM 
K2HPO4/KH2PO4, pH 7.2). CsgA or CsgA* was eluted from the column by 0.5 M 
imidazole 50 mM potassium phosphate buffer pH7.2. Purified proteins were passed 
through a 30 kDa cutoff filter (Amicon® Ultra, MA) to remove possible aggregates and 
seeds that might alter the polymerization kinetics. His tagged CsgA and CsgA* showed 
no difference to CsgA and CsgA* without a His tag in curli assembly in vivo (data not 
shown). Therefore, CsgA*-His and CsgA-His were referred to as “CsgA*” and “CsgA” 
for in vitro polymerization study throughout this report. 
Preparation of peptides  
Peptides R3, R4 and derivative peptides R3D4N/D17L and R4G13N/D17H were 
synthesized by Proteintech Group Inc., Chicago, IL. Peptides were prepared as in Chapter 
2 and 3.  
Thioflavin T assay 
Thioflavin T assays were performed and normalized as previously described 
(Wang et al., 2008). Seeds were prepared as previously described in Chapter 2. 
Transmission electron microscopy 
Philips CM12 transmission electron microscope was used to visualize the cells 
and fiber aggregates. Samples were placed on formvar coated copper grids (Ernest F. 
Fullam, Inc, Latham, NY) for 2 min, washed with deionized water twice, and stained 
with 2% uranyl acetate for 90 seconds.  
SDS-PAGE and western blotting 
Bacteria whole cell lysates or cells and underlying agar (plugs) were prepared and 
probed for CsgA using previously described methods (Chapman et al., 2002).  
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Overlay assay  
Purified proteins were spotted on the csgA cells and stained with 0.5 mg/ml 
Congo red solution as previously described in Chapter 3 and 4. 
Spotting assay for cell viability  
Freshly transformed cells with plasmids pMC3, empty vector pNH3, 
pCsgAslowgoTRC or pCsgA*TRC were scraped off the plates and normalized by 
absorbance at 600 nm. Cells with serial dilutions were spotted on LB chloramphenicol 
plates with various concentrations of IPTG to induce expression of CsgA, CsgAslowgo or 
CsgA*. After overnight growth, colony number was manually counted and colony 




Seeding specificity is encoded in R1 and R5  
I previously showed that R1 and R5 are the domains responsible for both 
CsgA-CsgB interaction, defined as nucleaton, and CsgA-CsgA interaction, defined as 
seeding (Wang et al., 2008). In support of the hypothesis that only R1 and R5 are the key 
seeding elements of CsgA and are important for fiber elongation, 8% (w/w) each 
repeating unit peptide was prepared as seeds and added to freshly purified CsgA and the 
polymerization was measured by ThT fluorescence over time as previously described in 
Chapter 3 (Wang et al., 2007). Before being used as seeds, R1, R3 and R5 peptides were 
polymerized into fibers as described (Wang et al., 2007). The lag phase of CsgA 
polymerization was completely eliminated when preformed R1 or R5 fibers were added 
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to the reaction (Figure 5.1B), while R2, R3 and R4 did not accelerate CsgA 
polymerization (Figure 5.1B). 1% or 2% R1 or R5 seeds were sufficient to accelerate 
CsgA polymerization as detected by ThT assay (data not shown). A nucleation-competent 
CsgB truncation mutant was purified as previously described (Hammer et al., 2007), and 
its nucleation effect on peptides were tested. Only peptide R1 and R5 polymerization was 
accelerated in the presence of 3% (w/w) CsgBtrunc (Figure 5.1C and Figure 5.2). We also 
tested the seeding specificity among the repeating unit peptides. R1 and R5 seeded both 
each other and themselves, while other repeats were deficient for both seeding and 
nucleation properties (Figure 5.1C and Figure 5.3). These results further support the idea 
that R1 and R5 govern the seeding and nucleation properties in CsgA. 
R1 and R5 are interchangeable in vivo 
R1 and R5 are somewhat functionally redundant: both seed CsgA polymerization 
and constitute nucleation responsive domains to CsgB and CsgA. To test the hypothesis 
that R1 and R5 are functionally redundant, the residues of R1 of CsgA (R12345) were 
replaced by the corresponding residues from R5 to form the mutant construct with the 
following repeating unit order: R52345 (Table 6.1). Despite the fact that the R52345 
molecule does not contain R1, when expressed from the plasmid, pR52345, it was able to 
complement a csgA mutant and assembles into fibers on the cell surface (Figure 5.1D). 
Similarly, a CsgA analogue in which R5 was replaced by R1 (R12341) was also able to 
assemble fibers on the cell surface (Figure 5.1D). Wild-type curli fibers are SDS 
insoluble and formic acid (FA) treatment is required to dissociate the monomers from the 
fibers (Collinson et al., 1991). Both R52345 and R12341 formed SDS insoluble fibers 
similar to those formed by wild-type CsgA (Figure 5.1E lanes 1, 2, 5, 6, 7 and 8), 
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suggesting that R1 and R5 are functionally redundant in vivo. Just like CsgA, the in vivo 
polymerization of R52345 and R12341 is dependent on CsgB (data not shown). R3 is 
also an amyloidogenic domain in CsgA and the sequence similarity (70%) and identity 
(48%) between R3 and R5 are higher than those between R1 and R5 (52% similarity and 
39% identity). We asked whether R3 can substitute for R1 or R5 in vivo. R32345 was 
somewhat defective in vivo as fewer fibers were observed by TEM from csgA/pR32345 
compared to csgA/pR12341 or csgA/pR52345 (Figure 5.1D). Furthermore R32345 
remained SDS soluble and did not require FA treatment to migrate into the gel (Figure 
5.1E lanes 9 and 10). The phenotype of R12343 was even more dramatic. R12343 was 
not detected by western blotting of the cell pellets but instead was only detected when 
both cells and the underlying agar were collected, suggesting R12343 was stably secreted 
and completely defective in curli assembly (Figure 5.1E lanes 11 and 12). Nearly no 
fibers were produced by csgA/pR12343 when analyzed by TEM (Figure 5.1D). Therefore, 
R3 was not able to substitute for R5 at the C-terminus, and was partially capable of 
replacing R1 at the N-terminus, suggesting the nucleation/seeding response and 
specificity is encoded only by R1 and R5 and not by R3 even though R5 is more similar 
to R3 than R1 at the amino acid level. 
Identification of gatekeeper residues of R3 that inhibit amyloidogenic properties 
My results indicate that common residues found in both R1 and R5 possibly are 
involved in the observed nucleation response and seeding specificity. Alternatively, R3 
should contain specific differences compared to R1 and R5 that make it less 
amyloidogenic than R1 and R5. Guided by this perspective, we compared R3 to R1/R5, 
looking for residues in R3 that were distinctive from both R1 and R5. Four residues were 
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targeted as candidates: Asp136, Arg140, Asp149 and Trp151 in the molecule R12343 (Figure 
5.4A). If these residues hinder the ability of R3 to successfully replace R5, then 
conversion of R12343 to wild-type CsgA in curli assembly could be accomplished by 
changing these residues to those found in either R1 or R5. Constructs pXW56 
(R12343D136N), pXW57 (R12343R140Y), pXW58 (R12343R140V), pXW59 (R12343D149L), 
pXW60 (R12343D149H), pXW61 (R12343W151T) and pXW62 (R12343W151Y) were 
engineered to test this hypothesis (Table 6.1) (Figure 5.4A). Strikingly, R12343D136N, 
R12343D149Land R12343D149H in csgA cells assembled into amyloid-like fibers shown by 
TEM and Congo red binding (Figure 5.4B and data not shown), while other mutant 
proteins such as R12343R140Y, R12343R140V, R12343W151T and 12343W151Y were as 
defective as R12343 in fiber formation in vivo as measured by TEM and Congo red 
binding (data not shown). There were also more SDS insoluble R12343D136N, 
R12343D149L and R12343D149H than SDS soluble forms detected by whole-cell western 
analysis, while other mutants such as R12343R140Y, R12343R140V, R12343W151T and 
12343W151Y remained similar to R12343 (Figure 5.4C). In vitro polymerization of 
R12343D149H was dramatically faster than that of R12343 as measured by previously 
described ThT assay (Figure 5.4D) (Wang et al., 2007).  
An overlay assay was previously constructed in Chapter 3 to test the response of 
CsgA and the CsgA mutant proteins to CsgB-mediated nucleation (Wang et al., 2008). In 
a CsgB-dependent manner, soluble freshly purified CsgA was converted into amyloid 
fibers on the csgA cells expressing CsgB as evidenced by TEM or Congo red staining 
(Wang et al., 2008). When R12343D149H and R12343 at 10 μM were spotted on csgA cells, 
R12343D149H assembled into fibers more readily than R12343 as indicated by stronger 
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Congo red staining (Figure 5.4D, inset). The Asn136 and His149 residues of CsgA are not 
conserved among CsgA homologues from different enteric bacteria (Figure 5.4E) and the 
His149 residue of R12343D149H can be replaced by Arg, Lys or Glu without interfering with 
curli assembly (data not shown). These results suggest Asn136 and His149 residues are not 
essential for fiber formation while Asp residues at positions 136 and 149 in the molecule 
R12343 specifically impede amyloidogenic properties of R3. Therefore, we designated 
Asp residues at positions 91 and 104 in R3 gatekeeper residues because they disrupt 
amyloidogenic properties of R3. The R3 derivative peptide with these Asp residues 
changed to R1-like residues (D4N/D17L) polymerized much faster than R3 peptide, 
supporting the idea that these Asp residues inhibit the intrinsic aggregation of R3 (Figure 
5.5).  
Identification of gatekeeper residues in R2 and R4  
Peptides R2 and R4 have poor amyloidogenic properties and cannot self-assemble 
into amyloid fibers efficiently in vitro (Wang et al., 2007). It is possible that R2 and R4 
also contain gatekeeper residues as in R3 that disrupt their amyloidogenic properties. 
Both R1 and R5 are required for curli assembly and deletion of either R1 or R5 or both 
result in nearly complete loss of fiber assembly in vivo (Wang et al., 2008). R2345 (ΔR1) 
and R1234 (ΔR5) were defective in curli assembly presumably because R2 and R4 
cannot function like R1 or R5. If the potential gatekeeper residues of R2 or R4 were 
mutated, R2345 or R1234 could be capable of assembling amyloid fibers. Guided by this 
perspective, we compared R4 to R1/R5, looking for residues in R4 that were different 
from both R1 and R5. Four residues were targeted as candidates: Thr114, Arg116, Gly123 
and Asp127 in the molecule R1234 (Figure 5.6A). When Gly123 or Asp127 or both were 
 154
mutated to the corresponding residues from R5 (Asn and His, respectively), the in vivo 
amyloidogenesis of R1234 was significantly improved as detected by Congo red binding 
and TEM, suggesting Gly123 and Asp127 are gatekeeper residues in R4 (Figure 5.6). 
Similarly, after Gly55, Asp57 and Gly59 were mutated to the corresponding residues from 
R1 (Ser, Leu and Leu, respectively), mutated R2345 could efficiently assemble into fibers 
as detected by Congo red binding and TEM (Figure 5.7). To test whether these gatekeeper 
residues impede self-polymerization of R2 or R4, we tested self-polymerization of the R4 
derivative peptide with mutations of gatekeeper residues (R4G13N/D17H). When the 
gatekeeper residues were mutated to the corresponding residues from R5, R4G13N/D17H 
polymerized into amyloid fibers much more efficiently compared to original R4 peptide 
as measured by ThT fluorescence and TEM (Figure 5.8 and data not shown). 
Gatekeeper residues are not tolerated in R5 
The five repeating units of CsgA have the consensus sequence 
Ser-X5-Gln-X4-Asn-X5-Gln. Seven gatekeeper residues (Gly78, Asp80, Gly82, Asp91, 
Asp104, Gly123 and Asp127 for E. coli CsgA) found in R2, R3 and R4 were located in the 5 
residues stretches between Ser and Gln or Asn and Gln (Figure 5.4E). R1 and R5 of CsgA 
homologues from different enteric bacteria do not have any Asp or Gly residues in the 
same regions (Figure 5.4E). This observation led us to hypothesize that the existence of 
gatekeeper residues discriminates R2, R3 and R4 from R1 and R5. We introduced Asp 
residues into R5 at positions 136 and 149 of wild-type CsgA and tested the amyloid 
formation properties of this mutant (CsgAN136D/H149D) in vivo. These positions 
corresponded to where Asp residues are found in R3. Like R12343, CsgAN136D/H149D did 
not assemble into amyloid fibers in vivo as detected by whole-cell western analysis and 
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TEM (Figure 5.9). 
CsgA lacking all gatekeeper residues polymerized in the absence of CsgB and CsgF 
in vivo  
All the CsgA homologues from enteric bacteria have gatekeeper residues in R2, 
R3 and R4, suggesting the gatekeeper residues play an important role in CsgA assembly. 
To gain some insight about the roles of gatekeeper residues in bacterial amyloid 
propagation, we constructed a CsgA mutant with all the gatekeeper residues changed to 
the corresponding residues from either R1 or R5 (CsgA G78S/D80L/G82L/D91N/D104L/G123N/D127H), 
called CsgA* (Figure 5.10A) and tested its behavior in curli assembly and 
self-polymerization. CsgB and CsgF are required for efficient curli assembly (Chapman 
et al., 2002; Hammar et al., 1996). CsgB tethered on the cell surface functions as a 
nucleator for CsgA polymerization and deletion of CsgF disrupts CsgB-mediated 
nucleation (Chapman et al., 2002; Hammar et al., 1996). Surprisingly, in the absence of 
CsgB and CsgF, CsgA*-expressing cells contained a deep Congo red staining pattern 
suggesting fiber had been assembled (Figure 5.10B). Western blotting of csgFBA/pCsgA 
cells and the underlying agar showed that CsgA remained SDS soluble in the absence of 
CsgB and CsgF (Figure 5.10C lanes 3 and 4), while CsgA* from csgFBA/pCsgA* cells 
was SDS insoluble (Figure 5.10C lanes 5 and 6). Many of the CsgA* fibers formed in 
csgFBA genetic background were mislocalized and were not tethered with cells as 
detected by TEM, while no fibers were produced by csgFBA/pCsgA cells (Figure 5.10D). 
In both csgBA and csgBF genetic backgrounds, CsgA* also formed SDS insoluble fibers 
and bound Congo red (Figure 5.10B, Figure 5.11 and data not shown). After cells were 
scraped off the plate, the agar plate stained with Congo red suggesting fibers composed of 
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CsgA* were mislocalized (data not shown). Like CsgA, the stability of CsgA* was still 
dependent on CsgG and CsgE. In the absence of CsgG or CsgE, CsgA* was undetectable 
by western blotting of cells and underlying agar and could not bind Congo red (Figure 
5.10B and Figure 5.11). Collectively, secretion of CsgA* is dependent on CsgG and CsgE. 
However, in contrast to CsgA, the polymerization of CsgA* in vivo does not require 
CsgB and CsgF. It is plausible that these gatekeeper residues render CsgA fiber assembly 
under the control of CsgB and CsgF. 
CsgA* polymerized faster than CsgA in vitro and induced expression caused E. coli 
to be less viable  
To understand what biochemical properties distinguish CsgA* from CsgA, we 
tried to purify CsgA and CsgA* and compared their polymerization kinetics in vitro using 
a previously described method (Wang et al., 2007). Wild-type CsgA was found to be 
secreted to the medium by co-overexpressing CsgA and CsgG (Wang et al., 2007). 
Overexpression of full length CsgA* resulted in cell lysis and no CsgA* was secreted to 
medium or associated with cells, which suggested that CsgA* is potentially cytotoxic. We 
took an alternative approach to purify mature CsgA and CsgA*. The expression vector 
containing CsgA or CsgA* lacking the Sec-dependent periplasmic signal sequence was 
transformed into the expression strain NEB C2566. Protein expression was induced by 
IPTG and was purified from cell pellets resuspended in guanidine hydrochloride (see 
Materials and Methods). Freshly purified CsgA polymerization follows a triphasic 
process with a lag, a rapid growth and stationary phase similarly as previously described 
(Wang et al., 2007). The lag phase for CsgA at a concentration higher than 5 μM is 
around ~2 hrs as detected by the ThT assay (Figure 5.12A) (Wang et al., 2007). In 
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contrast to CsgA, CsgA* started polymerization without a clear lag phase and the total 
time interval for its ThT signal to reach stationary phase is much shorter than that of 
CsgA (Figure 5.12A). Like CsgA, CsgA* self-assembled aggregates were ordered 
amyloid-like fibers as evidenced by TEM (data not shown). To carefully study the 
potential cytotoxicity of CsgA-like molecules, we used spotting assay to measure how 
cell viability was influenced by the induced expression of full-length CsgA, CsgA* or 
CsgAslowgo (CsgAQ49A/N54A/Q139A/N144A). CsgAslowgo was previously reported to be 
extremely defective in curli assembly and its self-polymerization has a lag time two 
orders of magnitude greater than that of CsgA polymerization (Wang and Chapman, 
2008). The viability of csgA cells did not change significantly when the expression of 
CsgAslowgo was induced (Figure 5.12B). At relative high IPTG concentration (>50 μM), 
expression of CsgA resulted in less viable cells compared to either CsgAslowgo or empty 
vector control (Figure 5.12B). The induced expression of CsgA* with IPTG at 25 μM 
caused a marked loss of cell viability compared to wild-type CsgA (Figure 5.12B and 
Figure 5.13) and colony forming units of cells expressing CsgA* were around three 
orders of magnitude lower than those of cells expressing CsgA at IPTG concentration 
higher than 25 μM (Figure 5.12B). Expression of CsgA* resulted in decreased viability 
of various E. coli K12 cells such as MC4100, C600 and BW25113 (data not shown). 
 
Discussion 
I previously showed that two repeating units of CsgA (the N- and C-terminal 
repeats) govern the nucleation/seeding response and are critical for fiber assembly (Wang 
et al., 2008). Data presented here identified the specific residues that inhibit 
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amyloidogenic properties of the middle repeats of CsgA. We call these residues 
gatekeeper residues. The gatekeeper residues of CsgA appear to reduce cytotoxicity 
associated with amyloidogenesis by controlling the polymerization kinetics of CsgA. 
When these gatekeepers are mutated CsgA polymerization is accelerated in vitro and 
occurs in vivo without the need for the nucleator protein, CsgB. 
During the disease-associated amyloidogenesis, the rate-limiting step is nucleus 
formation, the initial development of small, metastable oligomers of a protein (Jarrett and 
Lansbury, 1993; Selkoe, 2003). For curli assembly, this step is proposed to be overcome 
in E. coli via a template mediated mechanism where the nucleator protein, CsgB, adopts a 
β-sheet rich secondary structure and propagates the β-sheet rich amyloid fold onto CsgA 
molecules when it comes in contact with at the cell surface (Hammer et al., 2007). The 
nucleation of CsgA by CsgB requires the participation of specific conserved Gln and Asn 
residues in R1 and R5 of CsgA (Wang and Chapman, 2008). The middle repeats, R2, R3 
and R4, also have Gln and Asn residues at these conserved positions, yet they cannot 
respond to CsgB nucleation (Wang et al., 2008). Further, it seems that the 
nucleation/seeding specificity is not simply correlated to sequence similarity or identity 
because similarity and identity between R3 and R5 are higher than those between R1 and 
R5. Using rationally designed mutagenesis, we identified specific Asp and Gly residues 
required for unresponsiveness to CsgB nucleation and defectiveness of self-assembly 
(Figure 5.4-8). The changes of these residues render R2, R3 and R4 both efficient 
self-polymerization and responsiveness to CsgB-mediated nucleation. The intrinsic 
aggregation properties seem correlated to nucleation response, suggesting the 
self-polymerization and nucleated polymerization share common features.  
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Results from several different studies suggest that Pro, Asp and Gly are among the 
residues least likely to be incorporated into a β-sheet structure (Kallberg et al., 2001; 
Street and Mayo, 1999). In general, the residues that potently disrupt β-strand formation, 
such as Pro and Asp, inhibit amyloid formation (Chiti et al., 2003; Soto et al., 1998). It 
was postulated that charged residues and other β breaker residues in globular proteins 
could function as “gatekeeper” residues to prevent amyloid formation (Monsellier and 
Chiti, 2007; Otzen et al., 2000; Thirumalai et al., 2003). Some gatekeeper residues are 
found at the edge β strand (the peripheral β strand) in the native β sheet conformations to 
prevent protein aggregation (Richardson and Richardson, 2002). Since CsgA and CsgB 
are dedicated to form amyloid fibers efficiently, it is not surprising that there is not a 
single Pro residue in the five repeats of CsgA or CsgB from E. coli. What was not 
expected was the finding of somewhat conserved gatekeeper residues located in the 
middle repeats of CsgA homologues from different bacteria (Figure 5.4). Gatekeeper 
residues are not tolerated in end repeats of CsgA which was predicted to be the edge β 
strands (Figure 5.9) (Collinson et al., 1999). In contrast to gatekeepers residues in the 
edge β strand of globular proteins that appear to simply oppose aggregation (Richardson 
and Richardson, 2002), the gatekeeper residues of wild-type CsgA located in the middle 
repeats of CsgA do not completely inhibit CsgA polymerization, since CsgA still can 
self-assemble into amyloid fibers (Wang et al., 2007). The self-polymerization of a CsgA 
mutant lacking all gatekeeper residues (CsgA*) is much faster than CsgA and there is 
almost no lag time before its rapid polymerization (Fig. 4A). This strong aggregation 
propensity of CsgA* resulted in its efficient polymerization in the extracellular 
environment in the absence of CsgB and CsgF (Figure 5.10 and 5.11). Many of the 
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CsgA* fibers assembled in the absence of CsgB were not associated with cells and 
thereby presumably may not help cells to attach the surface. It is plausible that gatekeeper 
residues of CsgA modulate CsgA polymerization efficiency so that its polymerization and 
localization are under the control of CsgB and CsgF. 
It has been previously reported that the efficiency of amyloid formation correlates 
to cytotoxicity and disease development in various models (Hardy and Selkoe, 2002; 
Luheshi et al., 2007; Selkoe, 2003; Van Nostrand et al., 2001). Here, CsgA derivatives 
with distinct polymerization properties showed similar pattern (Figure 5.12B). The 
induced expression of rapidly-polymerizing CsgA* caused cells less viable compared to 
wild-type CsgA (Figure 5.12-13). One possibility is that the existence of gatekeeper 
residues in CsgA decreases the load of aggregated proteins for cellular molecular 
chaperones and dedicated quality control machinery. Alternatively, the toxic properties of 
CsgA* may be distinct from wild-type CsgA. Functional amyloid propagation is a 
balance to maximize polymerization efficiency while minimizing potential cytotoxicity 
associated with amyloidogenesis. The work presented in this chapter demonstrates that 
the absence of gatekeeper residues results in the uncontrolled aggregative properties and 
increased cytotoxicity. Therefore, the primary sequence of wild-type CsgA has been 
shaped by evolution to fit the requirements of both efficient polymerization and control 







Figures and Tables 
Figure 5.1. Seeding/nucleation specificity of CsgA was determined by R1 and R5.  
(A) The schematic of CsgA primary sequence. (B) 8% indicated seeds were added to 
CsgA polymerization. (C) Summary of CsgA and peptides seeding/nucleation specificity. 
Data previously reported were indicated by “*” (Hammer et al., 2007; Wang et al., 2008; 
Wang et al., 2007). (D) Negative-stain EM micrographs of csgA mutant strain containing 
plasmids pR12341, pR52345, pR32345 or pR12343. Scale bars are equal to 500 nm. (E) 
Western blots of whole-cell lysates (top panel) or plugs (whole cells and underlying agar) 
(bottom panel) from csgA mutant cells containing plasmids pCsgA (lanes 1 and 2), Vector 
control (lanes 3 and 4), pR12341 (lanes 5 and 6), pR52345 (lanes 7 and 8), pR32345 
(lanes 9 and 10) or pR12343 (lanes 11 and 12) grown for 48 hours at 26°C on YESCA 
plates. Cells were treated with (+) or without (-) FA prior to electrophoresis as indicated. 









Figure 5.2. CsgBtrunc seeds R1 and R5 polymerization in vitro. (A) 3% by weight 
sonicated CsgBtrunc fibers or buffer were added to freshly prepared 0.5 mg/ml peptide R1 
and mixed with ThT before fluorescence was measured at 438 nm after excitation at 495 
nm. (B) 3% by weight sonicated CsgBtrunc fibers were added to 0.2 mg/ml R5 in 1.0 M 
GdnHCl buffered by 50mM potassium phosphate at pH7.2. Samples were mixed with 































Figure 5.3. Seeding specificity of R1 and R5. (A)-(C) Indicated percentages by weight 
of R1, R3, R5 sonicated fibers and buffer vehicle were added to freshly prepared 1.0 
mg/ml oligopeptide R1 (A), 1.0 mg/ml μM oligopeptide R3 (B) and 17 μM (0.2 mg/ml) 
ΔR1 which contains repeats R2, R3, R4 and R5 (C). The polymerization was measured 



































Figure 5.4. Mutations of Asp residues of C-terminal R3 in R12343 rendered 
amyloidogenic properties. (A) Differences between R3 and R1/R5 amino acid sequence 
are indicated with boxes. Constructs to mutate C-terminal R3 of R12343 are indicated in 
the bottom panel. (B) Negative-stain EM micrographs of csgA cells containing plasmids 
pXW56 (R12343D136N), pXW59 (R12343D149L) and pXW60 (R12343D149H). Cells were 
grown 48 hours at 26°C on YESCA plates. Scale bars are equal to 500 nm. (C) Western 
blots of whole-cell lysates from csgA cells containing constructs pR12343 (lane 1 and 2; 
lane 17 and 18), pXW56 (R12343D136N lane 15 and 16), pXW57 (R12343R140Y lane 3 and 
4), pXW58 (R12343R140V lane 5 and 6), pXW59 (R12343D149L lane 7 and 8), pXW60 
(R12343D149H lane 9 and 10), pXW61(R12343W151T lane 11 and 12) and pXW62 
(R12343W151Y lane 13 and 14) grown 48 hours at 26°C on YESCA plates. Samples were 
treated with (+) or without (-) FA as indicated. The blots were probed with anti-CsgA 
antibody. (D) The polymerization of 20 μM R12343D149H and R12343 measured by ThT 
fluorescence. Congo red staining of csgA (CsgB+) cells overlaid with10 μM and 20 μM 
R12343D149H and R12343 was shown in graph inset. (E) The alignment of five repeating 
units of CsgA from different enteric bacteria. The consensus sequences Ser-X5-Gln and 
Asn-X5-Gln indicated in yellow background were predicted to form β-strands (Collinson 
et al., 1999). The identified gatekeeper residues of CsgA from E. coli are indicated with 
blue boxes. The putative gatekeeper residues of CsgA from other enteric bacteria are 






Figure 5.5. The polymerization of peptide R3 and R3D4N/D17L. The polymerization of 
0.5 mg/ml chemically synthesized peptides R3 and R3 D4N/D17L was measured by ThT 
fluorescence. The changes of amino acid sequence of derivative peptide R3D4N/D17L from 























Figure 5.6. Identification of gatekeeper residues of R4. Mutations of Asp or Gly 
residues of C-terminal R4 in R1234 can restore amyloidogenic properties. (A) 
Differences between R4 and R1/R5 amino acid sequence are indicated with boxes. 
Constructs to mutate R4 of R1234 are indicated in the bottom panel. (B) Congo 
red-YESCA plate with csgA cells transformed with the control vector or plasmids 
encoding CsgA (pCsgA), R1234, R1234T114N, R1234K116T, R1234G123N, R1234D127H or 
R1234G123N/D127H. (C)-(D) Negative-stain EM micrographs of csgA cells containing 
plasmids pR1234 (C) or pR1234G123N/D127H (D). Cells were grown 48 hours at 26°C on 



















Figure 5.7. Identification of gatekeeper residues of R2. Mutations of Asp and Gly 
residues of N-terminal R2 in R2345 can restore amyloidogenic properties. (A) 
Differences between R2 and R1/R5 amino acid sequence are indicated with boxes. 
Constructs to mutate R2 of R2345 are indicated in the bottom panel. (B) Congo red 
YESCA plate with csgA cells transformed with the control vector or plasmids encoding 
CsgA, pR2345, pR2345D44E or pR2345G55S/D57L/G59L. (C)-(D) Negative-stain EM 
micrographs of csgA cells containing plasmids pR2345 (C) or pR2345G55S/D57L/G59L (D). 

















Figure 5.8. The polymerization of peptide R4 and R4G13N/D17H. The polymerization of 
0.2 mg/ml chemically synthesized peptides R4 and R4G13N/D17H was measured by ThT 
fluorescence. The changes of amino acid sequence of derivative peptide R4 G13N/D17H from 























Figure 5.9. Gatekeeper residues can disrupt R5 amyloidogenic properties. (A) 
Western blots of whole-cell lysates from csgA cells containing constructs pCsgA (lane 1 
and 2), Control vector (lane 3 and 4) and pCsgAN136D/H149D (lane 5 and 6) grown 48 hours 
at 26°C on YESCA plates. Samples were treated with (+) or without (-) FA as indicated. 
The blots were probed with anti-CsgA antibody. (B)-(C) Negative-stain EM micrographs 
of csgA cells containing plasmids pCsgA (B) or pCsgAN136D/H149D (C). Cells were grown 



















Figure 5.10. In vivo polymerization of CsgA* is independent of nucleator CsgB and 
CsgF. (A) Seven gatekeeper residues were changed to R1/R5-like residues (indicated 
above the CsgA sequence) in CsgA*. (B) CR-YESCA plate with csgA, csgFBA, csgG, 
csgFB, csgE cells transformed with the plasmids encoding CsgA or CsgA*. Cells were 
grown 48 hours at 26°C on YESCA plates. (C) Western blot of whole cells and 
underlying agar (agar plugs) from csgFBA cells containing control vector (lanes 1 and 2) 
or pCsgA (lanes 3 and 4) or pCsgA* (lanes 5 and 6). Samples were treated with (+) or 
without (-) FA as indicated. The blots were probed with anti-CsgA antibody. (D) 
Negative-stain EM micrographs of csgFBA cells containing plasmids pCsgA or pCsgA*. 





























Figure 5.11. Western analysis of CsgA and CsgA* in different curli specific gene 
deletion backgrounds. Western blot of whole cells and underlying agar (agar plugs) 
from csgA csgBA, csgG and csgE cells containing pCsgA or pCsgA*. The blots were 
probed with anti-CsgA antibody. Lanes 1 and 2 contain csgA/pCsgA cells and lanes 3 and 
4 contains csgA/pCsgA*; lanes 5 and 6 contain csgBA/pCsgA cells and lanes 7 and 8 
contain csgBA/pCsgA* cells; lanes 9 and 10 contain csgG/pCsgA* and lanes 11 and 12 
contain csgE/pCsgA*. Samples were treated with (+) or without (-) FA as indicated. The 




























Figure 5.12. In vitro polymerization of CsgA* is faster than CsgA and induced 
expression of CsgA* cause cells less viable. (A) The polymerization of CsgA and 
CsgA* at 7 μM was measured by ThT fluorescence. (B) Normalized cell suspensions of 
csgA containing empty vector or plasmids encoding CsgAslowgo, CsgA or CsgA* were 
spotted on LB chloramphenicol plates in the presence of IPTG at various concentrations. 
















Figure 5.13. Spotting assay of cells with the induced expression of CsgA, CsgAslowgo 
or CsgA*. LSR10 cells freshly transformed with pNH3, pCsgAslowgoTRC, pMC3 or 
pCsgA*TRC were scraped off from the plates and normalized by absorbance at 600 nm. 
Cell suspensions with serial dilutions were spotted on the LB plates supplemented with 
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Conclusions and Future Directions  
Conclusions 
Amyloid propagation underlies diverse mammalian ailments such as Alzheimer’s 
disease, systemic amyloidosis, bovine spongiform encephalopathy (mad cow disease) and 
Creutzfeldt-Jacob disease (Chiti and Dobson, 2006). The product of protein misfolding, 
disease-associated amyloid formation can be erratic and apparently uncontrolled. 
Certainly, the physiological and physical constraints on disease-associated 
amyloidogenesis are poorly described and understood. This is due, in part, to the sporadic 
nature of in vivo amyloid model systems. However, certain organisms have developed the 
ability to faithfully direct amyloid formation temporally and spatially (Fowler et al., 2007; 
Hammer et al., 2008; Shorter and Lindquist, 2005). These “functional amyloids” are not 
toxic to the organism that produces them, but instead fulfill a variety of important 
physiological roles (Fowler et al., 2007; Hammer et al., 2008; Shorter and Lindquist, 
2005). Functional amyloids have been described in bacteria, fungi and mammals (Fowler 
et al., 2007; Hammer et al., 2008). Because functional amyloid formation can be a tightly 
controlled process, these biogenesis systems represent a unique platform from which to 
better understand amyloidogenesis and the cellular toxicity associated with it.  
The functional amyloid studied in this thesis is curli, bacterially produced 
extracellular fibers required for biofilm and other community behaviors (Barnhart and 
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Chapman, 2006). Curli fibers are composed of a major subunit, CsgA, and minor subunit, 
CsgB. Curli assembly is initiated by the CsgB nucleator protein, which is proposed to 
provide an amyloid template to CsgA on the cell surface (Hammer et al., 2007). Curli 
formation in E. coli requires a specific secretion machinery that directs curli subunits to 
the cell surface and prevents their polymerization inside the cell (Barnhart and Chapman, 
2006; Chapman et al., 2002; Robinson et al., 2006). This thesis work has been aimed at 
understanding the molecular details of CsgA polymerization and nucleation.  
Bacterial Amyloid Formation is a conserved folding pathway 
The final product of bacterial amyloid curli has been previously demonstrated to 
be biochemically similar to disease-associated amyloids (Chapman et al., 2002). Part of 
my thesis work was to determine how the polymerization of functional amyloids 
compared with that of disease-associated amyloids. The polymerization processes of 
many disease-associated amyloids share common features. Disease-associated amyloid 
propagation in vitro follows a nucleation-dependent process in which nucleus formation 
is the rate-limiting step (Jarrett and Lansbury, 1993). A common intermediate of many 
disease-associated amyloids during the lag phase of polymerization can be detected by a 
conformational specific antibody, A11 (Kayed et al., 2003). CsgA in vitro polymerization 
was shown to have similar properties to those of disease-associated amyloids in Chapter 
2. CsgA polymerization is a triphasic process as measured by ThT assay and preformed 
CsgA fibers can eliminate the lag phase. The lag phase of CsgA polymerization is 
independent of its concentration when CsgA concentration is higher than 4 μM, 
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reminiscent of in vitro polymerization of IAPP. Moreover, A11 antibody can recognize 
the transient form during CsgA lag phase. All these results suggest that not only the final 
amyloid fibers are conserved, but in vitro amyloidogenesis is also conserved between 
functional and disease-associated amyloids. This supports the notion that 
amyloidogenesis is an inherent property of polypeptides and assembly of these fibers is 
also common process. The self-seeding of CsgA also suggests that self-propagation is not 
only the critical step of disease-associated amyloidogenesis but also may play an 
important role in fiber assembly.           
Bacterial amyloid nucleation was controlled by N- and C-terminal repeats of CsgA 
At the cell surface, CsgA is secreted as a soluble, unstructured protein that is 
converted to an amyloid fiber in a CsgB-dependent fashion (Hammar et al., 1996). In 
vitro, certain CsgB truncation mutants readily assemble into amyloid, which suggested 
that CsgB might initiate in vivo CsgA amyloid formation in a mechanism akin to seeding 
(Hammer et al., 2007). To directly demonstrate that cell-associated wild-type CsgB 
accelerates CsgA polymerization, I performed overlay assays using purified CsgA protein 
and proved that CsgB on the cell surface could promote CsgA polymerization. Preformed 
CsgA amyloids also promote CsgA polymerization as shown in Chapter 2, demonstrating 
CsgA responds to self-seeding and CsgB nucleation. To explore the mechanistic details of 
CsgA polymerization into an amyloid, I extensively analyzed the sequence determinants 
for curli assembly using a powerful blend of genetic and biochemical approaches.   
The CsgA amino acid sequence can be divided into three domains, an N-terminal 
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Sec signal sequence (cleaved after secretion through the inner membrane), an N-terminal 
22 residues involved in secretion through the outer membrane and five imperfect 
repeating units (R1, R2, R3, R4 and R5) that comprise the protease-resistant amyloid core. 
I showed that peptides representing R1, R3 and R5 are amyloidogenic in vitro in Chapter 
2. I showed Peptides corresponding to R1 and R5 responsive to CsgA seeding and CsgB 
nucleation in Chapter 3. Moreover, deletion of R1, R5, or both R1 and R5 resulted in a 
molecule that no longer polymerized in vivo. A mutant CsgA molecule missing R1 and 
R5 (ΔR1&R5) was completely incapable of being nucleated by CsgB or being seeded by 
preformed CsgA fibers. From this analysis, I proposed a simple model of curli assembly 
in Chapter 3. After secretion across the outer membrane, the R1 and R5 regions of CsgA 
would interact with either membrane-associated CsgB, or CsgA fiber tips, which template 
a conformational change in CsgA so that it now adopts an amyloid form (Figure 3.10). 
The redundancy of seeding/nucleation responsive domains would make curli assembly a 
highly efficient process. 
Remarkably stringent requirements of specific side-chain interactions for curli 
assembly  
Many proteins, if not all, can assemble into amyloid-like fibers in vitro, which has 
lead to the suggestion that amyloid formation is an inherent property of polypeptides 
(Chiti and Dobson, 2006). Clearly, though, the chemical nature of particular side chains 
in the polypeptide can influence fiber assembly (Chiti and Dobson, 2006). However, the 
specific role of side-chain interactions during amyloid formation remains poorly 
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described. I addressed this question in Chapter 4 by dissecting the internally conserved 
residues in the CsgA repeating units which are predicted to form cross-beta structure 
(Collinson et al., 1999). The consensus sequence (Ser-X5-Gln-X4-Asn-X5-Gln) is found 
in each CsgA imperfect repeating unit. The high degree of the conservation of these polar 
residues suggests their potential important role in curli assembly. To explore the specific 
roles of side chains in curli assembly, I analyzed the contribution of conserved polar 
residues such as Ser, Gln and Asn residues and all the aromatic residues by Ala 
substitutions. I identified four critical residues, Gln and Asn residues at positions 49, 54, 
139 and 144 (Figure 4.1). These results also support the importance of N- and C-terminal 
repeats in curli assembly as shown in Chapter 3. Ala substitutions of these four residues 
resulted in a complete loss to CsgB nucleation and an extremely long lag time before 
fiber formation is initiated, suggesting these four polar side chains contribute to CsgB 
nucleation response and self-polymerization. Surprisingly, Gln residues at position 49 and 
139 cannot even be replaced by Asn residues without interfering with curli assembly. 
CsgAQ49N is defective in CsgB nucleation response and self-assembly compared to 
wild-type CsgA. My findings suggest interaction of CsgA to itself and to CsgB is tightly 
controlled by very specific side-chain contacts and these important side chains are located 
in R1 and R5 of CsgA. In addition, I found wild-type CsgA fibers still was able to seed 
the CsgA mutant with all four critical polar side chains abolished, suggesting CsgA fiber 
seeding and CsgB nucleation have distinguishable mechanisms. It is plausible that fiber 
mediated seeding is not dependent on polar side chains, whereas the CsgB nucleation 
 185
requires the participation of polar side chains. All aromatic residues of CsgA do not 
positively contribute curli assembly. Maintenance and formation of native globular 
structures depends on specific side-chain contacts. My work in Chapter 4 demonstrates 
that the formation of amyloid structure of CsgA also depends on specific side-chain 
interactions. These side-chain interactions between CsgA-CsgA and CsgA-CsgB allow 
bacterial amyloid propagation to occur at the correct time and correct location.  
Gatekeeper residues of CsgA exquisitely modulate its polymerization  
 R1 and R5 constitute the nucleation and seeding responsive regions of CsgA. 
Although the sequence similarity and identity between of R3 and R5 are higher than 
those between R1 and R5, R3 cannot replace R1 or R5 without interfering with curli 
assembly as shown in Chapter 5. This suggests that the nucleation/seeding specificity is 
not simply correlated to sequence similarity or identity. The critical Gln and Asn residues 
are also present in all five repeats, indicating this specificity is not determined by 
internally conserved Gln and Asn residues. The molecular determinants of this specificity 
will be an important step to understand how nature evolved this elegant amyloid 
propagation system. I extensively investigated the sequence determinants of CsgA for 
nucleation specificity and self-polymerization in Chapter 5. I found that there are 
gatekeeper residues in R2, R3 and R4. If these gatekeeper residues were mutated, R2, R3 
and R4 became similar as R1 and R5 in terms of intrinsic amyloidogenic properties and 
nucleation responsiveness. Moreover, I found that gatekeeper residues are not present in 
R1 and R5 and not tolerated in R5. The presence of gatekeeper residues distinguishes 
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repeats R2, R3 and R4 from amyloidogenic repeats R1 and R5. Since CsgA is dedicated 
for amyloid assembly, it is surprising to find the presence of gatekeeper residues in CsgA. 
I proposed that these gatekeeper residues potentially provide an exquisite way to 
modulate CsgA amyloidogenesis in vivo. Without these gatekeeper residues, CsgA 
polymerizes into fibers in extacellular space independent of CsgB and CsgF due to its 
extremely aggregative properties. In addition, the induced expression of CsgA molecule 
without gatekeeper residues has more significant toxicity than the expression of wild-type 
CsgA. It seems that the primary sequence of CsgA is shaped by evolution to fit the 




In this thesis I extensively explore the determinants for CsgA polymerization and 
nucleation. One of my most exciting discoveries is that nature uses gatekeeper residues to 
exquisitely modulate functional amyloid propagation and reduce the cytotoxicity. It 
seems the curli assembly is a balance between polymerization efficiency and control by 
curli assembling factors. Some interesting questions remain to be answered in the near 
future. 
Without gatekeeper residues, CsgA mutant, CsgA*, was shown to polymerize into 
amyloid fibers faster than wild-type CsgA. It is worth comparing the kinetic details of 
CsgA and CsgA* to understand how CsgA* overcomes the nucleation step common for 
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most amyloid propagation. Is CsgA* polymerization a downhill reaction instead of a 
nucleation dependent mechanism? By studying the kinetic details of CsgA* 
polymerization, we will gain some insights of the molecular details of lag phase, which is 
the rate-limiting step for amyloid propagation. How the efficient polymerization of 
CsgA* causes E. coli less viable is also an intriguing question. CsgA* may stuck in the 
periplasmic space or interfere with essential cellular process. We can test whether CsgA* 
exist in the periplasm extraction after induction by western blotting. It is also possible 
that there are CsgA-specific chaperones or degradation machines that cannot cope with 
CsgA* due to its uncontrolled polymerization. Chaperones or proteins that help cells to 
overcome cytotoxicity caused by expression of CsgA* can be identified by a genetic 
screen to look for more viable E. coli cells coexpressing two plasmids containing the 
sequences of a E. coli genomic library and CsgA* sequence, respectively. It is possible to 
identify the detoxifying machines for amyloid propagation in E. coli. 
The gatekeeper residue appears to oppose aggregation in some globular proteins 
(Monsellier and Chiti, 2007; Richardson and Richardson, 2002). The gatekeeper residues 
in the middle region of CsgA modulate functional amyloid propagation. It is possible that 
other functional amyloids also have gatekeeper residues to control their propagation. The 
gatekeeper residues such as Gly and Asp of CsgA are located in the five-residues 
stretches between Ser and Gln or between Asn and Gln in the consensus sequence 
Ser-X5-Gln-X4-Asn-X5-Gln. CsgB has a similar repeated primary structure with a 
consensus sequence X6-Gln-X4-Asn-X5-Gln. Interestingly, CsgB also has Gly and Asp 
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residues located in the six-residues stretches before the conserved Gln and five-residues 
stretches between Asn and Gln. Whether these putative gatekeeper residues play a role in 
the nucleation function of CsgB is worth investigation. It is also exciting to perform an 
extensive survey to identity the gatekeeper residues in other functional amyloid proteins 
and their potential roles in regulating amyloidogensis.  
Even though my mutagenesis work elucidates the sequence determinants of CsgA 
nucleation and polymerization, the exact the arrangement of β strands in CsgA fibrils 
remains elusive. My data showed that the fibers formed by different CsgA mutants have 
different SDS solubility suggesting the different structural details. The X-ray diffraction 
and atomic force microscopy were successfully used to reveal the structural features of 
different amyloid fibers and strength (Serpell et al., 1999; Smith et al., 2006). We can 
take these approaches to further elucidate the structural differences and their influence to 
nucleation response and fiber strength.  
ThT was convenient to trace the polymerization of CsgA and its mutants. But ThT 
binding sites on amyloids are unclear and ThT assay did not provide useful information 
in the early polymerization process. To better understand CsgA polymerization and its 
interplay with other curli assembling factors such as CsgB, CsgF and CsgE, more 
sensitive biophysical assays should be constructed such as light scattering and 
fluorescence correlation spectroscopy. To achieve this goal, I constructed a series of 
CsgA mutants with Cys residues inserted at various locations that can be labeled by 
thio-reactive fluorescence dyes. I found CsgAQ150C is wild-type like in vivo and it 
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self-assembles into amyloid fibers in vitro with less efficiency (data not shown). 
CsgAQ150C is able to respond CsgB nucleation and CsgA seeding (data not shown). This 
mutant is a useful candidate to start studying the early event of CsgA assembly and the 
interaction with other interaction partners by specifically labeling cysteine residue at 
position 150.  
      It was reported that seeding effects are strongly influenced by sequence similarity 
between seeds and soluble amyloid proteins (Chien et al., 2003; Krebs et al., 2004; 
O'Nuallain et al., 2004). For yeast prions, cross-species transmission was determined by 
amino acid sequence and conformations of prion proteins (Tanaka et al., 2005). Prion 
conversion, including mammal and yeast prions, requires a very high level of identity of 
the interacting protein sequences (Chen et al., 2007; Prusiner, 1998). In contrast to prion 
proteins, R1 and R5 constitute the critical seeding/nucleation regions of CsgA, although 
they share only 39% sequence identity between them. In addition, CsgB shares less than 
30% sequence identity to CsgA, and it can nucleate CsgA polymerization. The somewhat 
relaxed requirement of sequence identity for cross-seeding and nucleation in curli 
biogenesis may have important physiological consequences. It was reported that 
amyloid-like structures are very abundant in natural biofilms comprising different 
bacterial species (Larsen et al., 2007). Since the nucleated propagation occurs on the cell 
surface, bacterial cross-species nucleated amyloidogenesis might happen. Salmonella 
typhimurium csgA and csgB genes can complement Escherichia coli csgA and csgB 
mutations in terms of positive Congo red binding, indicating amyloid-like structure 
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formed on the cell surface (Figure 6.1A) (Romling et al., 1998). Like E. coli csgA, S. 
typhimurium CsgA formed SDS-insoluble, fibrous structures in E. coli ΔcsgA cells with 
the plasmid encoding S. typhimurium CsgA as detected by western analysis and electron 
microscopy (Figure 6.1B and data not shown). Presumably, E. coli CsgB converts soluble 
S. typhimurium CsgA to the amyloid conformation. This cross-species nucleation 
promiscuity supports the possibility that the CsgA-like molecules of one bacterial species 
could interact with the CsgB-like molecules of another bacterial species, facilitating the 
building of complicated matrixes covering bacterial communities (Figure 6.1C). The 
study of cross-species nucleation in bacteria could be interesting. 
       Cross seeding between bacterial amyloids and disease-associated amyloids may 
have pathological relevance. It has been shown that curli can bind a lot of host cell 
proteins including MHC-I molecules such as β2-microglobulin (Olsen et al., 1998). 
β2-microglobulin has been implicated in hemodialysis-related amyloidosis. Can curli 
promote the polymerization β2-microglobulin since they can physically interact with each 
other? It has been shown that natural fibrils such as curli could enhance the AA 
amyloidosis in mice model (Lundmark et al., 2005). Moreover, it was reported that the 
isolated E. coli associated with sudden infant death syndrome were curliated and the sera 
from the dead infant has certain amount of CsgA by immunoblotting (Goldwater and 
Bettelheim, 2002). The possible pathological role of bacterial amyloids remains 
unanswered. 
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Figure 6.1. Salmonella typhimurium CsgA responds to Escherichia coli CsgB in 
E.coli ΔcsgA cells and assembles into curli.  
(A) The YESCA plates supplemented with Congo red dye with E.coli ΔcsgA cells 
transformed with vector control or plasmids encoding E.coli CsgA or S. typhimurium 
CsgA. Cells were grown for 48 hrs at 26 °C. (B) The western blot of E.coli ΔcsgA cells 
transformed with vector control (lanes 3 and 4) or plasmids encoding E. coli CsgA (lanes 
1 and 2) or S. typhimurium CsgA (lanes 5 and 6). Samples were treated with (+) or 
without (-) formic acid (FA) to depolymerize the polymers. The blot was probed with 
anti-CsgA antibody. (C) Schematic shows cross nucleation and polymerization occurring 
between different bacterial species in the same environment. CsgA molecules secreted 
from species I (indicated in blue) interact with CsgB of Species II (indicated in red), 
undergo a conformation change and assemble into hybrid fibers (indicated in orange). 
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